Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3015322	s-alfa-1	g/l (g/l)	11317	25790	0.00%
3015322	s-alfa-1	— (—)	1972	2602	100.00%	Distribution not available
3015322	s-alfa-1-fraktio	g/l (g/l)	1155	2356	0.00%
3015322	alfa1-glob	g/l (g/l)	708	2811	0.00%
3015322	s-alfa-1	g/l_______ (g/l)	619	1918	0.00%
3015322	alfa-1	g/l (g/l)	436	903	0.00%
3015322	s-a1glob	g/l (g/l)	411	877	0.00%
3015322	s-alfa-1-fraktio	g/l_______ (g/l)	312	693	0.00%
3015322	alfa-1-glo	g/l (g/l)	84	95	0.00%
3015322	s-alfa1-globuliini(valetietues-prot-fr)	g/l (g/l)	60	82	0.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Codeine

3041

7434

2.27

320.18

2.2

2.0

2.88

2.83

g/l

1.67

2798

6731

Heart failure and antihypertensive medication

1121

1952

3.98

319.89

2.3

2.6

3.11

2.80

g/l

15.20

1041

1766

Erysipelas, including avohilmo

2832

9566

2.27

319.53

2.3

2.1

3.07

2.78

g/l

38.65

2605

8606

Nutritional anaemias

2273

9263

2.46

317.26

2.2

2.4

3.04

2.90

g/l

8.19

2042

8302

Asthma, unspecified (mode), excluding more controls

1869

5023

2.76

316.07

2.2

1.9

2.95

2.78

g/l

10.46

1728

4551

Abnormal findings on examination of blood, without diagnosis

2196

8400

2.49

312.10

2.8

2.4

2.99

2.88

g/l

5.23

2035

7625

Other and unspecified iron deficiency

1674

6285

2.82

310.37

2.1

2.4

3.06

2.89

g/l

8.19

1503

5613

Aplastic and other anaemias

3348

7962

4.28

307.65

2.6

2.3

2.99

2.91

g/l

3.73

3068

7075

Unspecified kidney failure

789

1683

5.40

307.65

2.7

2.2

3.15

2.92

g/l

7.51

739

1482

Renal failure

3648

7704

4.53

307.65

2.6

2.3

3.04

2.89

g/l

13.42

3405

6805

All chronic kidney diseases

3686

7325

4.40

307.65

2.5

2.3

2.99

2.85

g/l

11.82

3453

6544

Polyneuropathies and other disorders of the peripheral nervous system

1775

3997

5.16

307.65

2.5

2.4

2.60

2.95

g/l

41.51

1628

3600

Heart failure,strict

2426

6945

2.57

307.65

2.3

2.4

3.10

2.83

g/l

29.30

2223

6218

Primary_lymphoid and hematopoietic malignant neoplasms

2038

4315

5.53

307.65

8.8

1.4

2.81

2.92

g/l

4.90

1968

3835

ILD medications: immunosuppressive drugs

3365

8143

4.00

307.65

4.7

1.7

2.99

2.81

g/l

18.66

3187

7338

Other anaemias

3209

7612

4.41

307.65

2.6

2.3

2.99

2.91

g/l

3.46

2942

6753

Examination and observation for other reasons

2393

4552

3.09

307.65

2.5

2.2

3.00

2.98

g/l

0.39

2220

4174

Infections, IBD-co-morbidities

651

680

7.16

307.65

4.3

2.2

2.95

2.94

g/l

0.04

603

621

Condition for Implicit Sepsis (Organ dysfunction codes)

3554

10164

2.52

307.65

2.5

2.2

2.98

2.84

g/l

11.65

3229

9253

Bacterial Sepsis

2503

7523

2.93

307.65

3.1

2.2

3.14

2.86

g/l

28.70

2265

6763

Inflammatory bowel disease treatment related agents

4501

10378

2.49

307.65

2.2

2.4

2.99

2.82

g/l

19.09

4166

9353

Heart failure, not strict

3545

8816

2.86

307.65

2.6

2.3

3.04

2.81

g/l

27.41

3261

7970

ILD medications: prednisolone, methylprednisolone, prednisone

4512

8989

2.91

307.65

2.3

1.7

2.99

2.82

g/l

19.56

4166

8063

Anaemias

1089

623

12.06

307.65

2.4

1.2

2.93

2.69

g/l

6.05

1039

578

Oedema, not elsewhere classified

1507

4938

3.16

307.65

2.3

2.2

2.98

2.85

g/l

4.79

1365

4425

Pneumonia, organism unspecified

3552

10745

2.35

307.65

3.1

2.0

3.07

2.81

g/l

35.62

3266

9745

Dialysis, with operation codes

881

1787

5.67

307.65

4.0

2.2

3.20

2.86

g/l

16.10

836

1617

Implicit bacterial Sepsis

2240

7007

2.93

307.65

2.9

2.2

3.14

2.86

g/l

25.45

2026

6277

ILD medications

4716

9018

2.94

307.65

3.1

1.7

2.96

2.82

g/l

14.36

4371

8092

Second line medication for Crohn's disease

2707

9582

2.99

307.65

5.4

1.7

2.99

2.85

g/l

8.63

2554

8711

Gout

1548

4335

3.31

307.65

3.2

2.5

3.09

2.89

g/l

9.94

1442

3894

Fever of other and unknown origin

2564

7019

3.33

307.65

4.0

2.1

3.13

2.82

g/l

31.68

2383

6350

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

3724

11346

2.26

307.65

3.1

2.0

3.06

2.81

g/l

35.10

3435

10299

Liquid cancers

2413

5068

5.17

307.65

7.7

1.4

2.83

2.90

g/l

2.31

2308

4498

Metabolic disorders

3541

9390

2.34

307.65

2.4

2.2

2.93

2.86

g/l

3.19

3256

8507

Implicit Sepsis

3495

10001

2.70

307.65

2.5

2.2

3.01

2.84

g/l

16.86

3164

9070

Multiple myeloma, including Hilmo

854

697

22.09

307.65

17.1

1.4

2.55

2.97

g/l

19.03

840

611

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

5683

9854

4.18

307.65

2.6

2.2

2.95

2.84

g/l

10.39

5259

8879

L04AX Other immunosuppressants

2673

9378

3.02

307.65

5.4

1.7

2.99

2.85

g/l

8.41

2522

8526

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

561

430

25.07

307.65

20.4

1.5

2.54

3.02

g/l

14.64

552

370

Implicit bacterial Sepsis, including avohilmo

2440

7417

2.92

307.65

2.8

2.2

3.13

2.86

g/l

27.59

2206

6662

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

712

1311

6.61

307.65

3.5

2.3

3.13

2.95

g/l

3.20

658

1164

Multiple myeloma and malignant plasma cell neoplasms

861

808

18.69

307.65

17.0

1.6

2.54

3.01

g/l

23.16

846

717

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

1039

737

28.86

307.65

7.7

1.3

2.60

2.95

g/l

14.03

977

647

Liquid cancers, including Hilmo

2566

5773

4.38

307.65

7.4

1.4

2.82

2.89

g/l

2.55

2448

5132

First line medication for Crohn's disease

4311

8905

2.70

307.65

3.1

1.6

2.96

2.81

g/l

13.84

4013

7991

Pneumonias (Asthma/COPD co-morbidities)

3770

11212

2.27

307.65

3.2

2.0

3.05

2.81

g/l

33.49

3485

10173

Other systemic involvement of connective tissue (FG)

1480

3712

4.27

307.65

1.9

2.6

3.06

2.84

g/l

10.70

1349

3297

Chronic kidney disease

2671

5674

5.20

307.65

2.4

2.3

2.98

2.89

g/l

4.33

2505

4980

Other systemic involvement of connective tissue

1508

4764

3.43

307.65

1.9

2.4

3.06

2.89

g/l

7.12

1376

4264

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

3599

9872

2.56

307.65

2.4

2.2

2.95

2.83

g/l

8.63

3283

9007

Glomerular diseases

1155

2984

4.33

307.65

2.9

2.3

2.96

2.89

g/l

1.64

1093

2721

Bacterial infection, other or unspecified, including avohilmo

3138

8736

3.14

307.65

3.4

2.1

3.22

2.79

g/l

73.82

2890

7815

Systemic connective tissue disorders

1986

6178

3.49

307.65

2.0

2.4

3.12

2.88

g/l

17.42

1820

5519

Osteopathies and chondropathies

2525

9561

2.53

307.65

3.1

2.2

2.93

2.89

g/l

1.16

2242

8658

Other and unspecified anaemias

3195

7558

4.44

307.65

2.6

2.3

2.99

2.91

g/l

3.26

2929

6701

3366

8785

2.31

307.65

3.1

1.9

3.04

2.82

g/l

24.46

3116

7954

Bacterial infection, other or unspecified

2941

8389

3.16

307.65

3.5

2.1

3.24

2.80

g/l

72.22

2703

7490

Autoimmune diseases excluding thyroid diseases

3906

9554

2.29

307.65

2.1

2.5

2.96

2.86

g/l

6.05

3633

8629

Influenza and pneumonia

3849

10967

2.23

307.65

3.1

2.0

3.02

2.81

g/l

28.15

3559

9958

Glomerular disorders in diseases classified elsewhere

805

1869

4.92

307.65

2.9

2.3

2.97

2.92

g/l

0.64

761

1705

Finngen Rheumatological endpoints

3192

8128

2.29

307.65

2.2

2.4

2.94

2.81

g/l

9.61

2949

7401

Other bacterial diseases

4183

10701

2.71

307.65

3.0

2.1

3.11

2.78

g/l

61.48

3869

9665

Autoimmune diseases excluding thyroid diseases, strict definition

3770

9220

2.29

307.65

2.1

2.5

2.96

2.86

g/l

5.93

3507

8321

Renal tubulo-interstitial diseases

4461

10446

3.32

307.65

2.5

2.3

3.01

2.83

g/l

23.45

4112

9437

Other soft tissue disorders, not elsewhere classified

3459

8747

2.32

307.65

2.3

2.4

2.87

2.91

g/l

1.14

3198

7913

Other bacterial diseases, including avohilmo

4207

10285

2.66

307.65

2.9

2.0

3.08

2.77

g/l

56.79

3899

9285

Polyarthropathies

3098

6702

3.12

307.65

2.5

2.4

3.07

2.86

g/l

20.15

2889

6094

Other and unspecified polyneuropathies, also in other diseases

1650

3528

5.52

307.65

2.2

2.4

2.59

2.95

g/l

38.15

1510

3175

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

3366

8785

2.31

307.65

3.1

1.9

3.04

2.82

g/l

24.46

3116

7954

Acute renal failure

1489

3883

4.28

307.65

2.9

2.3

3.18

2.89

g/l

18.82

1390

3430

All pneumoniae

3783

11228

2.26

307.65

3.1

2.0

3.05

2.81

g/l

33.53

3500

10189

Tramadol

3225

7276

2.78

307.65

2.4

2.0

2.97

2.83

g/l

10.29

2963

6580

Oral corticosteroids

4403

10316

2.60

307.65

2.2

2.4

2.99

2.82

g/l

18.78

4085

9295

Multiple myeloma

561

430

25.07

307.65

20.4

1.5

2.54

3.02

g/l

14.64

552

370

All kidney diseases

4591

10188

3.18

307.65

2.4

2.3

2.97

2.83

g/l

15.04

4256

9209

Implicit Sepsis, including avohilmo

3616

10212

2.64

307.65

2.5

2.2

2.99

2.84

g/l

13.74

3272

9295

Malaise and fatigue

2413

6373

3.14

307.65

2.3

2.2

3.02

2.83

g/l

13.74

2175

5741

Pain in limb

3235

8663

2.46

307.65

2.3

2.4

2.90

2.91

g/l

0.13

2982

7839

General symptoms and signs

3673

7725

2.45

307.65

2.5

2.1

2.93

2.82

g/l

7.53

3392

7019

Iron deficiency anaemia

1991

8030

2.56

305.12

2.1

2.4

3.05

2.90

g/l

7.62

1781

7197

Persons encountering health services for specific procedures and health care

3627

10716

2.05

302.85

2.7

2.1

2.91

2.87

g/l

1.73

3372

9693

Other heart diseases

1387

2925

3.19

294.22

2.5

2.1

2.96

2.75

g/l

9.81

1304

2699

Gout, FINNGEN

1548

5756

2.87

291.45

3.2

2.4

3.09

2.86

g/l

14.04

1442

5144

Nephropathy related operations

785

1954

4.55

290.46

4.0

2.3

3.20

2.90

g/l

12.40

749

1780

Explicit Sepsis, including avohilmo

1971

7488

2.50

284.18

3.2

2.2

3.12

2.85

g/l

21.54

1791

6745

Disorders of lipoprotein metabolism and other lipidaemias

3040

8912

2.14

284.05

2.4

2.3

2.94

2.86

g/l

3.47

2788

8055

Implicit viral Sepsis, including avohilmo

1459

5388

2.87

279.11

2.8

2.2

3.01

2.86

g/l

6.41

1328

4831

Heart failure, strict

2648

8631

2.24

278.08

2.3

2.5

3.11

2.86

g/l

26.01

2420

7713

Explicit Sepsis

1933

7395

2.49

277.66

3.3

2.2

3.12

2.85

g/l

20.71

1757

6658

Septicaemia

1889

7170

2.52

277.13

3.3

2.1

3.12

2.80

g/l

27.09

1715

6389

Care involving dialysis

579

1179

5.71

276.54

2.6

2.1

3.15

2.88

g/l

7.15

548

1077

Asthma, unspecified (mode)

1939

5734

2.53

276.01

2.2

1.9

2.95

2.80

g/l

8.25

1787

5185

Osteoporosis

1430

4816

2.94

275.98

2.3

2.2

2.91

2.94

g/l

0.48

1226

4261

Pure hypercholesterolaemia

2844

8658

2.16

273.04

2.3

2.94

2.87

g/l

3.35

2611

7812

Dental caries

1160

3590

3.23

271.99

4.0

2.1

3.03

2.91

g/l

3.18

1074

3282

Autoimmune diseases related-to ILD

3039

12777

2.04

270.45

2.1

2.4

3.04

2.85

g/l

18.21

2813

11560

Opioids

3011

7467

2.13

270.08

2.5

2.0

2.92

2.83

g/l

4.32

2780

6762

Medical observation and evaluation for suspected diseases and conditions

2158

4595

2.47

268.29

2.4

2.2

2.84

2.98

g/l

7.37

1941

4207

Codeine or tramadol medication

3811

10977

1.93

264.73

2.2

2.3

2.89

2.88

g/l

0.30

3502

9936

All-cause Heart Failure

2584

8525

2.21

263.76

2.3

2.5

3.10

2.86

g/l

24.77

2362

7611

Reimbursement for rheumatic diseases

2232

10204

2.26

262.56

1.8

2.4

3.10

2.86

g/l

22.38

2081

9193

Hypertension, essential

2421

6156

2.29

261.96

2.3

2.92

2.79

g/l

7.58

2251

5591

Hypertensive diseases (excluding secondary)

1451

2958

2.94

260.88

2.3

2.1

2.91

2.73

g/l

8.13

1364

2723

Pain in joint

2058

5366

2.43

260.22

2.1

2.3

2.88

2.91

g/l

0.62

1873

4854

Any gastric operation

2214

4759

2.39

256.51

2.3

1.9

2.93

2.80

g/l

6.09

2029

4334

GASTRO-related operations

2214

4759

2.39

256.51

2.3

1.9

2.93

2.80

g/l

6.09

2029

4334

Caries of dentine

1046

3238

3.31

255.98

3.8

2.1

3.02

2.91

g/l

2.25

967

2968

Transplanted organ and tissue status

601

1358

4.99

251.26

5.8

2.2

2.86

2.91

g/l

0.43

581

1242

Diseases of arteries, arterioles and capillaries (FINNGEN)

954

1895

3.67

250.53

2.5

2.3

3.11

2.75

g/l

17.17

891

1722

Other arthritis (FG)

1253

4519

2.92

250.48

2.3

2.6

3.13

2.81

g/l

20.49

1163

4093

Diseases of oesophagus, stomach and duodenum

3579

11370

1.90

242.88

2.2

2.4

2.85

2.90

g/l

2.25

3243

10364

Other specific joint derangements/joint disorders

2345

6774

2.22

242.23

2.1

2.4

2.85

g/l

0.06

2142

6191

Other diseases of blood and blood-forming organs, wide

1102

3803

3.12

242.10

3.5

2.3

2.96

2.89

g/l

1.30

1035

3446

Certain infectious and parasitic diseases

2986

7474

2.05

239.46

2.6

1.9

2.96

2.78

g/l

15.69

2761

6730

Covid-19 confirmed case

1680

7167

2.46

237.86

3.1

2.2

3.05

2.89

g/l

8.49

1530

6453

Persons encountering health services for other counselling and medical advice, not elsewhere classified

3742

10841

1.88

237.54

2.2

2.4

2.88

2.90

g/l

0.77

3493

9739

Dyspnoea

3228

12406

1.93

237.19

2.5

2.3

2.93

2.88

g/l

1.89

2946

11256

Diverticular disease of intestine

2759

8585

2.07

236.53

2.6

2.3

2.95

2.89

g/l

2.55

2516

7767

Other septicaemia, including avohilmo

1682

6742

2.45

234.62

2.9

2.1

3.12

2.81

g/l

24.31

1526

5991

Other septicaemia

1652

6619

2.47

233.34

3.0

2.1

3.12

2.81

g/l

23.35

1497

5871

Acute tubulo-interstitial nephritis

2228

8928

2.17

233.29

2.4

2.3

3.08

2.85

g/l

19.83

2002

7993

Pain, not elsewhere classified

1082

3755

3.02

231.65

2.8

2.1

2.88

2.81

g/l

1.48

1001

3399

Oxycodone

1641

5910

2.48

230.98

4.8

2.1

3.06

2.85

g/l

10.06

1474

5295

Abnormalities of breathing

2777

7939

2.05

230.78

2.4

2.2

2.88

2.89

g/l

0.20

2552

7215

Autoimmune diseases

3519

9592

1.90

230.75

2.2

2.5

2.90

2.86

g/l

1.28

3256

8663

Hypertensive diseases

2345

6205

2.19

229.04

2.2

2.3

2.92

2.79

g/l

7.93

2180

5635

Asthma, excluding more controls

2212

5147

2.26

228.22

2.1

1.9

2.93

2.78

g/l

8.86

2054

4671

Hypertension

2340

6205

2.18

227.24

2.2

2.3

2.92

2.79

g/l

7.91

2175

5635

Used for control exclusion in common control thyroid runs

3297

8781

1.94

226.73

2.2

2.5

2.89

2.87

g/l

0.77

3043

7937

Provisional assignment of new diseases of uncertain etiology

2041

9527

2.20

226.08

3.0

2.2

3.03

2.87

g/l

10.49

1866

8611

Codes for special purposes

2043

9543

2.20

225.84

3.0

2.2

3.03

2.87

g/l

10.50

1867

8626

Polymyalgia rheumatica

834

2572

3.60

224.79

1.9

2.4

3.21

2.92

g/l

9.43

745

2274

Low back pain

2595

8782

2.05

223.23

2.6

2.2

2.88

2.92

g/l

1.43

2384

7956

Erysipelas

2150

8866

2.17

222.54

2.3

2.1

3.09

2.79

g/l

31.22

1977

7956

L04AA Selective immunosuppressants

992

3385

3.13

221.24

1.8

2.4

3.07

2.87

g/l

7.69

953

3104

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

452

540

6.28

221.07

2.4

2.3

3.08

2.98

g/l

0.97

431

486

Other heart diseases, wide

2755

8522

2.00

218.23

2.3

2.93

2.82

g/l

6.81

2564

7775

Other specified/unspecified arthritis

1113

4093

2.86

214.73

2.3

2.5

3.14

2.86

g/l

13.80

1029

3716

Complications of surgical and medical care, not elsewhere classified

3408

12677

1.84

212.69

2.3

2.96

2.87

g/l

4.64

3115

11491

L04AD Calcineurin inhibitors

571

1410

4.47

211.75

2.4

2.5

3.04

2.88

g/l

3.05

556

1310

Asthma (only as main-diagnosis), excluding more controls

2026

5147

2.23

206.74

2.1

1.9

2.94

2.78

g/l

9.12

1880

4671

Exposure to unspecified factor

3379

12946

1.82

204.33

2.3

2.96

2.87

g/l

5.35

3047

11799

Other diseases of intestines

3202

9742

1.87

204.00

2.4

2.2

2.86

2.87

g/l

0.39

2934

8874

Cardiovascular diseases (excluding rheumatic etc)

1448

3302

2.56

202.80

2.2

2.0

2.91

2.74

g/l

7.75

1373

3052

Viral Sepsis

994

3568

2.97

202.22

3.2

2.1

3.02

2.88

g/l

4.02

907

3199

Implicit viral Sepsis

992

3564

2.96

201.47

3.2

2.1

3.02

2.88

g/l

4.03

905

3195

Persons encountering health services in other circumstances, wide

3711

10884

1.79

201.46

2.2

2.4

2.87

2.90

g/l

1.08

3447

9770

Asthma

2334

5871

2.10

201.44

2.1

1.9

2.94

2.80

g/l

7.85

2169

5316

Pain in throat and chest

2595

7897

1.99

201.20

2.3

2.2

2.88

2.89

g/l

0.30

2397

7173

Gout, idiopatic and unspecified

1270

5189

2.62

200.80

2.1

2.5

3.14

2.89

g/l

14.33

1178

4676

Headache

1932

7053

2.17

199.70

2.1

2.80

2.82

g/l

0.27

1778

6413

Asthma (mode)

2306

5917

2.10

199.26

2.1

1.9

2.93

2.81

g/l

6.44

2145

5359

Continuous positive airway pressure

796

2056

3.42

198.40

2.3

2.4

2.99

2.85

g/l

2.88

717

1875

Diabetic nephropathy, excluding more controls

789

2002

3.51

197.09

1.9

2.2

2.93

2.90

g/l

0.30

743

1797

Other disorders of skin and subcutaneous tissue

2690

12242

1.91

196.77

2.3

2.4

2.96

2.88

g/l

4.00

2460

11055

Spondylopathies

2707

8437

1.95

196.24

2.6

2.2

2.85

2.93

g/l

3.64

2494

7618

Symptoms and signs involving the skin and subcutaneous tissue

2547

12831

1.93

195.90

2.4

2.3

2.79

2.91

g/l

8.26

2330

11639

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

2562

11900

1.94

194.94

2.6

2.4

2.91

2.89

g/l

0.44

2347

10729

Cerebrovascular diseases (FINNGEN)

976

2340

3.03

194.84

2.2

2.3

2.97

2.74

g/l

9.07

892

2138

Other disorders of fluid, electrolyte and acid-base balance

1357

5395

2.49

194.83

2.6

2.3

3.02

2.91

g/l

3.43

1222

4801

Ulcer of lower limb, not elsewhere classified

830

2778

3.27

194.06

2.4

2.3

3.28

2.91

g/l

18.59

763

2478

Syncope and collapse

1590

5941

2.31

192.43

2.3

2.2

2.88

2.84

g/l

1.02

1404

5340

Symptoms and signs involving cognition, perception, emotional state and behaviour

3203

12071

1.81

192.32

2.1

2.4

2.85

2.89

g/l

1.82

2906

11019

Non-Hodgkin lymphoma, all, including Hilmo

717

2211

3.55

192.09

3.1

1.4

3.06

2.88

g/l

4.19

682

1966

Rheumatoid arthritis

1261

4556

2.56

191.67

1.9

2.6

3.11

2.86

g/l

13.05

1174

4096

Follow-up examination after treatment for conditions other than malignant neoplasms

1422

3978

2.45

187.95

2.4

2.2

2.91

2.98

g/l

1.77

1307

3643

Coagulation defects, purpura and other haemorrhagic conditions

893

3150

3.03

187.85

2.5

2.3

2.94

2.92

g/l

0.34

833

2853

Disorders of mineral metabolism

499

1223

4.54

187.53

3.6

2.3

2.90

2.91

g/l

0.04

449

1112

Preparatory care for dialysis

354

666

6.46

186.95

2.3

2.7

3.17

2.90

g/l

4.77

338

615

Disturbances of skin sensation

1041

3971

2.75

186.67

2.0

2.3

2.68

2.89

g/l

12.37

963

3645

Diseases of arteries, arterioles and capillaries

2602

10296

1.92

185.89

2.2

2.5

3.10

2.87

g/l

23.27

2373

9243

Disorders of calcium metabolism

425

932

5.19

185.16

4.0

2.4

2.91

g/l

0.00

381

850

Symptoms and signs involving the urinary system

2737

11337

1.87

184.75

2.2

2.4

2.89

2.90

g/l

0.13

2460

10265

Enlarged lymph nodes

664

2008

3.51

180.81

2.1

2.2

2.97

2.82

g/l

2.92

630

1824

Asthma (only as main-diagnosis)

2122

5871

2.07

180.13

2.1

1.9

2.94

2.80

g/l

7.78

1965

5316

Gout, unspecified

1048

4133

2.73

178.85

2.2

2.4

3.13

2.89

g/l

11.53

980

3712

Dorsalgia

3006

8861

1.83

178.54

2.4

2.2

2.84

2.92

g/l

3.84

2759

8026

Small fibre neuropathy

279

442

8.00

176.74

2.7

2.3

2.69

3.01

g/l

5.22

254

401

Hypertensive heart and/or renal disease

1131

3276

2.65

175.29

2.1

2.5

3.09

2.83

g/l

12.57

1037

2889

Symptoms and signs concerning food and fluid intake

529

1411

4.05

174.68

1.9

2.2

2.83

2.88

g/l

0.56

486

1268

Gout, strict definition

964

3699

2.82

174.43

2.2

2.5

3.16

2.89

g/l

13.60

897

3329

Disorders of thyroid, IBD co-morbidities

468

697

4.75

174.30

2.2

2.88

2.92

g/l

0.31

435

634

Atrial fibrillation and flutter

961

2218

2.90

173.18

2.7

2.3

2.97

2.75

g/l

7.38

900

2021

Cardiovascular diseases

1248

2629

2.57

172.05

2.1

1.9

2.91

2.74

g/l

6.54

1179

2436

Other CVD (FINNGEN)

543

1083

4.12

170.30

2.8

2.2

2.89

2.80

g/l

1.01

484

962

Heart failure and bmi 25plus

1401

4108

2.39

170.07

2.3

2.6

3.15

2.86

g/l

19.79

1271

3619

Lower back pain or/and sciatica

3445

12779

1.71

166.78

2.5

2.3

2.87

2.89

g/l

0.50

3154

11592

Type 2 diabetes, wide definition

2738

9706

1.83

165.05

2.1

2.6

2.95

2.87

g/l

3.56

2508

8780

Certain infectious and parasitic diseases, including avohilmo

2073

5211

2.04

164.50

2.4

1.9

2.96

2.78

g/l

11.68

1926

4675

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

3027

11085

1.76

163.35

2.8

2.2

2.88

2.89

g/l

0.12

2783

10132

Disorders resulting from impaired renal tubular function

288

511

6.81

161.48

2.4

2.5

3.10

2.94

g/l

1.67

279

470

Non-ischemic cardiomyopathy

1390

5040

2.30

160.86

2.4

3.09

2.86

g/l

13.18

1260

4456

Glomerulonephritis

518

1457

3.91

160.19

3.1

2.4

2.99

2.93

g/l

0.62

496

1333

Neurological diseases, wide definition

599

785

3.91

157.18

2.2

2.1

2.81

2.95

g/l

1.91

562

719

Fall on same level

3382

10773

1.70

157.08

2.3

2.4

2.91

2.85

g/l

2.68

3009

9994

Seropositive rheumatoid arthritis

942

3705

2.65

157.07

1.9

2.6

3.07

2.83

g/l

10.24

877

3297

Symptoms and signs involving the nervous and musculoskeletal systems

2074

11179

1.91

156.54

2.1

2.4

2.72

2.92

g/l

17.99

1911

10091

Other pulmonary diagnosis

2245

5923

1.94

155.58

2.6

1.9

2.96

2.80

g/l

8.61

2079

5363

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

1106

2821

2.53

155.22

2.5

2.1

2.86

2.74

g/l

3.29

1034

2596

Cardiac arrhythmias

1598

4880

2.15

155.06

2.4

2.88

2.80

g/l

2.11

1490

4485

Osteoporosis with pathological fracture (FG)

424

1063

4.45

154.96

2.0

2.7

2.95

2.87

g/l

0.84

353

917

Excluding asthma or asthma-COPD overlap

2240

5923

1.93

154.22

2.6

1.9

2.95

2.80

g/l

8.37

2076

5363

Diseases of the skin and subcutaneous tissue

2898

8376

1.77

151.18

2.4

2.3

2.89

2.88

g/l

0.24

2658

7574

Abnormalities of gait and mobility

660

2238

3.22

151.05

2.0

2.4

2.91

2.94

g/l

0.34

610

2024

Other necrotizing vasculopathies (FG)

354

791

5.04

150.37

1.6

2.9

3.56

2.81

g/l

21.36

322

705

Asthma (diagnoses ohter than nonallergic)

2788

13276

1.73

148.65

2.1

2.4

2.94

2.88

g/l

3.14

2564

12028

Other dorsopathies, not elsewhere classified

2929

8868

1.75

147.89

2.4

2.2

2.82

2.92

g/l

6.03

2688

8033

Other and unspecified dermatitis

1825

9618

1.95

147.64

2.2

2.4

2.83

2.90

g/l

2.18

1681

8698

Malignant neoplasm, including Hilmo

2572

8490

1.80

147.39

3.6

1.4

2.92

2.86

g/l

2.39

2399

7690

COPD differential diagnosis

2212

5919

1.91

147.06

2.6

1.9

2.96

2.81

g/l

8.74

2052

5361

ILD differential diagnosis

2210

5917

1.91

146.64

2.6

1.9

2.96

2.81

g/l

8.68

2050

5359

Dermatitis and eczema

3483

12739

1.65

146.05

2.2

2.4

2.83

2.91

g/l

4.49

3210

11534

Purpura and other haemorrhagic conditions

638

2157

3.18

145.54

2.6

2.4

2.90

2.93

g/l

0.24

595

1950

Bleeding

2817

11700

1.73

144.52

2.3

2.4

2.99

2.88

g/l

6.52

2554

10585

Asthma, hospital admission 2, infections

1976

10487

1.88

143.38

2.3

2.4

3.02

2.88

g/l

8.86

1822

9445

Asthma-related infections

1976

10487

1.88

143.38

2.3

2.4

3.02

2.88

g/l

8.86

1822

9445

Malignant neoplasm, wide definition

2568

8539

1.79

143.29

3.6

1.4

2.92

2.86

g/l

2.39

2399

7733

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

805

1379

2.99

143.24

2.2

1.9

2.95

2.85

g/l

1.54

751

1255

Diabetic nephropathy

795

3018

2.82

143.23

1.9

2.1

2.93

2.94

g/l

0.05

748

2735

Dermatitis

2109

11469

1.85

143.04

2.2

2.4

2.84

2.90

g/l

2.36

1939

10383

COPD/asthma/ILD related infections

2974

8785

1.73

142.95

3.0

1.9

2.96

2.82

g/l

9.93

2730

7954

COPD/asthma related infections

2974

8785

1.73

142.95

3.0

1.9

2.96

2.82

g/l

9.93

2730

7954

Secondary hypertension

347

771

4.78

142.88

2.1

2.3

3.03

2.80

g/l

3.45

330

692

Extracorporeal dialysis

374

912

4.67

142.83

2.6

2.4

3.17

2.92

g/l

4.08

353

842

Malignant neoplasm

2535

8465

1.79

142.66

3.9

1.4

2.91

2.86

g/l

1.65

2367

7662

Endocrine, nutritional and metabolic diseases

1965

5148

1.96

141.86

2.3

2.4

2.92

2.84

g/l

2.81

1823

4711

Malignant neoplasm

2534

8479

1.79

141.65

3.8

1.4

2.91

2.86

g/l

1.72

2368

7674

Benign neoplasm of colon, rectum, anus and anal canal

2371

11574

1.78

138.97

2.4

2.5

2.94

2.90

g/l

1.39

2116

10462

Complications of medical and surgical care

2462

12946

1.75

137.95

2.5

2.3

2.96

2.88

g/l

3.38

2253

11716

Constipation

2926

11987

1.69

137.70

2.7

2.3

2.83

2.91

g/l

3.37

2625

10926

Pain (limb, back, neck, head abdominally)

2078

5568

1.91

137.66

2.3

2.89

2.91

g/l

0.45

1910

5013

Symptoms and signs involving the circulatory and respiratory systems

2721

7944

1.75

136.23

2.3

2.2

2.88

2.89

g/l

0.25

2518

7220

Atrial fibrillation and flutter with reimbursement

814

1909

2.79

135.96

2.6

2.3

2.99

2.76

g/l

6.93

759

1729

Spinal stenosis

1878

7442

1.92

135.74

2.3

2.83

2.95

g/l

5.19

1693

6676

Hypothyroidism (congenital or acquired)

463

644

4.11

135.27

2.6

1.2

2.77

2.70

g/l

0.56

441

598

Amyloidosis, other/unspecified

193

278

9.09

134.30

8.0

2.3

2.63

2.99

g/l

4.61

187

252

Complications of procedures, not elsewhere classified

2597

12455

1.72

133.75

2.2

2.4

2.94

2.87

g/l

2.69

2378

11284

Hypothyroidism and >3 levothyroxin purchases

459

642

4.09

133.43

2.4

1.2

2.78

2.70

g/l

0.72

437

596

Hypothyroidism, levothyroxine purchases

459

642

4.09

133.43

2.4

1.2

2.78

2.70

g/l

0.72

437

596

Other special examinations and investigations of persons without complaint or reported diagnosis

1769

4595

1.99

132.64

2.4

2.2

2.78

2.98

g/l

11.80

1626

4207

Dizziness and giddiness

2458

11238

1.74

131.98

2.2

2.4

2.83

2.90

g/l

3.01

2224

10228

Other disorders of urethra and urinary system

2244

8889

1.80

131.93

2.3

2.91

2.88

g/l

0.63

2052

8055

Soft tissue disorders

2869

8782

1.70

131.85

2.3

2.4

2.86

2.91

g/l

1.83

2641

7944

Myelodysplastic syndrome, including Hilmo

243

445

6.56

131.77

2.4

1.4

2.89

2.99

g/l

0.64

226

388

Any reimbursement code in KELA

1244

2781

2.28

131.75

2.5

1.5

2.92

2.70

g/l

10.47

1178

2498

Haemorrhage from respiratory passages

1296

5548

2.14

131.45

2.3

3.00

2.92

g/l

2.23

1185

4949

Amyloidosis

208

330

7.88

131.33

7.7

2.3

2.65

2.99

g/l

4.70

200

300

Nephrotic syndrome

221

371

7.05

130.49

2.9

2.5

3.01

2.97

g/l

0.19

215

343

ILD medications: azathioprine

489

1502

3.42

129.45

1.8

1.6

3.08

2.79

g/l

6.85

460

1369

Depression medications

497

657

3.87

129.17

1.7

1.2

2.90

2.69

g/l

3.56

480

611

Other necrotizing vasculopathies

412

1157

3.97

128.65

1.8

2.7

3.54

2.89

g/l

19.19

377

1045

Valvular heart disease excluding rheumatic fever

1608

5964

1.98

127.90

2.5

2.4

3.00

2.84

g/l

7.43

1459

5355

Rheumatoid arthritis, including avohilmo

1394

7068

2.05

127.45

1.9

2.4

3.10

2.88

g/l

11.69

1296

6328

Fracture of lumbar spine and pelvis

992

4420

2.36

127.25

2.3

2.96

2.94

g/l

0.20

836

3918

Parasetamol

1830

4872

1.93

126.75

2.5

2.0

2.92

2.84

g/l

2.00

1675

4493

Intestinal infectious diseases, including avohilmo, including avohilmo

3506

12471

1.59

126.43

2.8

2.2

2.95

2.87

g/l

4.21

3218

11297

Disorders of parathyroid gland

901

3833

2.45

125.98

2.3

2.86

2.96

g/l

2.50

812

3403

Non-rheumatic valve diseases

1599

5951

1.98

125.64

2.5

2.4

3.00

2.84

g/l

7.15

1450

5343

Intestinal infectious diseases

2887

13288

1.64

125.57

3.0

2.2

2.98

2.87

g/l

6.83

2649

12047

Disorders of other endocrine glands

1448

7332

2.00

125.54

2.4

2.3

2.86

2.90

g/l

0.83

1320

6613

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

239

455

6.33

124.54

2.5

1.4

2.81

3.02

g/l

2.45

225

396

Chronic lymphocytic leukaemia

239

455

6.33

124.54

2.5

1.4

2.81

3.02

g/l

2.45

225

396

Chronic lymphocytic leukaemia, helper endpoint

239

455

6.33

124.54

2.5

1.4

2.81

3.02

g/l

2.45

225

396

Diseases of the musculoskeletal system and connective tissue

1251

2877

2.22

124.38

2.3

2.2

2.93

2.88

g/l

0.89

1159

2617

Kidney transplant status

285

624

5.12

124.05

1.8

2.5

3.16

2.86

g/l

4.70

279

583

Spondylosis

1854

8006

1.86

123.84

2.2

2.3

2.83

2.93

g/l

4.05

1693

7231

Chronic gastritis

1100

5187

2.22

123.02

2.2

2.4

2.95

g/l

0.04

989

4654

Diarrhoea and gastroenteritis of presumed infectious origin

2168

11274

1.75

122.92

2.8

2.1

2.98

2.87

g/l

5.70

1989

10209

Cardiomyopathy

723

2845

2.68

122.65

2.6

2.3

3.05

2.84

g/l

6.19

679

2546

Certain disorders involving the immune mechanism

752

3027

2.62

121.88

2.8

2.2

2.85

2.89

g/l

0.53

708

2767

Other diseases of urinary system

2952

10255

1.64

121.64

2.3

2.4

2.90

2.87

g/l

1.05

2710

9351

Asthma-related pneumonia

1366

6967

2.02

121.23

2.4

2.3

3.10

2.90

g/l

10.34

1274

6185

Other/unspecified dorsalgia

1233

5996

2.09

121.04

2.8

2.2

2.88

2.93

g/l

0.81

1121

5399

Neoplasms

1784

4984

1.91

120.65

2.7

1.2

2.88

2.87

g/l

0.17

1670

4541

Asthma, hospital admissions 3, pneumonia

1366

6979

2.02

120.61

2.4

2.3

3.10

2.90

g/l

10.32

1274

6195

Asthma-related pneumonia or sepsis

1366

6979

2.02

120.61

2.4

2.3

3.10

2.90

g/l

10.32

1274

6195

Hyperlipidaemia, other/unspecified

1427

6636

2.00

120.56

2.4

2.97

2.89

g/l

2.34

1286

5936

Other antidepressants

3079

9804

1.63

120.24

2.1

2.4

2.86

2.89

g/l

0.91

2774

8963

Gastro-oesophageal reflux disease

2177

10755

1.75

120.24

2.1

2.4

2.77

2.90

g/l

7.85

1934

9805

Acquired haemolytic anaemia

204

348

7.21

119.65

3.4

2.3

2.86

3.03

g/l

1.33

194

314

Injuries to the abdomen, lower back, lumbar spine and pelvis

1452

7542

1.96

117.61

2.4

2.3

2.95

2.91

g/l

0.83

1256

6789

Diseases of liver

1260

6352

2.06

117.10

1.9

2.5

2.90

2.88

g/l

0.46

1126

5814

Genitourinary diseases

1444

3616

2.04

116.18

2.1

2.3

2.93

2.88

g/l

1.02

1348

3307

Persons encountering health services for examination and investigation

1721

4595

1.91

115.53

2.3

2.2

2.88

2.98

g/l

3.68

1572

4207

Hypertensive Renal Disease

247

513

5.49

115.03

1.9

2.7

3.04

2.90

g/l

1.10

238

455

Care involving use of rehabilitation procedures

1944

10077

1.77

114.72

2.5

2.2

2.89

2.87

g/l

0.28

1853

9093

Neurological diseases

2215

6423

1.76

114.48

2.2

2.5

2.82

3.00

g/l

13.40

2028

5870

Haemolytic anaemias

232

460

5.85

114.46

3.2

2.3

2.86

3.04

g/l

1.72

221

414

Non-follicular lymphoma

499

1696

3.22

114.08

2.7

2.5

3.10

2.91

g/l

3.21

474

1531

Other functional intestinal disorders

1496

7265

1.92

113.84

2.6

2.3

2.79

2.90

g/l

4.05

1353

6531

Heart failure and coronary heart disease

1722

6670

1.88

113.77

2.1

2.5

3.12

2.89

g/l

15.29

1579

5911

Myalgia

792

3358

2.45

113.32

2.2

2.3

2.80

2.90

g/l

2.05

723

3044

Hypercalcemia

298

735

4.69

112.93

4.1

2.6

2.88

2.96

g/l

0.63

271

659

Abnormal findings on diagnostic imaging of lung

1814

9819

1.81

112.76

2.5

2.4

2.95

2.91

g/l

1.18

1651

8816

STROKE

1717

6361

1.86

112.60

2.5

2.6

2.92

2.83

g/l

3.09

1554

5761

Use of hypnotics and sedatives

3177

11676

1.58

112.08

2.7

2.3

2.87

2.89

g/l

0.30

2890

10645

Arthropathies

2335

6969

1.72

111.64

2.2

2.4

2.91

2.86

g/l

1.44

2155

6353

Chronic apical periodontitis

3292

11987

1.56

110.71

2.4

2.3

2.88

2.89

g/l

0.07

2982

10912

Hypothyroidism, drug reimbursement

312

498

4.50

110.60

2.3

1.2

2.83

2.70

g/l

1.19

298

457

Diaphragmatic hernia

1362

7201

1.96

110.37

2.4

2.3

2.97

2.91

g/l

1.30

1220

6453

Other and unspecified diseases of blood and blood-forming organs

203

374

6.51

109.46

5.4

2.5

2.97

2.99

g/l

0.08

195

349

Antihypertensive medication - note that there are other indications

1191

2961

2.13

109.38

2.0

2.3

2.89

2.77

g/l

3.11

1120

2729

Other disorders of white blood cells

308

793

4.35

108.95

2.2

2.5

2.98

2.94

g/l

0.33

284

725

Chronic lower respiratory diseases

3442

11916

1.54

107.84

2.1

2.4

2.96

2.86

g/l

6.77

3176

10809

Any event in cancer register

2540

9134

1.65

107.65

3.5

1.6

2.91

2.85

g/l

1.96

2366

8309

Chronic periodontitis, including avohilmo

3051

12597

1.57

107.29

2.5

2.3

2.92

2.88

g/l

1.68

2741

11490

Lymphoid leukaemia

328

895

4.12

107.22

2.8

2.7

2.87

2.99

g/l

1.39

312

809

Nerve, nerve root and plexus disorders

3222

12643

1.56

107.03

2.2

2.4

2.78

2.92

g/l

13.16

2950

11464

Diabetes, varying definitions

2887

10655

1.60

106.55

2.0

2.5

2.92

2.86

g/l

2.31

2639

9666

Dorsopathies

2795

8873

1.62

106.49

2.4

2.2

2.83

2.92

g/l

4.77

2566

8037

Hypertensive Heart Disease

915

3146

2.30

106.48

2.1

2.5

3.09

2.84

g/l

10.25

827

2771

Other disorders involving the immune mechanism, not elsewhere classified

202

377

6.19

106.38

2.3

2.4

2.93

2.96

g/l

0.11

193

352

3374

11212

1.55

106.31

3.2

2.1

2.91

2.88

g/l

0.81

3089

10124

Intracranial trauma

1469

5278

1.91

106.24

2.2

2.4

2.84

2.99

g/l

6.19

1322

4842

Other intervertebral disc disorders

2388

8672

1.67

106.23

2.3

2.2

2.78

2.92

g/l

9.16

2185

7844

Sicca syndrome [Sjögren]

404

1261

3.48

106.20

1.8

2.6

2.78

2.89

g/l

1.31

374

1140

1363

7208

1.92

106.12

2.4

2.3

2.99

2.87

g/l

4.64

1256

6519

Diabetes mellitus

2895

10658

1.59

106.08

2.0

2.5

2.92

2.86

g/l

2.05

2646

9670

Periodontitis

3046

12593

1.57

105.92

2.5

2.3

2.92

2.88

g/l

1.54

2739

11484

Azathioprine

489

1696

3.02

105.31

1.8

2.5

3.08

2.81

g/l

6.34

460

1552

Gastrointestinal diseases

1384

3533

2.00

105.28

2.4

1.9

2.90

2.89

g/l

0.11

1275

3242

Other joint disorders

2245

6967

1.71

105.26

2.1

2.4

2.84

2.86

g/l

0.23

2058

6351

Bacterial pneumoniae

1396

6581

1.92

104.60

3.7

2.0

3.11

2.82

g/l

19.48

1319

5898

Disorders of eyelid, lacrimal system and orbit

2708

12656

1.60

104.14

2.4

2.3

2.83

2.90

g/l

3.42

2445

11501

Abnormal weight loss

466

1607

3.14

103.41

1.9

2.4

2.81

2.93

g/l

1.89

426

1455

Adjustment and management of implanted device

794

3533

2.37

103.18

2.7

2.1

3.13

2.93

g/l

7.05

734

3118

Bacterial pneumonia, not elsewhere classified

1336

6242

1.94

103.04

3.7

2.0

3.12

2.83

g/l

19.93

1268

5592

Weight loss

487

1723

3.05

102.92

2.0

2.4

2.83

2.93

g/l

1.36

446

1557

Benign neoplasm: Colon

1977

11143

1.71

102.34

2.4

2.5

2.96

2.90

g/l

1.70

1757

10068

Type 2 diabetes

2838

10530

1.59

101.81

2.0

2.5

2.93

2.86

g/l

2.65

2592

9546

Dialysis

216

446

5.45

100.96

2.5

2.1

3.16

2.90

g/l

2.62

209

414

Disorders of lens

2133

7963

1.70

100.86

2.6

2.4

2.89

g/l

0.12

1941

7343

Thrombocytopenia, unspecified

369

1129

3.58

100.46

2.1

2.5

2.87

2.95

g/l

0.76

342

1034

Isolated proteinuria

187

345

6.31

99.95

3.0

2.7

2.80

2.95

g/l

1.08

179

317

Other disorders of kidney and ureter

585

2320

2.69

98.74

2.4

2.96

2.91

g/l

0.68

558

2107

Other autoimmune haemolytic anaemias

131

174

10.12

98.24

2.7

2.3

2.72

3.07

g/l

2.97

126

157

Other arthrosis

1631

6176

1.81

97.98

2.1

2.5

2.89

2.86

g/l

0.56

1497

5611

Other arrhythmias

1789

7810

1.74

97.08

2.2

2.3

2.82

g/l

0.04

1636

7103

Sulfasalazine

862

4044

2.20

96.66

1.8

2.5

3.12

2.81

g/l

14.75

805

3649

General examination and investigation of persons without complaint and reported diagnosis

1599

4588

1.84

96.62

2.4

2.2

2.65

2.98

g/l

27.96

1436

4202

Disorders of choroid and retina

2630

11856

1.58

96.60

2.3

2.4

2.89

2.90

g/l

0.14

2346

10770

Hernia of abdominal wall, postoperative

589

2329

2.60

96.45

2.4

2.2

2.92

2.82

g/l

1.66

541

2129

Injuries to the hip and thigh

1721

9047

1.75

96.41

2.2

2.4

3.01

2.91

g/l

3.53

1433

8199

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1982

11867

1.68

96.13

2.4

2.3

2.97

2.88

g/l

2.96

1821

10712

COPD (mode)

1056

4118

2.07

95.66

1.9

2.0

3.19

2.81

g/l

26.08

948

3683

Injuries to the head

3215

12750

1.52

95.60

2.3

2.91

2.88

g/l

1.10

2896

11640

All influenza

879

4179

2.18

95.48

4.6

2.0

2.92

2.82

g/l

2.21

803

3755

Cough

1262

6323

1.91

95.22

2.6

2.3

2.87

2.90

g/l

0.58

1155

5698

Gonarthrosis [arthrosis of knee](FG)

2125

7426

1.68

95.03

2.2

2.5

2.88

2.81

g/l

2.51

1949

6732

Seronegative rheumatoid arthritis

435

1508

3.05

94.38

2.2

2.8

3.18

2.83

g/l

7.79

406

1362

Hyperparathyroidism

753

3368

2.33

93.79

2.4

2.3

2.87

2.97

g/l

2.01

680

2977

Unspecified haematuria

1500

6927

1.82

93.21

2.3

2.5

2.96

2.90

g/l

1.20

1361

6269

Dipeptidyl peptidase 4 (DPP-4) inhibitors

1982

9500

1.68

93.12

2.2

2.6

2.94

2.89

g/l

1.12

1794

8528

467

1689

2.89

93.09

2.3

3.10

2.87

g/l

4.80

431

1540

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

182

350

5.97

92.72

2.0

2.5

2.96

2.94

g/l

0.09

174

326

Venous thromboembolism

1863

10894

1.69

92.54

2.7

2.3

3.01

2.90

g/l

5.45

1709

9765

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

2893

12091

1.54

92.04

2.5

2.3

2.90

2.88

g/l

0.38

2645

10994

Viral pneumonia

513

1968

2.75

91.82

4.2

1.9

3.00

2.83

g/l

3.26

479

1771

Infections of the skin and subcutaneous tissue

1737

10207

1.71

91.51

2.6

2.3

2.98

2.86

g/l

5.29

1611

9323

Sciatica+with lumbago

1533

7817

1.77

90.75

2.1

2.2

2.85

2.92

g/l

1.91

1408

7091

Cerebrovascular diseases

2458

10973

1.59

90.62

2.3

2.4

2.97

2.89

g/l

3.46

2185

9961

Paroxysmal tachycardia

582

1933

2.57

90.49

2.0

2.2

2.91

2.76

g/l

2.93

537

1754

Other and unspecified disorders of white blood cells

236

576

4.63

90.08

2.1

2.6

2.97

2.98

g/l

0.07

221

527

Other diseases of intestine

616

2605

2.49

89.75

2.4

2.3

2.99

2.91

g/l

1.13

583

2362

Coxarthrosis [arthrosis of hip](FG)

1671

6730

1.75

89.38

2.2

2.6

2.88

2.82

g/l

1.51

1516

6079

Other diseases of blood and blood-forming organs

340

1067

3.48

88.86

4.2

2.5

2.91

2.92

g/l

0.08

315

979

SLE (Finngen)

186

380

5.47

87.90

1.7

2.4

3.09

2.91

g/l

1.31

175

347

Bronchitis

3162

12870

1.49

87.65

3.2

2.1

2.91

2.88

g/l

0.93

2906

11651

Hernia

2712

11946

1.53

86.05

2.5

2.3

2.90

2.89

g/l

0.22

2458

10834

Other medical care

1607

7989

1.73

85.67

3.4

2.2

3.13

2.90

g/l

13.99

1469

7131

Benzodiazepine use

2919

13280

1.51

85.58

2.2

2.4

2.89

g/l

0.13

2610

12119

Explicit bacterial Sepsis, including avohilmo

450

1680

2.84

85.21

4.6

2.2

3.14

2.89

g/l

4.55

408

1520

Hyperkalaemia

302

905

3.64

84.93

2.5

2.2

3.11

2.92

g/l

2.12

276

800

Pruritus

454

1705

2.81

84.86

2.1

2.4

2.74

2.95

g/l

5.03

421

1547

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

2909

12563

1.51

84.85

2.6

2.2

2.95

2.87

g/l

3.75

2669

11382

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

2661

10408

1.54

84.66

2.0

2.5

2.93

2.87

g/l

2.67

2428

9433

Cystitis

2406

9235

1.57

84.42

2.3

2.91

2.87

g/l

0.96

2174

8377

Symptoms and signs involving the digestive system and abdomen

2787

9238

1.53

84.12

2.3

2.85

2.91

g/l

2.25

2558

8353

Streptococcal septicaemia, including avohilmo

397

1401

3.02

83.96

4.6

2.1

3.13

2.81

g/l

6.60

359

1249

Polyuria

858

4264

2.10

83.64

2.0

2.5

2.86

2.92

g/l

0.89

774

3855

DVT of lower extremities and pulmonary embolism

1471

8608

1.75

83.47

2.8

2.3

3.01

2.91

g/l

3.71

1347

7700

Fracture of rib(s), sternum and thoracic spine

1127

6136

1.90

83.40

2.6

2.3

2.91

2.92

g/l

0.07

1000

5546

Falls/tendency to fall

2800

9304

1.53

83.23

2.2

2.4

2.88

2.86

g/l

0.56

2516

8648

Senile cataract

1981

7473

1.65

83.16

2.6

2.4

2.89

2.90

g/l

0.24

1795

6880

IgA nephropathy (IgA glomerulonephritis)

154

283

6.33

82.72

2.0

2.6

3.00

2.95

g/l

0.23

146

262

Bacterial pneumonia (organism specified)

1495

7970

1.74

82.65

3.9

2.1

3.11

2.88

g/l

14.52

1411

7098

Other external causes of accidental injury

2123

6634

1.63

82.57

2.3

2.4

2.90

2.86

g/l

0.93

1912

6163

Benign neoplasms

2616

9365

1.54

82.38

2.3

2.85

2.90

g/l

1.32

2396

8564

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

2600

13500

1.52

82.29

2.8

2.2

2.85

2.89

g/l

1.64

2376

12281

Other cataract

1487

6447

1.76

82.28

2.7

2.4

2.88

2.91

g/l

0.75

1346

5914

Other bacterial intestinal infections, including avohilmo

824

4053

2.11

82.15

3.6

2.1

2.98

2.89

g/l

1.51

750

3646

Insulin medication

1872

9661

1.64

82.11

2.1

2.5

2.98

2.88

g/l

3.55

1716

8709

Seropositive rheumatoid arthritis, wide

942

4867

2.01

82.03

1.9

2.4

3.07

2.89

g/l

6.21

877

4365

Vocal cord dysfunction

362

1052

3.13

81.92

2.5

2.6

2.86

2.75

g/l

1.05

329

977

Peripheral artery disease

1604

7601

1.72

81.45

2.1

2.4

3.14

2.88

g/l

18.20

1459

6772

Other diseases of pleura

1627

8549

1.70

81.32

2.5

2.4

3.08

2.90

g/l

10.74

1480

7666

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

918

4721

2.02

81.07

1.9

2.4

3.07

2.90

g/l

5.54

855

4236

Injuries to the thorax

1540

9225

1.71

80.89

2.4

2.3

2.92

2.90

g/l

0.41

1375

8368

Viral hepatitis, IBD co-morbidity

140

233

6.27

80.88

1.9

2.0

2.97

2.85

g/l

0.62

128

221

Hypo-osmolality and hyponatraemia

673

3061

2.28

80.86

2.7

2.2

2.97

2.92

g/l

0.51

599

2700

Idiopathic gout

441

1684

2.82

80.84

2.1

2.4

3.15

2.91

g/l

4.72

403

1519

Hard cardiovascular diseases

2420

9340

1.56

80.65

2.3

2.5

2.93

2.85

g/l

3.50

2229

8483

Other/unspecified seropositive rheumatoid arthritis

931

4821

2.01

80.55

1.9

2.4

3.07

2.90

g/l

6.00

866

4321

Arthrosis

1941

6568

1.65

80.45

2.2

2.5

2.87

2.86

g/l

0.12

1783

5968

Other disorders of lacrimal gland

1194

6680

1.84

80.43

2.7

2.4

2.80

2.91

g/l

3.86

1074

6045

Diseases of the respiratory system

1700

5054

1.71

80.24

2.6

2.0

2.97

2.82

g/l

6.67

1563

4557

Mood disorders, excluding more controls

2645

10352

1.52

80.15

2.1

2.4

2.87

2.89

g/l

0.31

2401

9488

Polyarthrosis

736

3135

2.20

79.94

2.4

2.6

2.93

2.89

g/l

0.47

650

2799

Presence of cardiac and vascular implants and grafts

1594

7030

1.71

79.91

1.8

2.4

2.97

2.94

g/l

0.50

1401

6342

Diseases of the eye and adnexa

1840

5594

1.67

79.54

2.3

2.1

2.85

2.89

g/l

0.98

1713

5181

Vasculitis limited to skin, not elsewhere classified

172

363

5.48

79.16

2.3

2.6

3.08

3.05

g/l

0.12

167

332

Concussion

1218

5247

1.83

79.09

2.1

2.4

2.82

2.99

g/l

6.79

1096

4812

Other symptoms and signs involving cognitive functions and awareness

1609

8673

1.69

78.58

2.2

2.5

2.90

2.93

g/l

0.54

1405

7804

Giant cell arteritis

250

703

4.02

78.58

1.7

2.7

3.68

2.95

g/l

13.54

223

626

Obesity related asthma

1099

6040

1.87

78.48

2.0

2.5

2.91

2.85

g/l

1.52

1010

5510

Urinary track infection

1402

3968

1.80

78.34

2.2

2.90

2.85

g/l

1.23

1281

3590

Diseases of the digestive system

1536

9214

1.70

78.12

2.3

2.4

2.97

2.91

g/l

1.65

1408

8273

Myelodysplastic syndrome

118

179

8.30

77.92

2.1

1.3

2.86

3.04

g/l

0.74

108

155

Explicit bacterial Sepsis

430

1642

2.77

77.89

4.7

2.2

3.12

2.89

g/l

4.01

390

1487

Sleep disorders (combined)

3105

11166

1.47

77.85

2.0

2.4

2.83

2.92

g/l

4.56

2819

10136

Other nutritional deficiencies

1867

10769

1.61

77.72

1.9

2.4

2.95

2.86

g/l

4.11

1715

9881

Other bacterial intestinal infections

675

3151

2.23

77.58

3.8

2.1

2.99

2.92

g/l

0.88

614

2827

Acute myeloid leukaemia and myelodysplastic syndromes

162

331

5.68

77.45

1.9

1.4

3.00

3.02

g/l

0.06

151

290

Fibromyalgia

314

1011

3.27

77.33

2.2

2.75

2.88

g/l

1.43

295

937

Depression or dysthymia

1940

6610

1.63

77.30

2.3

2.5

2.86

2.90

g/l

0.87

1740

6098

Streptococcal septicaemia

379

1365

2.96

77.19

4.7

2.2

3.11

2.81

g/l

5.95

343

1214

Persons encountering health services for specific procedures, not carried out

324

1066

3.21

77.14

2.2

2.0

3.07

2.88

g/l

3.19

308

979

Non-Hodgkin lymphoma, all

245

686

3.96

76.90

3.9

1.4

3.13

2.96

g/l

1.57

236

594

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1812

11431

1.62

76.53

2.3

2.4

2.96

2.89

g/l

2.19

1661

10324

Chronic rhinitis, nasopharyngitis and pharyngitis

977

5211

1.93

76.44

2.2

2.3

2.86

2.89

g/l

0.41

892

4750

Other disorders of veins

1321

7592

1.76

76.33

2.2

2.3

2.95

2.89

g/l

1.57

1182

6860

Accidents

2090

6634

1.60

76.25

2.3

2.4

2.90

2.86

g/l

1.01

1882

6163

Type 2 diabetes, definitions combined

2649

10391

1.50

75.57

2.1

2.5

2.93

2.87

g/l

2.27

2403

9412

Other retinal disorders

2116

10463

1.57

75.56

2.3

2.4

2.89

2.92

g/l

0.48

1874

9448

Implicit fungal Sepsis, including avohilmo

328

1107

3.19

75.53

3.1

2.3

3.00

2.90

g/l

0.91

295

1003

Type 2 diabetes, strict (exclude DM1)

2664

10465

1.50

75.48

2.1

2.5

2.92

2.87

g/l

2.13

2418

9480

Abnormal findings on examination of urine, without diagnosis

227

613

4.09

75.01

3.3

2.6

2.81

2.96

g/l

1.33

216

563

Dysphagia

896

4707

1.97

74.06

2.3

2.5

2.84

2.95

g/l

2.81

811

4233

Systemic lupus erythematosus

186

440

4.71

73.62

1.7

2.4

3.09

2.88

g/l

1.71

175

404

Factors influencing health status and contact with health services

731

1679

2.23

73.56

2.4

1.9

2.92

2.96

g/l

0.38

671

1526

Sleep apnoea

2758

11923

1.48

73.52

2.1

2.4

2.80

2.90

g/l

7.00

2530

10878

Asthma, including avohilmo

3274

12699

1.44

73.37

2.1

2.4

2.93

2.88

g/l

2.00

3020

11499

Asthma, hospital admissions , main diagnosis only

2292

13316

1.52

73.37

2.1

2.4

2.95

2.88

g/l

2.64

2107

12072

Fracture of femur

1037

5141

1.88

73.08

2.3

3.06

2.95

g/l

2.40

815

4586

Abdominal and pelvic pain

2712

9238

1.49

72.62

2.4

2.3

2.84

2.91

g/l

3.47

2494

8353

Other acute lower respiratory infections

1600

9459

1.64

72.25

3.3

2.2

3.00

2.89

g/l

3.92

1481

8524

Other diseases of hard tissues of teeth

1703

5407

1.66

72.13

2.3

2.2

2.87

2.95

g/l

2.28

1522

4891

Statin medication

1581

5375

1.68

71.72

2.1

2.6

2.91

2.82

g/l

2.69

1466

4881

Shoulder lesions

2123

8290

1.56

71.64

2.2

2.4

2.87

2.91

g/l

1.12

1938

7491

Abnormalities of heart beat

1054

5691

1.84

71.33

2.2

2.3

2.80

2.91

g/l

3.16

951

5083

Pulmonary heart disease, diseases of pulmonary circulation

1142

6548

1.80

71.14

2.5

2.3

3.08

2.91

g/l

6.93

1050

5850

Undetermined asthma, excluding more controls

409

1585

2.68

71.09

2.1

1.7

2.95

2.76

g/l

3.74

377

1417

Unspecified privation

412

1614

2.70

71.02

2.0

2.3

3.20

2.93

g/l

5.65

385

1472

Irritable bowel syndrome

784

3984

2.02

70.87

2.3

2.2

2.71

2.89

g/l

6.34

708

3618

Disorders of gallbladder, biliary tract and pancreas

2872

12434

1.46

70.81

2.3

2.4

2.90

2.89

g/l

0.32

2601

11300

Other CVD

814

4216

2.01

70.81

2.5

2.3

2.90

2.95

g/l

0.60

708

3728

Diabetes, insulin treatment (Kela reimbursement)

2866

11843

1.46

70.70

2.0

2.5

2.94

2.87

g/l

2.47

2623

10725

Diseases of oral cavity, salivary glands and jaws

1716

5457

1.65

70.57

2.4

2.1

2.91

2.95

g/l

0.76

1532

4933

Disorders of lacrimal system

1376

8170

1.70

70.21

2.7

2.4

2.79

2.91

g/l

5.26

1231

7376

Other specified/unspecified systemic involvement of connective tissue

252

760

3.59

70.06

1.9

2.8

3.02

2.89

g/l

1.06

240

687

Episodal and paroxysmal disorders

2882

10116

1.46

69.83

2.0

2.5

2.81

2.94

g/l

9.77

2619

9199

Other and unspecified vasculitis limited to skin

152

322

5.45

69.65

2.4

3.12

3.04

g/l

0.37

147

291

Hypotension

728

3662

2.08

69.04

2.6

2.3

2.89

2.96

g/l

1.17

626

3236

Secondary and unspecified malignant neoplasm of lymph nodes

355

1315

2.88

68.75

1.8

1.4

3.18

2.90

g/l

4.70

336

1165

Gonarthrosis

1782

6346

1.61

68.67

2.1

2.5

2.88

2.86

g/l

0.23

1638

5757

Marginal zone B-cell lymphoma, including Hilmo

122

219

6.72

67.84

2.7

1.4

2.93

2.91

g/l

0.07

117

188

Nausea and vomiting

861

4468

1.93

67.72

3.0

2.4

2.92

2.95

g/l

0.28

791

3971

Postmenopausal osteoporosis with pathological fracture

332

1208

3.00

67.41

2.0

2.3

2.90

2.98

g/l

0.80

272

1071

Bacterial intestinal infections, IBD co-morbidities

671

3299

2.12

67.40

3.9

2.2

2.98

2.93

g/l

0.65

611

2967

Immunodeficiencies

216

605

3.89

67.40

4.5

2.4

2.81

2.90

g/l

0.60

202

561

Atherosclerosis, excluding cerebral and coronary sclerosis

1485

7219

1.66

66.87

2.1

2.4

3.16

2.88

g/l

19.56

1354

6426

Immunodeficiency with predominantly antibody defects

149

320

5.27

66.84

5.0

2.1

2.85

2.95

g/l

0.52

140

304

Biological medication for rheuma

499

2182

2.36

66.77

1.5

2.3

3.10

2.85

g/l

5.76

478

2040

Type 2 diabetes, definitions combined, including avohilmo

2597

10333

1.47

66.77

2.0

2.5

2.92

2.86

g/l

1.95

2359

9369

Asthma/COPD (KELA code 203)

2578

11914

1.46

66.25

2.1

2.4

2.93

2.86

g/l

3.12

2350

10808

Insulin, intermediate and long-acting

1700

10569

1.58

65.94

2.1

2.4

2.96

2.89

g/l

2.03

1557

9565

Temporal arteritis

212

601

3.97

65.90

1.7

2.7

3.74

2.95

g/l

13.30

188

530

Obesity

1712

10382

1.58

65.81

1.9

2.4

2.95

2.86

g/l

3.67

1576

9525

Coxarthrosis

1497

5947

1.66

65.56

2.2

2.6

2.88

2.87

g/l

0.06

1354

5379

Obesity and other hyperalimentation

1720

10438

1.57

65.47

1.9

2.4

2.95

2.86

g/l

3.66

1582

9574

Visual disturbances and blindness

1604

10225

1.60

65.30

2.3

2.84

2.91

g/l

2.03

1441

9215

Solid cancers, including Hilmo

2182

8490

1.52

65.25

2.3

1.4

2.98

2.86

g/l

5.60

2019

7685

Conduction disorders

971

4309

1.86

65.22

2.3

2.95

2.86

g/l

1.73

864

3833

Gingivitis and periodontal diseases

2764

9945

1.45

65.13

2.4

2.2

2.89

2.90

g/l

0.09

2484

9023

Other gastritis (incl. Duodenitis)

765

3984

1.99

65.07

2.3

2.4

3.01

2.93

g/l

1.47

688

3601

Acute bronchitis

1264

7463

1.70

65.06

3.3

2.2

3.02

2.90

g/l

4.11

1169

6681

Other diseases of liver

616

2972

2.15

65.01

2.0

2.4

2.83

2.89

g/l

0.94

561

2730

Lumbar disc prolapse

1737

8277

1.58

64.61

2.4

2.2

2.79

2.92

g/l

6.22

1604

7525

Other diseases of pericardium

209

589

3.86

64.58

1.7

2.4

3.34

2.91

g/l

4.80

190

522

Fibrosis and cirrhosis of liver

341

1283

2.85

64.36

1.6

2.6

2.94

2.90

g/l

0.34

315

1178

Insulin, combination of fast acting with intermediate-acting or long-acting

1872

11209

1.54

64.27

2.1

2.4

2.98

2.89

g/l

3.01

1716

10131

Diabetes medication

2818

11587

1.44

64.24

2.0

2.5

2.93

2.87

g/l

2.50

2567

10498

Ischemic heart diseases

2386

9718

1.48

63.94

2.4

2.5

2.92

2.86

g/l

1.93

2209

8776

Cardiomyopathy in other diseases

13.65

63.70

7.9

2.0

2.72

3.03

g/l

1.19

Any mental disorder

2978

10565

1.43

63.59

2.2

2.4

2.87

2.89

g/l

0.51

2685

9676

Other (seronegative) rheumatoid arthritis, wide

666

3339

2.08

63.51

2.1

2.3

3.16

2.91

g/l

6.61

615

2995

Retention of urine

1184

5668

1.74

63.40

2.1

2.5

2.98

2.91

g/l

1.36

1066

5118

SLE, ICD10

174

439

4.41

63.36

1.8

2.0

3.08

2.93

g/l

1.03

164

405

SLE, strict definition

174

439

4.41

63.36

1.8

2.0

3.08

2.93

g/l

1.03

164

405

Pulmonary embolism

1028

5925

1.79

62.97

2.6

2.3

3.07

2.91

g/l

5.73

945

5312

Pulmonary heart disease

1028

5931

1.79

62.74

2.6

2.3

3.07

2.91

g/l

5.62

945

5318

Cardiomyopathy, other and unspecified

309

1116

2.95

62.71

2.3

3.05

2.86

g/l

2.86

291

996

Soft tissue disorders related to use, overuse and pressure

862

4724

1.88

62.27

2.4

2.5

2.88

2.91

g/l

0.41

789

4271

Other abnormal findings of blood chemistry

216

639

3.67

62.01

3.0

2.4

2.87

2.92

g/l

0.30

207

588

Diffuse large B-cell lymphoma

238

752

3.46

61.84

1.8

1.4

3.32

2.93

g/l

4.98

222

665

Diffuse large B-cell lymphoma, including Hilmo

238

752

3.46

61.84

1.8

1.4

3.32

2.93

g/l

4.98

222

665

Diffuse large B-cell lymphoma, helper endpoint

238

752

3.46

61.84

1.8

1.4

3.32

2.93

g/l

4.98

222

665

Osteonecrosis

281

976

3.11

61.73

7.8

2.1

3.02

2.90

g/l

1.07

263

901

ILD, hospital admission 2, with pulmonary infections

403

1674

2.55

61.61

2.5

1.9

3.15

2.85

g/l

7.49

379

1494

Other dialysis

166

415

4.50

61.49

2.6

2.7

3.12

2.94

g/l

1.31

161

385

Zoster [herpes zoster], including avohilmo

1651

10369

1.57

61.40

3.0

2.3

2.85

2.91

g/l

1.84

1484

9327

Cutaneous abscess, furuncle and carbuncle

774

4116

1.93

61.40

2.1

2.3

2.99

2.87

g/l

2.50

724

3778

Hypokalaemia

440

1899

2.43

61.34

2.7

2.2

3.03

2.91

g/l

1.68

402

1691

Dental caries, including avohilmo

2129

7303

1.52

61.24

2.2

2.4

2.91

2.93

g/l

0.33

1916

6599

Other diseases of anus and rectum

951

5373

1.81

61.18

2.3

2.90

2.92

g/l

0.24

830

4813

Mycoses, including avohilmo

2534

13559

1.44

61.14

2.3

2.86

2.89

g/l

0.62

2294

12363

Undetermined asthma

409

1704

2.49

61.10

2.1

1.8

2.95

2.79

g/l

2.84

377

1532

Sleep apnoea, including avohilmo

2796

12013

1.43

61.09

2.0

2.4

2.79

2.91

g/l

7.54

2564

10958

Chronic periodontitis, complicated

1748

11247

1.55

60.90

2.5

2.97

2.87

g/l

3.98

1587

10276

Enterocolitis due to Clostridium difficile

430

1848

2.45

60.83

4.3

2.3

3.05

2.95

g/l

1.10

397

1657

Visual disturbances

1471

9367

1.60

60.56

2.3

2.84

2.90

g/l

1.72

1341

8477

Anxiety disorders, excluding more controls

2163

9401

1.49

60.16

2.3

2.4

2.81

2.88

g/l

2.91

1981

8639

Endocarditis

170

438

4.25

59.84

2.1

2.4

3.58

2.97

g/l

7.12

160

392

Percutaneous Coronary Intervention

2278

9544

1.47

59.25

2.2

2.5

2.93

2.86

g/l

2.50

2125

8612

Early onset COPD, excluding more controls

594

2917

2.10

59.24

2.1

2.0

3.15

2.78

g/l

14.09

548

2650

Urticaria and erythema

972

5593

1.78

59.19

2.3

2.84

2.88

g/l

0.62

895

5104

Chronic nephritic syndrome

187

521

3.95

59.10

2.7

2.6

3.15

2.93

g/l

2.19

179

482

Obesity, other/unspecified

892

5015

1.82

58.88

1.7

2.3

2.96

2.84

g/l

3.37

831

4623

Systemic lupus erythematosus, unspecified

153

371

4.60

58.83

1.8

2.0

3.09

2.93

g/l

0.95

145

344

Mood disorders

2749

12556

1.42

58.73

2.1

2.4

2.88

2.89

g/l

0.26

2502

11431

Mood [affective] disorders

2742

12549

1.42

58.52

2.1

2.4

2.88

2.89

g/l

0.26

2495

11425

Viral infections characterized by skin and mucous membrane lesions

1212

7419

1.67

58.48

3.4

2.3

2.85

2.89

g/l

0.88

1120

6740

Diseases of pulp and periapical tissues and dental caries

1917

6509

1.53

58.40

2.2

2.3

2.93

g/l

0.02

1720

5868

Exposure to other specified factors

2160

12818

1.47

58.13

2.1

2.3

2.94

2.87

g/l

2.44

1946

11740

Giant cell arteritis with polymyalgia rheumatica

212

653

3.64

58.09

1.7

2.6

3.74

2.96

g/l

12.97

188

580

Persons with potential health hazards related to communicable diseases

811

4401

1.86

57.95

2.3

2.1

2.84

2.85

g/l

0.03

784

4093

Malignant neoplasm of skin, including Hilmo

1572

6784

1.58

57.52

2.6

1.4

2.86

2.88

g/l

0.39

1418

6077

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

544

2634

2.16

57.36

1.5

2.5

2.98

2.90

g/l

1.04

488

2422

Agranulocytosis

405

1750

2.43

56.58

4.2

2.4

2.96

2.91

g/l

0.39

392

1595

Methotrexate

429

1895

2.35

56.38

1.9

2.6

3.06

2.83

g/l

4.62

403

1705

Emergency coronary revascularization (for ACS)

2501

10682

1.43

56.30

2.1

2.5

2.94

2.88

g/l

2.40

2322

9604

Convulsions, not elsewhere classified

573

2789

2.07

56.20

1.8

2.2

3.04

2.80

g/l

6.28

527

2542

Primary hyperparathyroidism

445

2013

2.34

56.15

2.7

2.4

2.79

2.96

g/l

3.08

398

1806

External causes of morbidity and mortality

1614

5191

1.58

55.95

2.3

2.92

2.86

g/l

1.27

1464

4812

GI-bleeding

1092

6608

1.70

55.78

2.3

3.04

2.92

g/l

3.59

1000

5909

Caries of dentine, including avohilmo

2230

7857

1.47

55.70

2.2

2.4

2.90

2.93

g/l

0.64

2008

7110

Coronary revascularization (ANGIO or CABG)

2258

9548

1.46

55.60

2.2

2.5

2.94

2.86

g/l

2.69

2106

8615

Other diseases of the digestive system

1089

6602

1.69

55.28

2.3

2.4

3.03

2.92

g/l

3.07

993

5911

Symptoms and signs involving speech and voice

1045

6266

1.71

55.26

2.5

2.3

2.86

2.90

g/l

0.85

947

5653

Idiopathic thrombocytopenic purpura

154

393

4.35

55.25

2.5

2.4

2.70

3.04

g/l

4.10

145

356

Other headache syndromes

1105

6688

1.68

54.98

1.9

2.6

2.76

2.92

g/l

6.70

1004

6097

Solid cancers

2091

8409

1.48

54.91

2.3

1.4

2.97

2.86

g/l

5.12

1930

7605

Anxiety (asthma-related co-morbidities)

1414

6853

1.59

54.83

1.9

2.4

2.82

2.85

g/l

0.74

1303

6344

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

1468

6362

1.59

54.70

2.6

1.4

2.86

2.89

g/l

0.52

1319

5670

Other and unspecified coagulation defects

200

609

3.52

54.65

2.6

3.02

2.96

g/l

0.40

190

561

Motor neuron disease ALS

114

232

5.55

54.46

1.4

2.2

2.47

3.04

g/l

7.58

108

214

Arthropathies in other diseases classified elsewhere

159

419

4.13

54.19

2.3

2.7

2.93

2.82

g/l

0.68

147

383

Later onset COPD, excluding more controls

743

3060

1.92

54.08

1.7

2.0

3.18

2.83

g/l

16.59

662

2678

Volume depletion

360

1508

2.50

53.80

1.9

2.3

3.10

2.93

g/l

2.01

311

1330

Noninfective enteritis and colitis

1259

7935

1.61

53.68

2.4

2.3

2.96

2.88

g/l

2.15

1153

7213

Motor neuron disease (with DMD)

114

235

5.45

53.59

1.4

2.2

2.47

3.04

g/l

7.70

108

216

Unspecified fall

1516

9795

1.55

53.49

2.2

2.3

2.98

2.90

g/l

2.04

1312

8873

Cardiomyopathies, Primary/intrinsic

421

1894

2.32

53.31

2.0

2.3

3.10

2.85

g/l

5.22

392

1687

Amputation

414

1855

2.35

53.30

2.1

2.3

3.21

2.91

g/l

7.03

379

1646

Diseases of pulp and periapical tissues, including avohilmo

2798

10471

1.40

53.28

2.2

2.3

2.89

2.90

g/l

0.06

2530

9495

COPD

1476

7822

1.57

53.17

1.9

2.5

3.14

2.88

g/l

19.60

1335

7030

Major coronary heart disease event

2412

10245

1.43

53.14

2.2

2.5

2.94

2.87

g/l

3.29

2235

9242

Other anxiety disorders

1049

5355

1.69

53.08

1.9

2.2

2.84

2.86

g/l

0.27

967

4955

Selective serotonin reuptake inhibitors

2631

9805

1.41

52.99

2.2

2.4

2.90

2.89

g/l

0.19

2398

8964

Other respiratory diseases principally affecting the interstitium

674

3630

1.93

52.28

2.5

2.3

3.11

2.91

g/l

6.11

635

3243

Obesity due to excess calories

1220

7694

1.61

52.16

1.9

2.5

2.91

2.84

g/l

1.66

1121

7075

Chronic ulcer of skin, not elsewhere classified

291

1124

2.76

52.11

2.2

2.3

3.02

2.93

g/l

0.65

268

1007

Depression

2483

11917

1.41

52.03

2.1

2.4

2.86

2.88

g/l

0.58

2259

10882

Type 1 diabetes

659

3504

1.92

51.96

1.8

2.4

2.94

2.87

g/l

0.89

621

3213

Candidiasis, including avohilmo

862

4983

1.77

51.95

2.6

2.3

2.84

2.90

g/l

0.97

773

4513

Non-allergic asthma (mode), excluding more controls

489

2323

2.14

51.88

2.0

1.9

3.07

2.78

g/l

8.81

452

2084

Cardiomyopathy (excluding other)

431

1980

2.27

51.85

1.9

2.4

3.10

2.85

g/l

5.40

402

1766

Malignant neoplasm of skin

1492

6592

1.56

51.70

2.6

1.4

2.86

2.89

g/l

0.56

1342

5890

Cirrhosis of liver, NAS

251

906

3.00

51.65

1.6

2.7

2.94

g/l

0.00

235

830

AV-block

631

2820

1.98

51.60

2.3

2.96

2.87

g/l

1.35

559

2467

Prurigo nodularis

139

348

4.50

51.49

1.7

2.9

2.89

3.07

g/l

1.28

127

315

Rotator cuff syndrome

1725

8003

1.51

51.40

2.3

2.5

2.87

2.91

g/l

0.94

1571

7239

Speech therapy

834

4810

1.79

51.11

2.4

2.3

3.05

2.90

g/l

4.37

796

4331

Iron deficiency anaemia secondary to blood loss (chronic)

557

2835

2.04

50.94

2.2

2.4

2.96

2.92

g/l

0.33

491

2534

Other coagulation defects

267

998

2.82

50.67

2.5

3.07

2.96

g/l

1.00

250

909

Conjunctivitis

1925

10741

1.46

50.63

2.3

2.84

2.88

g/l

1.34

1755

9781

All anxiety disorders

1427

7212

1.55

50.59

1.9

2.3

2.82

2.87

g/l

1.07

1316

6652

Substance abuse, excluding more controls

1476

8128

1.54

50.40

1.7

2.5

2.98

2.87

g/l

3.80

1317

7513

Amputation of toe

308

1251

2.63

49.89

2.1

2.5

3.19

2.96

g/l

3.23

282

1129

Subjective visual disturbances

775

4407

1.81

49.71

2.3

2.82

2.90

g/l

1.74

711

4002

Basal cell carcinoma, including Hilmo

1413

6231

1.57

49.63

2.6

1.4

2.88

2.89

g/l

0.09

1258

5549

ILD, hospital admissions 3, with pneumonia sepsis

346

1483

2.47

49.53

2.4

2.0

3.16

2.85

g/l

7.00

325

1327

Missing teeth due to accident, extraction or parodontitis

1903

11867

1.46

49.45

2.3

2.5

2.84

2.90

g/l

1.70

1643

10846

Pericarditis

156

434

3.89

49.17

1.9

2.2

3.42

2.93

g/l

5.20

143

389

Other neurological diseases

2167

11969

1.42

49.16

2.3

2.4

2.82

2.92

g/l

5.08

1932

10826

Insulin, fast-acting

1038

6395

1.66

49.09

2.0

2.4

2.93

2.88

g/l

0.78

961

5806

Seropositive rheumatoid arthritis, strict definition

504

2511

2.09

49.08

1.7

2.4

3.16

2.90

g/l

7.18

469

2279

Other inflammation of eyelid, including avohilmo

1110

6948

1.62

48.91

2.7

2.3

2.82

2.87

g/l

1.14

1001

6373

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

1337

8349

1.56

48.86

2.1

2.2

2.86

2.88

g/l

0.33

1213

7611

Other and unspecified immunodeficiencies with predominantly antibody defects

137

7.05

48.81

5.3

2.4

3.01

2.96

g/l

0.16

129

Abnormal involuntary movements

454

2182

2.16

48.67

2.2

2.4

2.78

2.94

g/l

2.85

410

1986

Other diseases of upper respiratory tract

2982

11534

1.36

48.53

2.3

2.85

2.92

g/l

3.26

2721

10437

Nonalcoholic fatty liver disease

338

1442

2.45

48.52

2.0

2.5

2.79

2.90

g/l

1.56

311

1337

Peripheral artery operations in Hilmo

482

2374

2.12

48.49

2.3

3.14

2.88

g/l

6.47

437

2116

Other diseases of arteries and capillaries

336

1434

2.46

48.38

2.4

3.15

2.88

g/l

4.34

305

1300

Injuries to the shoulder and upper arm

2392

13389

1.39

48.33

2.6

2.3

2.90

2.89

g/l

0.21

2129

12194

Chronic sinusitis

1146

7249

1.61

48.20

2.5

2.4

2.83

2.89

g/l

1.35

1063

6614

Other disorders of skin and subcutaneous tissue, not elsewhere classified

488

2423

2.09

47.92

2.2

2.84

2.93

g/l

1.09

437

2179

Open wound of head

1583

10104

1.49

47.53

2.3

2.4

2.97

2.90

g/l

2.16

1404

9182

Disorders of conjunctiva

2160

11974

1.41

47.35

2.3

2.84

2.89

g/l

1.57

1968

10900

Neurotic, stress-related and somatoform disorders

2226

11000

1.41

47.12

2.3

2.4

2.81

2.89

g/l

3.44

2042

10062

Other reaction to severe stress, and adjustment disorders

804

4676

1.75

46.88

2.6

2.2

2.79

2.86

g/l

1.38

754

4329

Allergic conjunctivitis

1380

8798

1.53

46.81

2.0

2.3

2.86

2.87

g/l

0.18

1253

8034

Other noninfective gastroenteritis and colitis

717

4055

1.81

46.66

2.7

2.3

2.97

2.91

g/l

0.94

657

3659

Anxiety disorders

2249

11110

1.40

46.53

2.3

2.81

2.89

g/l

3.56

2061

10156

Psychiatric diseases

2571

9395

1.39

46.40

2.3

2.5

2.87

2.89

g/l

0.52

2322

8634

Other and unspecified types of non-Hodgkin lymphoma, hilmo

198

667

3.24

46.35

3.1

2.7

3.06

3.01

g/l

0.23

185

602

Abnormal findings on diagnostic imaging of other body structures

496

2509

2.05

46.31

2.9

2.4

2.86

2.91

g/l

0.60

460

2268

Other malignant neoplasms of skin (=non-melanoma skin cancer)

1385

6191

1.55

46.27

2.6

1.4

2.86

2.89

g/l

0.70

1242

5513

Tumor necrosis factor alpha inhibitors

407

1909

2.19

46.02

1.4

2.4

3.09

2.86

g/l

4.28

388

1786

Deforming dorsopathies

748

4298

1.78

45.96

2.4

2.3

2.80

2.93

g/l

3.19

678

3880

Ischaemic heart disease, wide definition

2240

9929

1.41

45.93

2.4

2.5

2.94

2.87

g/l

2.40

2076

8952

Other (not insulin) diabetes medications

2626

11363

1.37

45.82

2.0

2.5

2.93

2.87

g/l

2.27

2382

10286

Acute upper respiratory infections

2835

12681

1.35

45.79

3.2

2.1

2.86

2.90

g/l

1.24

2596

11468

Sequelae of external causes of morbidity and mortality

811

4786

1.74

45.75

2.3

2.4

3.05

2.90

g/l

4.18

765

4333

Acute upper respiratory infections of multiple and unspecified sites

1982

10241

1.43

45.63

3.4

2.1

2.87

2.90

g/l

0.63

1829

9313

Zoster [herpes zoster]

640

3537

1.87

45.57

3.9

2.3

2.84

2.93

g/l

1.49

573

3159

Pleural effusion

574

3072

1.94

45.50

2.7

2.3

3.25

2.90

g/l

11.81

537

2751

Urticaria

743

4281

1.77

45.19

2.3

2.2

2.83

2.87

g/l

0.72

681

3922

Secondary uncertain malignant neoplasm

453

2238

2.10

45.14

1.9

1.4

3.24

2.89

g/l

8.35

421

1982

Fungal Sepsis

189

628

3.25

45.05

3.6

2.3

3.10

2.89

g/l

1.67

174

574

ILD, hospital admissions

570

3057

1.94

45.03

2.4

3.10

2.91

g/l

4.60

539

2746

Special screening examination for infectious and parasitic diseases

455

1593

2.11

44.96

2.4

2.2

2.84

2.90

g/l

0.67

414

1517

Benign neoplasm: Colon, unspecified

865

5226

1.71

44.94

2.4

2.95

2.90

g/l

0.63

748

4712

Diabetic retinopathy, excluding more controls

780

2486

1.81

44.73

1.9

2.2

2.95

2.89

g/l

0.82

711

2241

Other chronic obstructive pulmonary disease

1390

7615

1.53

44.59

1.9

2.5

3.16

2.88

g/l

20.31

1257

6847

Trochanteric bursitis

459

2289

2.07

44.39

2.3

2.4

2.90

2.94

g/l

0.43

414

2062

Voice disturbances

801

4751

1.73

44.30

2.7

2.3

2.87

2.89

g/l

0.23

736

4312

Stroke, including SAH

1949

9949

1.43

44.27

2.4

2.5

2.99

2.91

g/l

2.84

1736

8997

Drug-induced osteoporosis with pathological fracture

112

271

4.83

44.01

1.7

2.7

3.06

3.07

g/l

0.04

244

Calcific aortic valvular stenosis, including rheumatic fever

1052

6435

1.61

43.94

2.4

3.10

2.93

g/l

6.12

946

5687

Other interstitial pulmonary diseases

573

3103

1.92

43.90

2.4

3.11

2.91

g/l

4.96

542

2783

Osteomyelitis

250

976

2.72

43.81

2.4

2.2

3.18

2.94

g/l

2.83

231

902

Calcific aortic valvular stenosis, operated

1048

6420

1.61

43.72

2.4

3.10

2.93

g/l

6.15

942

5674

Calcific aortic valvular stenosis

1048

6420

1.61

43.72

2.4

3.10

2.93

g/l

6.15

942

5674

Overexertion and strenuous or repetitive movements

318

1383

2.40

43.70

2.5

2.4

3.10

2.91

g/l

2.94

289

1280

Interstitial lung disease endpoints

573

3109

1.92

43.64

2.4

3.11

2.91

g/l

4.88

542

2789

Interstitial lung disease

573

3109

1.92

43.64

2.4

3.11

2.91

g/l

4.88

542

2789

L01XX Other antineoplastic agents

261

1048

2.68

43.61

3.4

2.5

2.91

2.95

g/l

0.30

242

953

Operations 2 for CAVS

1047

6416

1.61

43.61

2.4

3.10

2.93

g/l

6.14

941

5670

Calcific aortic valvular stenosis, diagnosis (helper)

1047

6416

1.61

43.61

2.4

3.10

2.93

g/l

6.14

941

5670

Injuries to the knee and lower leg

3117

12819

1.33

43.27

2.0

2.4

2.89

2.88

g/l

0.16

2820

11677

Type 1 diabetes, wide definition, subgroup 1

512

2665

1.96

43.23

1.8

2.4

2.91

2.87

g/l

0.46

478

2464

Disorder of lipoprotein metabolism, unspecified

445

2221

2.08

43.19

1.9

2.3

3.08

2.90

g/l

3.21

409

1979

Fracture of shoulder and upper arm

1068

6833

1.59

43.04

2.7

2.3

3.00

2.92

g/l

1.90

929

6165

Isolated proteinuria with specified morphological lesion

141

6.54

42.97

4.7

2.7

2.92

2.97

g/l

0.16

129

Lichen simplex chronicus and prurigo

242

940

2.73

42.82

1.9

2.7

2.85

2.94

g/l

0.74

222

852

Insulin, fast-acting or short human

1042

6649

1.60

42.63

2.0

2.4

2.93

2.89

g/l

0.58

965

6031

Stroke, excluding SAH

1874

9631

1.43

42.43

2.4

2.5

2.99

2.91

g/l

2.79

1665

8698

Other symptoms and signs involving the nervous and musculoskeletal systems

1122

7294

1.57

42.23

2.1

2.4

2.57

2.91

g/l

27.39

1040

6614

Secondary right heart disease

196

692

3.07

42.18

1.9

2.5

3.04

3.02

g/l

0.08

183

625

Dental operations

1762

6308

1.46

42.12

2.3

2.2

2.91

2.96

g/l

1.04

1579

5702

Need for immunization against other single viral diseases

100

227

4.94

42.01

3.1

2.4

2.93

2.96

g/l

0.08

210

Disorders of continuity of bone

301

1300

2.41

41.91

3.9

2.1

2.84

2.90

g/l

0.48

276

1204

Basal cell carcinoma

1334

6074

1.53

41.86

2.6

1.4

2.88

2.89

g/l

0.18

1192

5403

Complications of internal orthopaedic prosthetic devices, implants and grafts

762

4539

1.73

41.77

2.1

2.4

2.99

2.91

g/l

1.29

683

4028

Spondylopathies (FG)

327

1462

2.30

41.64

1.8

2.6

2.98

2.78

g/l

3.12

312

1341

Implicit fungal Sepsis

174

579

3.25

41.43

3.8

2.3

3.05

2.89

g/l

1.08

159

529

Cellulitis

653

3730

1.80

41.33

2.9

2.3

3.02

2.89

g/l

2.50

611

3400

L04AC Interleukin inhibitors

203

731

2.91

41.32

1.6

2.4

3.05

2.90

g/l

1.12

194

683

Adverse effects, not elsewhere classified

512

2712

1.94

41.30

2.2

2.3

2.88

g/l

0.04

487

2498

Artrosis, including avohilmo

2116

8376

1.40

41.17

2.1

2.5

2.85

2.89

g/l

1.08

1924

7668

Rash and other nonspecific skin eruption

318

1420

2.34

41.15

2.4

2.96

g/l

0.03

300

1287

Coronary atherosclerosis

1896

8543

1.42

41.09

2.4

2.5

2.97

2.88

g/l

3.30

1753

7663

Asthma and allergy, excluding more controls

248

970

2.58

41.00

2.0

1.5

2.75

g/l

0.00

228

892

Ischaemic Stroke, excluding all haemorrhages

1782

9322

1.43

40.98

2.4

2.5

3.00

2.92

g/l

2.51

1583

8394

Injury, poisoning and certain other consequences of external causes

1260

4118

1.55

40.95

2.3

2.4

2.94

2.86

g/l

1.90

1148

3798

Non-allergic asthma (mode)

489

2532

1.96

40.90

2.0

1.9

3.07

2.80

g/l

7.66

452

2271

Superficial injury of head

722

4257

1.73

40.56

2.0

2.3

3.06

2.91

g/l

3.53

640

3831

Biguanides

2572

11641

1.35

40.53

1.9

2.5

2.94

2.87

g/l

2.47

2342

10544

Meniscus derangement

1394

6263

1.50

40.37

2.3

2.5

2.83

2.86

g/l

0.51

1273

5696

Diseases of the myoneural junction and muscle

422

2121

2.07

40.28

1.8

2.3

2.98

2.93

g/l

0.46

365

1912

Anaemia in chronic diseases classified elsewhere

123

337

4.04

40.11

1.9

2.6

2.81

3.02

g/l

1.40

114

306

Functional dyspepsia

731

4342

1.72

40.05

2.5

2.4

2.78

2.91

g/l

3.13

672

3960

ILD, hospital admissions 1, main diag only

509

2741

1.94

39.84

2.5

2.4

3.10

2.91

g/l

4.28

480

2464

Open wound of lower leg

468

2444

1.98

39.67

2.0

2.3

3.13

2.93

g/l

4.11

420

2211

Rheumatism, unspecified

394

1941

2.10

39.48

2.2

2.5

2.81

2.95

g/l

1.89

366

1740

Disease of hard tissues of teeth, NOS

1468

5238

1.49

39.32

2.2

2.82

2.94

g/l

4.60

1328

4751

Pacemaker

1221

7630

1.52

39.31

2.1

2.4

2.97

2.94

g/l

0.43

1078

6782

Other degenerative diseases of the nervous system

811

3578

1.69

39.27

1.9

2.5

2.84

3.04

g/l

5.86

708

3231

Somatoform disorder

446

2297

2.00

39.25

2.4

2.3

2.79

2.90

g/l

1.71

405

2112

Personality disorders, excluding more controls

524

2828

1.88

39.25

1.7

2.3

2.89

2.83

g/l

0.63

488

2654

Allergic asthma (mode), excluding more controls

450

2256

1.98

39.18

1.9

1.8

2.81

2.76

g/l

0.48

420

2061

Eosinophilic disease (BM)

141

5.92

39.05

2.5

1.6

3.05

2.83

g/l

0.90

130

Other inflammation of eyelid

455

2373

1.98

38.85

3.1

2.4

2.83

2.93

g/l

1.38

394

2160

Alcohol use disorder, Swedish definition

1465

9267

1.46

38.78

1.7

2.5

2.98

2.86

g/l

4.40

1316

8538

Migraine without aura

393

1938

2.06

38.66

2.0

2.2

2.78

2.87

g/l

1.12

371

1808

Atopic dermatitis

1294

6974

1.49

38.52

1.8

2.3

2.86

2.87

g/l

0.03

1182

6412

Acute sinusitis

1237

7581

1.50

38.41

3.4

2.1

2.84

2.88

g/l

0.78

1138

6940

Spondyloarthritis

484

2581

1.92

38.30

2.2

2.3

3.16

2.87

g/l

6.59

459

2338

Coxibs

724

2203

1.75

37.96

2.2

2.4

2.92

2.95

g/l

0.35

659

1998

Pain in thoracic spine

407

2056

2.03

37.82

2.9

2.2

2.72

2.94

g/l

4.44

381

1857

Other chronic obstructive pulmonary disease, including avohilmo

1672

9818

1.42

37.82

1.8

2.5

3.11

2.88

g/l

16.57

1510

8877

Other symptoms and signs involving the urinary system

355

1715

2.16

37.78

2.5

2.83

2.91

g/l

0.75

339

1548

Reactive arthropathies, FINNGEN

201

754

2.78

37.77

2.3

2.7

3.01

2.78

g/l

2.56

181

687

Viral pneumonia (unknown virus, not influenza)

228

914

2.62

37.66

3.5

2.5

3.07

2.95

g/l

0.88

216

839

1527

9610

1.44

37.61

1.6

2.5

2.99

2.87

g/l

5.28

1372

8851

Charcot foot

218

4.76

37.53

2.3

3.0

2.88

2.89

g/l

0.00

197

Other pulmonary heart/vessel disease

203

779

2.80

37.22

1.9

2.5

3.03

3.02

g/l

0.07

188

704

Nonorganic sleeping disorders, excluding more controls

480

2573

1.90

37.19

1.8

2.3

2.82

2.87

g/l

0.53

445

2394

Other general symptoms and signs

145

452

3.31

37.18

1.4

2.5

2.86

2.94

g/l

0.43

134

415

Type 1 diabetes, wide definition

527

2909

1.85

37.10

1.7

2.3

2.91

2.88

g/l

0.25

492

2675

Myeloproliferative diseases

309

1430

2.27

37.03

2.7

2.4

2.92

g/l

0.04

280

1293

Other extrapyramidal and movement disorders in other diseases

760

4671

1.67

36.83

2.2

2.4

2.78

2.91

g/l

3.53

685

4232

1584

9805

1.42

36.77

1.6

2.5

2.98

2.86

g/l

5.10

1425

9036

Other abnormalities of plasma proteins

214

4.82

36.77

5.4

2.8

3.08

3.02

g/l

0.20

192

Cholelithiasis, broad definition with cholecystitis

2362

11860

1.34

36.38

2.4

2.89

g/l

0.02

2138

10751

Hypoparathyroidism

164

570

3.12

36.38

1.8

2.4

2.86

3.02

g/l

1.23

144

516

DVT of lower extremities

592

3418

1.78

36.35

3.1

2.3

2.94

2.92

g/l

0.19

536

3083

Hypothyroidism, strict autoimmune

1725

8128

1.41

36.21

2.1

2.5

2.81

2.87

g/l

1.42

1564

7300

In situ neoplasms

1186

8073

1.50

36.13

2.5

2.4

2.95

2.91

g/l

0.67

1068

7226

Asthma and allergy

248

1030

2.42

36.08

2.0

1.6

2.75

g/l

0.02

228

942

Acetic acid derivatives and related substances

721

2191

1.73

35.96

2.2

2.4

2.95

g/l

0.00

656

1986

Diabetic neuropathy

419

2184

2.00

35.86

2.0

2.2

2.88

2.93

g/l

0.44

388

1981

Other diseases of lip and oral mucosa

1146

7754

1.50

35.85

2.6

2.4

2.81

2.88

g/l

2.01

1032

7070

Stomatitis and related lesions

550

3121

1.81

35.68

2.7

2.3

2.87

2.91

g/l

0.48

509

2845

Budesonide

362

1792

2.07

35.64

2.0

2.4

2.89

2.80

g/l

0.91

330

1630

Other disorders of bone

491

2694

1.87

35.53

3.8

2.0

2.87

g/l

0.00

450

2502

Other peripheral vascular diseases

272

1215

2.34

35.30

1.9

2.4

2.86

2.90

g/l

0.23

250

1111

Injuries to the elbow and forearm

1832

11526

1.38

35.14

2.1

2.4

2.93

2.88

g/l

1.18

1627

10496

Recurrent or chronic depression

900

3970

1.59

35.08

2.1

2.4

2.83

2.86

g/l

0.54

823

3719

Haemorrhage, not elsewhere classified

152

514

3.15

35.04

2.8

2.5

3.24

2.98

g/l

2.33

142

459

Psoriatic and enteropathic arthropathies

295

1361

2.23

35.00

1.8

2.6

3.04

2.78

g/l

3.84

277

1252

Persons encountering health services in other circumstances

997

6510

1.54

34.91

2.4

2.74

2.90

g/l

5.96

931

5842

Rare circulating lymphoid malignancy, including Hilmo

121

359

3.64

34.77

4.5

1.4

2.98

2.97

g/l

0.04

115

317

Gastroduodenal ulcer

801

5041

1.62

34.68

2.1

2.4

3.00

2.94

g/l

0.79

726

4529

All influenza (not pneumonia)

388

1989

2.00

34.62

4.7

1.9

2.87

2.81

g/l

0.55

355

1813

Hypocalcemia

116

338

3.79

34.60

4.6

2.6

2.99

3.00

g/l

0.04

102

315

Phobic anxiety disorders

257

1119

2.34

34.54

2.1

2.85

2.87

g/l

0.14

244

1052

Systemic atrophies primarily affecting the central nervous system

178

664

2.88

34.50

1.6

2.6

2.50

2.95

g/l

8.97

167

602

Bipolar affective disorders

407

2121

1.96

34.42

1.9

2.3

2.90

2.84

g/l

0.52

381

1979

Superficial injury of lower leg

675

4089

1.68

34.34

1.9

2.3

2.89

2.88

g/l

0.03

601

3715

Major coronary heart disease event excluding revascularizations

1784

8597

1.39

34.32

2.3

2.5

3.01

2.88

g/l

5.75

1620

7697

Mycoses

781

4912

1.62

34.30

3.0

2.4

2.85

2.89

g/l

0.61

718

4466

Myeloproliferative diseases (CML excluded)

282

1299

2.29

34.27

2.9

2.5

2.94

2.91

g/l

0.14

255

1177

Other disorders of eye and adnexa

400

2088

1.97

34.00

2.0

2.3

2.91

2.90

g/l

0.08

376

1913

Phlebitis and thrombophlebitis (not including DVT)

651

3926

1.70

33.95

2.9

2.3

2.89

2.90

g/l

0.06

596

3555

Abnormal serum enzyme levels

928

5870

1.56

33.95

2.2

2.4

2.97

2.87

g/l

2.38

863

5354

Caries of enamel

2406

12015

1.32

33.94

2.7

2.3

2.85

2.88

g/l

0.49

2200

11015

Paralytic ileus and intestinal obstruction

743

4631

1.64

33.74

2.9

2.4

3.00

2.92

g/l

1.15

678

4159

Cholelithiasis

2260

11713

1.33

33.46

2.4

2.88

2.89

g/l

0.11

2043

10607

Other viral diseases, including avohilmo

802

5041

1.60

33.40

3.3

2.1

2.90

2.86

g/l

0.61

770

4663

Benign neoplasm of other and ill-defined parts of digestive system

571

3348

1.76

33.37

2.2

2.4

2.92

g/l

0.05

523

3024

Non-invasive ventilation

522

2542

1.80

33.35

3.2

2.4

2.50

2.84

g/l

10.44

481

2324

Raynaud syndrome

265

1198

2.30

33.33

1.6

2.5

2.70

2.91

g/l

2.85

246

1100

Allergic asthma (mode)

450

2383

1.87

33.29

1.9

1.8

2.81

2.79

g/l

0.18

420

2179

Other and unspecified effects of external causes

643

3882

1.69

33.09

2.1

2.2

2.88

g/l

0.02

604

3571

Localized swelling, mass and lump of skin and subcutaneous tissue

859

5572

1.57

32.93

2.3

2.4

2.84

2.90

g/l

1.00

787

5050

Adalimumab

252

1119

2.32

32.89

1.4

2.4

3.00

2.88

g/l

1.04

241

1048

Disorders of synovium and tendon

1284

7614

1.45

32.81

2.0

2.4

2.79

2.90

g/l

3.94

1167

6912

Mental and behavioural disorders due to psychoactive substance use

1516

10020

1.40

32.72

1.7

2.5

2.99

2.86

g/l

5.21

1353

9213

Substance abuse

1476

9856

1.41

32.70

1.7

2.4

2.98

2.86

g/l

4.83

1317

9069

Reactive arthropathies

238

1039

2.37

32.41

2.2

2.5

2.99

2.85

g/l

1.26

213

956

Extrapyramidal and movement disorders

1156

8017

1.47

32.08

2.1

2.4

2.81

2.92

g/l

3.84

1031

7227

Metatarsalgia

274

1276

2.22

31.92

2.3

2.75

2.92

g/l

2.51

250

1168

Other enthesopathies

734

4623

1.61

31.85

2.0

2.4

2.75

2.89

g/l

3.62

666

4217

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

879

5773

1.55

31.84

2.3

2.87

2.89

g/l

0.22

807

5246

Hypertrophic cardiomyopathy

169

640

2.83

31.84

2.6

2.7

3.12

2.97

g/l

1.18

160

586

Intracranial injury

1537

10419

1.39

31.68

2.2

2.3

2.89

g/l

0.04

1365

9444

Disorders of sclera, cornea, iris and ciliary body

1426

10274

1.41

31.61

2.3

2.89

g/l

0.00

1315

9336

Gastric ulcer

555

3275

1.74

31.56

2.2

2.4

2.98

2.94

g/l

0.37

497

2936

Peripheral arterial reconstruction

589

3543

1.72

31.42

2.2

2.4

3.14

2.91

g/l

6.21

536

3148

Pyogenic arthritis

211

888

2.48

31.41

2.7

2.6

3.11

2.87

g/l

2.24

198

805

Conjunctivitis (acute, non atopic), including avohilmo

2567

12046

1.30

31.27

2.3

2.4

2.86

2.89

g/l

1.10

2358

10962

Papulosquamous disorders

1066

7311

1.48

31.26

2.2

2.4

2.92

2.88

g/l

0.50

982

6665

Other viral diseases

633

3849

1.67

31.19

3.6

2.1

2.93

2.86

g/l

0.97

609

3556

Diseases of spleen

228

4.27

31.12

2.1

3.05

3.04

g/l

0.02

209

Elevated blood glucose level

258

1189

2.26

31.02

2.0

2.2

2.97

2.92

g/l

0.32

230

1085

Myocardial infarction

1450

7289

1.41

31.00

2.2

2.5

3.05

2.88

g/l

8.08

1307

6510

Systemic sclerosis (FG)

264

3.94

30.97

2.0

3.1

2.93

2.71

g/l

1.53

240

Progressive vascular leukoencephalopathy

186

751

2.67

30.95

2.2

2.5

3.06

3.03

g/l

0.19

160

666

Polyarthritis, unspecified

131

437

3.18

30.95

2.7

2.5

3.30

2.81

g/l

4.58

125

398

Essential (haemorrhagic) thrombocythaemia

149

536

2.98

30.92

2.5

1.4

2.87

2.91

g/l

0.23

132

473

Fracture of lower leg, including ankle

1437

10210

1.40

30.84

2.1

2.4

2.91

2.88

g/l

0.37

1290

9285

Etanercept

188

757

2.59

30.75

1.5

2.4

3.17

2.90

g/l

2.54

182

707

Cervicalgia

546

3226

1.73

30.69

2.2

2.3

2.81

2.94

g/l

2.33

493

2913

Migraine

1044

5518

1.49

30.56

2.0

2.4

2.78

2.90

g/l

3.97

967

5088

Other metabolic disorders

332

1688

2.02

30.43

3.5

2.2

2.83

2.87

g/l

0.35

318

1540

Sequelae with surgical and medical care as external cause

621

3815

1.67

30.34

2.1

2.4

3.04

2.91

g/l

2.36

583

3444

Substance use, excluding alcohol

471

2678

1.80

30.31

1.6

2.4

2.96

2.86

g/l

1.26

409

2506

Presence of other functional implants

1710

8679

1.37

30.11

2.3

2.89

2.92

g/l

0.63

1521

7846

Sequelae of cerebrovascular disease

1153

6884

1.46

30.09

2.1

2.4

2.99

2.92

g/l

1.44

987

6184

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

458

2597

1.82

30.08

1.9

1.4

3.08

2.88

g/l

3.60

432

2328

Valvular operations

418

2306

1.87

30.03

1.7

2.3

3.12

2.85

g/l

5.73

380

2046

COPD, early/later onset

1406

8540

1.41

29.94

1.9

2.5

3.16

2.88

g/l

20.11

1270

7690

Recurrent aphthous stomatitis , including avohilmo

409

2245

1.87

29.85

2.6

2.3

2.83

2.94

g/l

1.38

378

2041

Other enthesopathy of foot (+metatarsalgia)

285

1383

2.12

29.83

2.3

2.74

2.92

g/l

2.72

259

1266

Migraine with aura

496

2873

1.75

29.65

1.7

2.4

2.79

2.89

g/l

1.71

460

2657

Generalized anxiety disorder

312

1560

2.03

29.60

1.8

2.3

2.77

2.87

g/l

1.14

289

1452

Diseases of external ear

974

6641

1.49

29.49

2.3

2.4

2.87

2.89

g/l

0.28

828

6051

Postprocedural endocrine and metabolic disorders, not elsewhere classified

309

1550

2.05

29.46

3.4

2.2

2.86

2.87

g/l

0.10

295

1412

Enthesopathies of lower limb, excluding foot

559

3361

1.70

29.37

2.4

2.2

2.85

2.90

g/l

0.56

509

3059

COPD related to multimorbidity

1255

7563

1.43

29.30

1.8

2.5

3.14

2.88

g/l

16.00

1127

6801

Viral pneumonia (known virus, not influenza)

122

406

3.25

29.22

6.8

2.7

2.87

2.98

g/l

0.56

113

365

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

269

1290

2.16

29.21

3.6

2.3

2.92

2.90

g/l

0.16

250

1176

Other hammer toe(s) (acquired)

489

2579

1.77

29.16

1.9

2.6

2.99

2.92

g/l

0.88

422

2287

Oxicams

617

2108

1.69

29.14

2.4

2.82

2.95

g/l

2.42

551

1906

Non-selective monoamine reuptake inhibitors

985

6474

1.48

28.87

2.3

2.5

2.92

2.89

g/l

0.44

894

5858

Superficial injury of hip and thigh

460

2641

1.79

28.85

1.9

2.3

3.04

2.94

g/l

1.15

397

2387

Gonarthrosis,primary

2514

11894

1.29

28.68

2.2

2.5

2.90

2.89

g/l

0.05

2270

10777

Decubitus ulcer and pressure area

230

1049

2.30

28.65

1.8

2.4

3.25

2.99

g/l

2.99

201

934

COPD, hospital admissions

1382

8476

1.40

28.42

1.9

2.5

3.16

2.88

g/l

19.25

1248

7634

Disorders of adult personality and behaviour

563

3420

1.67

28.29

1.8

2.2

2.87

2.84

g/l

0.37

526

3200

Diseases of salivary glands

839

5598

1.52

28.28

2.3

2.4

2.82

2.89

g/l

1.12

760

5099

Other complications of surgical and medical care, not elsewhere classified

287

1427

2.08

28.26

2.5

2.3

2.95

2.90

g/l

0.33

263

1301

Disorders of muscles

280

1381

2.09

28.09

1.7

2.2

2.86

2.91

g/l

0.47

260

1266

Use of pramipexole

660

4199

1.61

27.94

1.9

2.4

2.81

2.93

g/l

2.36

577

3777

Noninfectious colitis NAS

378

2067

1.88

27.94

2.7

2.3

3.03

2.92

g/l

1.26

351

1879

Fitting and adjustment of other devices

1078

6650

1.45

27.84

2.4

2.2

2.55

2.92

g/l

27.15

938

5898

Degeneration of macula and posterior pole

1523

8705

1.37

27.75

2.3

2.4

2.91

2.94

g/l

0.50

1324

7788

Restless leg syndrome

422

2396

1.81

27.66

2.0

2.4

2.73

2.92

g/l

3.64

379

2185

Oter anti-inflammatory and antirheumatic agents, non-steroids

611

2041

1.68

27.62

2.4

2.5

2.91

2.95

g/l

0.42

545

1839

Vascular disorders of the intestines

245

1162

2.20

27.59

2.5

2.1

3.06

2.96

g/l

0.77

228

1026

Collagenous colitis

289

1456

2.06

27.57

2.9

2.4

2.95

2.92

g/l

0.14

265

1324

Nonischemic cardiomyopathy

326

1711

1.97

27.56

2.3

3.04

2.88

g/l

2.15

304

1537

Disorders of the thyroid gland

2384

12125

1.29

27.50

2.2

2.4

2.84

2.89

g/l

2.15

2171

11019

Spondylolisthesis/Spondylolysis

480

2826

1.74

27.47

2.7

2.3

2.78

2.94

g/l

3.01

440

2557

Other pleural conditions

358

1944

1.91

27.41

2.9

2.4

3.18

2.92

g/l

5.21

327

1730

Paracetamol or NSAID medication

323

804

2.05

27.36

2.5

1.9

3.01

2.90

g/l

1.05

297

749

Injuries to unspecified part of trunk, limb or body region

306

1575

2.01

27.36

2.1

2.4

3.20

2.92

g/l

4.78

275

1433

Any death

1865

9956

1.33

27.19

3.0

2.4

3.26

2.81

g/l

53.81

1674

9038

Fissure and fistula of anal and rectal regions

596

3719

1.63

27.09

2.3

2.79

2.89

g/l

1.56

539

3391

Panic disorder

288

1449

2.03

27.07

1.6

2.3

2.80

2.89

g/l

0.96

266

1352

Cervical disc disorders

921

6318

1.48

27.01

2.4

2.3

2.76

2.92

g/l

5.79

834

5742

Cerebral palsy and other paralytic syndromes

315

1646

1.97

26.89

2.2

2.3

2.90

2.93

g/l

0.24

290

1505

Sequelae of other external causes

188

808

2.43

26.87

2.8

2.6

3.04

2.94

g/l

0.61

181

738

Heart failure and hypertrophic cardiomyopathy

284

3.68

26.73

3.0

2.7

3.20

2.99

g/l

1.14

256

Other and unspecified acquired haemolytic anaemias

136

5.19

26.59

3.1

1.7

2.92

2.97

g/l

0.14

126

Psoriasis

742

4894

1.54

26.52

2.0

2.4

2.98

2.88

g/l

2.15

686

4479

5-aminosalicylic acid

441

2559

1.75

26.40

1.9

2.4

2.97

2.79

g/l

3.33

410

2342

Injuries to the ankle and foot

1649

10631

1.34

26.35

2.2

2.3

2.87

g/l

0.10

1515

9773

Cardiodefibrillation

1101

7865

1.42

25.76

2.3

2.4

3.10

2.90

g/l

8.66

1015

7072

Crystal arthropathies, rheuma endpoint

267

3.64

25.40

1.6

3.1

3.31

2.87

g/l

2.26

236

Disorders of skin appendages

1124

8033

1.41

25.33

2.3

2.87

2.86

g/l

0.12

1048

7358

Migraine without aura and triptan purchases

299

1560

1.95

25.30

1.6

2.1

2.80

2.83

g/l

0.24

283

1448

Carpal tunnel syndrome

1579

10352

1.34

25.08

2.3

2.4

2.78

2.91

g/l

7.05

1462

9382

Neuromuscular dysfunction of bladder

273

1397

2.02

24.92

2.1

2.5

2.86

2.87

g/l

0.02

252

1268

Benign neoplasm: Transverse colon

367

2071

1.84

24.89

2.7

2.4

2.95

2.90

g/l

0.45

327

1878

Atopic dermatitis, strict definition with reimbursement

535

3178

1.64

24.87

1.9

2.1

2.85

2.86

g/l

0.12

489

2948

Other specified and unspecified disorders of eye and adnexa

136

523

2.75

24.82

2.3

2.4

2.97

2.93

g/l

0.18

128

479

Mixed and other personality disorders

183

802

2.35

24.76

1.7

2.1

2.89

2.87

g/l

0.12

176

756

Other or unspecified ileus, impaction or obstruction

520

3219

1.65

24.58

2.9

2.3

2.99

2.92

g/l

0.87

477

2887

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

1395

9474

1.35

24.53

2.0

2.4

2.88

2.86

g/l

0.21

1290

8698

Faecal incontinence

293

1545

1.96

24.52

1.7

2.5

2.83

3.00

g/l

1.92

266

1371

Myocardial infarction, strict

1333

6965

1.37

24.52

2.1

2.5

3.05

2.88

g/l

7.55

1206

6219

Other symptoms and signs involving the circulatory and respiratory systems

191

859

2.30

24.42

2.2

2.3

2.72

2.93

g/l

1.90

171

771

Fracture of forearm

1391

9328

1.35

24.35

2.0

2.4

2.94

2.89

g/l

0.92

1224

8436

Nonorganic sleeping disorders

480

2916

1.67

24.32

1.8

2.3

2.82

2.87

g/l

0.47

445

2694

Sub-endpoint used in defining T1D endpoints

694

4518

1.53

24.27

1.8

2.2

2.93

2.90

g/l

0.38

650

4099

Eosinophilia

208

3.97

24.17

2.5

2.4

3.05

3.07

g/l

0.05

193

Conjunctivitis (acute, non atopic)

645

4192

1.56

24.08

2.9

2.2

2.81

2.88

g/l

1.06

595

3843

Myocardial infarction, without ST-elevation

1249

8313

1.38

24.03

2.1

2.4

3.04

2.92

g/l

3.60

1116

7426

Herpesviral [herpes simplex] infections, including avohilmo

570

3624

1.60

23.95

2.8

2.2

2.86

2.88

g/l

0.16

528

3315

Other disorders of glucose regulation and pancreatic internal secretion

236

1163

2.10

23.90

2.0

2.4

2.92

2.97

g/l

0.32

213

1058

Amputation of foot

116

422

2.98

23.87

2.3

2.6

3.14

2.99

g/l

0.79

107

382

Persistent mood disorders

473

2881

1.67

23.82

2.1

2.3

2.88

2.91

g/l

0.28

438

2627

Cramp and spasm

148

605

2.56

23.70

2.7

2.4

2.74

2.92

g/l

1.63

136

561

Personality disorders

524

3273

1.62

23.66

1.7

2.2

2.89

2.84

g/l

0.58

488

3057

Other embolism and thrombosis

369

2111

1.80

23.64

2.9

2.2

3.09

2.93

g/l

2.14

345

1900

Other disorders of eyelid

1291

9057

1.36

23.61

2.2

2.4

2.87

2.93

g/l

1.65

1162

8135

Pneumonia derived septicemia

124

467

2.81

23.60

6.0

2.4

2.82

2.95

g/l

0.65

108

425

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

513

3146

1.63

23.59

1.9

2.2

2.88

2.85

g/l

0.37

466

2940

KRA_PSY_EATING, excluding more controls

116

412

2.84

23.57

1.4

1.8

2.79

2.86

g/l

0.37

110

388

Other and unspecified urticaria

451

2723

1.69

23.48

2.3

2.2

2.82

2.89

g/l

0.79

409

2500

Chronic pancreatitis

372

2140

1.79

23.46

1.8

2.4

3.03

2.89

g/l

1.79

339

1962

Malignant neoplasm of urinary organs, including Hilmo

349

1973

1.82

23.38

2.0

1.4

3.13

2.88

g/l

4.10

321

1745

Other infectious diseases, including avohilmo

274

1436

1.97

23.37

2.7

2.3

3.25

2.96

g/l

4.05

256

1307

Radiculopathy

442

2664

1.70

23.32

2.5

2.3

2.77

2.97

g/l

4.84

406

2387

Bullous disorders

204

968

2.21

23.17

1.9

2.5

2.88

2.98

g/l

0.72

193

877

Pneumococcal septicemia

119

444

2.84

23.09

5.9

2.5

2.81

2.97

g/l

0.88

104

405

Protozoal diseases

119

446

2.86

23.05

6.7

2.6

3.16

2.98

g/l

0.96

113

409

Fracture of foot, except ankle

570

3660

1.58

22.99

2.5

2.2

2.84

2.88

g/l

0.55

522

3378

Inflammatory bowel disease

726

4909

1.50

22.97

2.1

2.4

2.95

2.87

g/l

1.58

668

4515

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

309

1695

1.88

22.92

1.9

1.4

3.16

2.89

g/l

3.97

285

1500

Other encephalitis

100

341

3.12

22.91

2.0

2.7

2.93

2.95

g/l

0.06

317

Systemic sclerosis

321

3.22

22.88

2.0

2.2

2.93

2.91

g/l

0.06

293

Scoliosis

206

979

2.16

22.87

2.3

2.2

2.87

2.98

g/l

0.97

183

880

Other respiratory disorders and diseases

616

4040

1.56

22.87

2.1

2.3

3.03

2.91

g/l

1.93

547

3616

Other diseases of the respiratory system

616

4040

1.56

22.87

2.1

2.3

3.03

2.91

g/l

1.93

547

3616

Hallux valgus (acquired)

775

3761

1.49

22.85

2.2

2.6

2.96

2.87

g/l

1.60

687

3384

Dermatophytosis, including avohilmo

1621

12244

1.31

22.83

2.3

2.85

2.88

g/l

0.70

1462

11186

Other/unspecified reactive arthropathies

187

861

2.26

22.71

2.4

2.5

3.01

2.89

g/l

0.85

169

798

Ankylosing spondylitis

218

1064

2.11

22.61

1.6

2.2

3.01

2.94

g/l

0.46

209

977

Vasomotor and allergic rhinitis

777

5212

1.47

22.54

2.2

2.75

2.88

g/l

3.31

707

4783

Diabetic maculopathy, excluding more controls

296

1608

1.89

22.51

1.5

2.4

2.88

2.91

g/l

0.22

273

1463

Other crystal arthropathies

290

3.34

22.30

1.6

2.4

3.31

2.90

g/l

1.95

256

Heartburn

302

1656

1.87

22.23

2.1

2.4

2.69

2.94

g/l

5.15

268

1500

Idiopathic urticaria

228

3.60

22.23

1.3

2.0

2.76

2.94

g/l

0.84

217

Memory loss

310

1723

1.87

22.21

2.1

2.4

3.00

2.96

g/l

0.25

271

1558

COPD, hospital admission 2, with asthma infections

976

6028

1.42

22.20

1.9

2.5

3.21

2.89

g/l

17.64

877

5425

Mixed connective tissue disease

210

3.77

22.20

1.9

2.5

2.95

2.99

g/l

0.11

193

Unspecified acute lower respiratory infection

397

2356

1.72

22.19

3.2

2.2

2.99

2.91

g/l

0.81

373

2148

Psoriatic arthropathies

246

1262

2.00

22.18

1.9

2.6

3.06

2.84

g/l

2.34

228

1164

Open wound of ankle and foot

275

1466

1.93

22.17

2.5

2.3

3.08

2.93

g/l

1.76

251

1353

Congenital malformations, deformations and chromosomal abnormalities

1216

8567

1.36

22.01

2.0

2.3

2.86

g/l

0.10

1130

7869

Sarcoidosis

363

2111

1.77

22.00

1.9

2.3

2.83

2.90

g/l

0.69

340

1938

Encephalitis

103

366

2.99

21.91

1.9

2.6

2.89

2.94

g/l

0.17

340

Protozoal diseases, including avohilmo

120

465

2.76

21.76

6.6

2.8

3.16

2.95

g/l

1.24

114

427

Dilated cardiomyopathy

366

2147

1.76

21.67

1.9

2.4

3.10

2.91

g/l

3.10

341

1954

Benign neoplasm of other and unspecified endocrine glands

377

2230

1.74

21.53

2.5

2.3

2.87

2.91

g/l

0.33

339

2046

Amiodarone users

330

1887

1.81

21.49

2.2

2.4

3.08

2.92

g/l

2.23

311

1705

Carcinoma in situ of skin of other and unspecified parts of face

319

1811

1.83

21.39

2.3

2.4

3.00

2.99

g/l

0.05

293

1598

Exclusions for E4_PCOS_BROAD

403

2424

1.69

21.31

2.9

2.3

2.80

2.88

g/l

1.01

376

2235

Other and unspecified myopathies

280

1526

1.90

21.30

1.9

2.4

2.99

2.96

g/l

0.23

234

1373

Agoraphobia

199

3.64

21.24

1.8

1.9

2.88

2.94

g/l

0.21

190

Benign neoplasm: Sigmoid colon

577

3797

1.56

21.23

2.5

2.4

2.98

2.91

g/l

0.88

523

3431

Coxarthrosis, primary

1746

11376

1.29

21.21

2.2

2.5

2.89

2.92

g/l

0.46

1561

10223

Transient ischemic attack

1516

9302

1.31

21.18

2.2

2.4

2.85

2.92

g/l

1.83

1348

8372

Retinal detachments and breaks

1016

7425

1.39

21.10

2.7

2.5

2.89

2.91

g/l

0.23

916

6719

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

1251

9076

1.34

21.03

2.3

2.4

2.79

2.89

g/l

3.22

1147

8303

COPD, hospital admissions 3, with asthma pneumonia sepsis

846

5125

1.44

21.01

2.0

2.5

3.25

2.90

g/l

18.71

762

4585

Hydronephrosis

304

1702

1.83

20.98

1.9

2.2

3.09

2.89

g/l

2.48

280

1533

Diabetic retinopathy

1004

4502

1.41

20.92

1.8

2.1

2.94

g/l

0.02

906

4109

Diagnoses used for exclusion with ILD

702

4815

1.48

20.90

2.3

2.95

2.90

g/l

0.71

635

4348

Other skin changes

562

3687

1.56

20.86

3.1

2.4

2.79

2.94

g/l

2.68

497

3326

Ascites

238

1241

1.99

20.74

1.5

2.4

2.98

g/l

0.01

219

1126

Bronchiectasis

265

1434

1.92

20.72

2.8

2.5

3.00

2.91

g/l

0.88

246

1277

Lesion of ulnar nerve

369

2191

1.72

20.69

2.1

2.2

2.85

2.90

g/l

0.46

347

2025

Mental and behavioural disorders due to alcohol

1243

8921

1.34

20.69

1.6

2.5

2.99

2.87

g/l

4.21

1119

8230

Hyperplasia of prostate

990

4008

1.41

20.67

2.5

2.6

2.81

2.93

g/l

3.11

910

3703

Other and unspecified drugs and medicaments

243

1276

1.97

20.66

3.5

2.4

2.89

2.93

g/l

0.28

226

1161

Alcoholic liver disease

298

1670

1.84

20.66

1.3

2.4

2.99

2.91

g/l

0.69

252

1544

Demyelinating diseases of the central nervous system

194

939

2.12

20.60

1.6

2.2

2.69

2.89

g/l

2.14

182

874

Mucosal proctocolitis

290

1608

1.84

20.57

2.2

2.4

3.06

2.87

g/l

2.65

279

1498

Candidiasis

370

2204

1.72

20.49

3.2

2.3

2.87

2.92

g/l

0.36

335

2006

Vitreous haemorrhage

301

1696

1.83

20.49

2.1

2.4

2.89

2.93

g/l

0.21

281

1547

Intestinal malabsorption

147

642

2.39

20.40

2.0

2.6

2.93

2.91

g/l

0.07

138

586

Allergic urticaria

199

978

2.09

20.31

2.2

2.5

2.85

2.92

g/l

0.52

184

898

Disorders of vestibular function (Vertigo)

1284

9507

1.33

20.31

2.1

2.4

2.81

2.92

g/l

3.95

1143

8544

Chronic tubulo-interstitial nephritis

118

468

2.64

20.20

2.3

2.2

3.02

2.93

g/l

0.37

107

423

Other infectious diseases

232

1210

1.99

20.20

2.8

2.3

3.28

2.95

g/l

4.30

217

1099

1279

8745

1.34

20.20

2.8

2.4

2.85

2.95

g/l

2.66

1129

7781

Special screening examination for other diseases and disorders

266

1442

1.88

20.17

2.5

2.3

2.64

2.98

g/l

6.80

252

1326

Respiratory insufficiency

234

1219

1.97

20.14

1.7

2.99

2.80

g/l

2.10

203

1080

Thoracic aortic aneurysm

438

2742

1.64

20.14

2.5

2.6

3.02

2.84

g/l

3.61

392

2515

Autoimmune hepatitis, wide definition

131

546

2.50

20.12

1.7

2.7

2.99

2.91

g/l

0.37

121

490

Diseases of inner ear

1470

10909

1.30

19.93

2.0

2.4

2.81

2.91

g/l

3.94

1313

9841

Vitamin B12 deficiency anaemia

307

1755

1.80

19.85

2.2

2.4

3.02

2.93

g/l

0.83

279

1575

Mental and behavioural disorders due to alcohol, excluding acute intoxication

1090

8050

1.36

19.79

1.7

2.4

2.98

2.86

g/l

3.81

979

7425

Juvenile arthritis (FINNGEN)

290

3.05

19.78

1.9

2.2

2.96

2.79

g/l

0.84

272

Benign neoplasm: Stomach

305

1747

1.81

19.74

2.5

2.4

2.98

2.93

g/l

0.37

277

1584

Disorders of vitreous body and globe

1441

10562

1.31

19.69

2.5

2.82

2.90

g/l

2.85

1305

9563

Congenital malformations of the urinary system, including avohilmo

159

727

2.26

19.66

2.0

2.5

3.09

2.93

g/l

1.30

151

674

Fenamates

363

1453

1.73

19.65

2.2

2.4

2.97

2.95

g/l

0.14

330

1305

Other/unspecified rheumatoid arthritis

367

2212

1.71

19.64

1.9

2.3

3.05

2.95

g/l

1.06

332

1975

Ulcerative colitis

560

3713

1.53

19.63

2.2

2.3

2.96

2.87

g/l

1.23

514

3416

Fibroblastic disorders

605

4081

1.51

19.58

2.4

2.5

2.84

2.91

g/l

1.23

549

3680

Special screening examination for neoplasms

177

845

2.16

19.58

2.8

2.2

2.88

2.98

g/l

0.59

160

780

Carcinoma in situ of skin of scalp and neck

125

523

2.58

19.54

2.1

2.7

3.02

3.05

g/l

0.11

114

466

Cutaneous lupus erythematosus

340

2.96

19.53

2.1

2.2

2.72

2.97

g/l

1.78

310

Internal derangement of knee

812

5722

1.42

19.49

2.2

2.5

2.89

2.85

g/l

0.54

721

5223

Folate deficiency anaemia

158

4.12

19.40

2.8

2.0

3.10

3.07

g/l

0.07

142

Abnormal results of function studies

239

1275

1.93

19.35

2.4

2.6

2.72

2.91

g/l

2.44

221

1177

Migraine with aura and triptan purchases

280

1562

1.82

19.34

1.6

2.0

2.77

2.85

g/l

0.79

266

1439

Congenital malformations of the urinary system

150

675

2.30

19.30

2.0

2.5

3.10

2.94

g/l

1.14

143

625

Herpesviral [herpes simplex] infections

296

1687

1.80

19.26

3.3

2.4

2.93

2.90

g/l

0.16

280

1541

Thyroiditis, ILD-related definition

262

1439

1.86

19.23

2.3

2.4

2.86

g/l

0.01

237

1310

Artificial joint operation, meniscal resection

2411

12628

1.23

19.17

2.2

2.4

2.90

2.89

g/l

0.18

2183

11460

Thyrotoxicosis, other and/or unspecified

486

3145

1.57

19.13

2.0

2.3

2.94

2.90

g/l

0.50

446

2860

Psoriasis vulgaris

473

3047

1.58

19.07

1.8

2.3

3.00

2.88

g/l

1.86

436

2809

Chronic laryngitis and laryngotracheitis

380

2325

1.67

19.06

1.9

2.3

2.65

2.94

g/l

6.84

333

2108

Suppurative and necrotic conditions of lower respiratory tract

182

892

2.13

19.02

2.6

2.5

3.29

2.95

g/l

3.76

170

811

Other disorders of ear

2341

12361

1.23

19.00

2.3

2.78

2.92

g/l

9.16

2092

11291

Personal history of malignant neoplasm

237

1270

1.92

18.96

2.5

2.1

3.26

2.91

g/l

4.56

217

1157

Skin changes due to chronic exposure to nonionizing radiation

1222

8435

1.33

18.96

2.9

2.4

2.85

2.95

g/l

2.86

1080

7492

Systemic sclerosis, icd10

352

2.89

18.90

2.0

2.1

2.93

2.91

g/l

0.05

324

Thyrotoxicosis

620

4236

1.49

18.83

1.9

2.3

2.97

2.89

g/l

1.22

563

3834

Actinic keratosis

1198

8296

1.33

18.83

2.9

2.4

2.85

2.95

g/l

2.98

1057

7366

Pain associated with micturition

321

1885

1.75

18.83

2.4

2.57

2.93

g/l

9.67

286

1709

Mixed hyperlipidaemia

129

552

2.45

18.83

1.6

2.2

2.99

2.93

g/l

0.25

118

505

Barrett oesophagus

167

797

2.19

18.77

2.4

2.8

2.78

2.94

g/l

1.08

151

732

Fall on and from stairs and steps

673

4675

1.46

18.75

2.3

2.4

2.95

2.91

g/l

0.61

597

4252

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

355

2072

1.69

18.74

1.8

2.4

2.95

2.89

g/l

0.58

331

1911

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

382

2276

1.66

18.73

1.8

2.3

2.96

2.89

g/l

0.67

355

2094

Other disorders of the musculoskeletal system and connective tissue

419

2640

1.63

18.72

2.4

2.3

2.92

g/l

0.03

394

2402

Traumatic subdural haemorrhage

387

2229

1.66

18.71

2.3

2.4

2.96

3.07

g/l

1.36

333

2001

Primary gonarthrosis, bilateral

1477

9662

1.29

18.70

2.0

2.5

2.94

2.90

g/l

0.82

1321

8696

Delirium, not induced by alcohol and other psychoactive substances

403

2513

1.64

18.68

2.1

2.4

3.10

2.95

g/l

2.01

351

2236

Other shoulder lesions

228

1210

1.93

18.67

1.5

2.3

2.84

2.90

g/l

0.44

211

1114

Cyst of kidney

235

1267

1.93

18.66

2.5

2.6

2.85

2.95

g/l

0.80

221

1153

Disorders of vitreous body

1398

10345

1.30

18.63

2.4

2.5

2.81

2.90

g/l

3.12

1268

9372

Early onset COPD

594

4039

1.50

18.61

2.1

2.5

3.15

2.84

g/l

10.27

548

3686

Oesophageal varices

138

614

2.36

18.48

1.6

2.4

3.01

2.92

g/l

0.53

126

560

Primary biliary cholangitis, wide definition

278

3.10

18.44

1.5

2.4

3.04

2.95

g/l

0.41

253

Other and unspecified local infections of skin and subcutaneous tissue

262

1461

1.84

18.43

3.1

2.4

2.97

2.92

g/l

0.29

239

1335

Fracture of skull and facial bones

518

3428

1.54

18.39

2.8

2.3

2.91

2.88

g/l

0.23

464

3158

Haemorrhoids and perianal venous thrombosis

849

6113

1.40

18.39

2.4

2.77

2.91

g/l

4.00

765

5490

Other local infections of skin and subcutaneous tissue

275

1559

1.81

18.29

3.1

2.4

2.96

2.92

g/l

0.24

247

1421

Hypoglycaemia, other or unspecified

182

902

2.08

18.29

1.7

2.3

2.91

2.98

g/l

0.46

166

821

Atopic dermatitis, strict definition

500

3206

1.54

18.26

1.9

2.1

2.86

2.84

g/l

0.18

463

2997

Injury of unspecified body region

219

1159

1.95

18.26

1.7

2.5

3.20

2.94

g/l

3.10

193

1053

Iridocyclitis

561

3783

1.51

18.24

2.4

2.3

2.95

2.90

g/l

0.58

517

3442

Allergic rhinitis

557

3692

1.51

18.23

2.3

2.1

2.72

2.86

g/l

3.13

510

3422

Alcohol induced polyneuropathy

137

4.24

18.20

1.4

2.0

2.73

3.07

g/l

1.39

124

Intestinal stricture

864

6305

1.39

18.19

2.8

2.4

2.98

2.91

g/l

1.08

783

5663

Other viral diseases, not elsewhere classified, including avohilmo

529

3498

1.52

18.15

3.2

2.2

2.89

2.87

g/l

0.18

505

3224

Other diseases of stomach and duodenum

201

1038

2.01

18.10

2.3

2.6

2.95

2.97

g/l

0.10

188

940

Other diseases of pancreas

259

1453

1.84

18.02

2.3

2.5

2.99

2.93

g/l

0.41

236

1326

Acute pancreatitis

521

3479

1.53

17.84

2.0

2.4

3.01

2.90

g/l

1.64

478

3166

Biomechanical lesions, not elsewhere classified

164

793

2.16

17.81

2.4

2.5

2.88

2.94

g/l

0.46

155

724

Hypothyroidism, other/unspecified

2124

11378

1.24

17.78

2.2

2.4

2.81

2.90

g/l

3.97

1934

10323

Guillain-Barre syndrome

202

3.48

17.62

3.1

2.1

2.79

3.07

g/l

1.26

187

Ocular pain

213

1129

1.94

17.60

1.6

2.6

2.87

2.93

g/l

0.45

200

1031

Poisoning by drugs, medicaments and biological substances

464

3025

1.55

17.59

2.0

2.3

2.99

2.86

g/l

2.13

423

2812

Social phobias

135

602

2.28

17.52

1.9

2.80

2.91

g/l

0.65

130

571

Spirochaetal infections, other/unspecified

257

1451

1.83

17.48

2.5

2.81

2.91

g/l

0.86

218

1329

Epilepsy

722

5125

1.42

17.45

2.0

2.5

2.92

2.94

g/l

0.26

642

4659

Pyothorax

142

655

2.27

17.43

2.9

2.6

3.24

2.99

g/l

1.80

131

597

Aortic aneurysm

676

4675

1.44

17.42

2.3

2.4

3.10

2.86

g/l

8.12

603

4221

Pollen allergy

298

1720

1.73

17.38

2.5

2.2

2.80

2.87

g/l

0.64

268

1626

Other inflammatory liver diseases

186

948

2.03

17.38

1.8

2.7

3.02

2.91

g/l

0.69

166

866

Diseases of male genital organs

1173

4465

1.34

17.35

2.2

2.5

2.83

2.93

g/l

2.67

1092

4141

Invasive ventilation

216

1159

1.93

17.35

2.4

2.5

3.46

2.94

g/l

10.25

200

1056

Other/unspecified enthesopathies of lower limb, excluding foot

175

873

2.06

17.23

2.3

2.2

2.89

2.93

g/l

0.15

162

800

Other lack of coordination

215

3.35

17.23

2.0

2.8

2.69

3.00

g/l

1.71

194

Exclusions for E4_PCOS_CONSORTIUM

1500

7354

1.28

17.21

2.2

2.86

2.90

g/l

0.63

1350

6670

Diplopia

356

2205

1.65

17.10

2.0

2.3

2.82

2.93

g/l

1.11

326

2015

Adhesive capsulitis of shoulder

413

2647

1.59

17.08

2.0

2.5

2.90

2.92

g/l

0.13

377

2402

Primary biliary cholangitis (PBC)

269

3.04

17.03

1.7

2.1

2.96

2.99

g/l

0.09

245

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

275

1595

1.77

17.01

2.8

2.5

3.02

2.93

g/l

0.68

258

1460

Hernia of abdominal wall

1178

9081

1.31

17.01

2.4

2.91

2.88

g/l

0.30

1089

8258

Lesion of lateral popliteal nerve

142

662

2.23

16.89

2.5

2.4

2.73

2.94

g/l

1.73

127

612

therapeutic use

117

506

2.45

16.89

2.1

2.6

2.77

2.95

g/l

0.96

456

Covid-19 suspected case

431

2791

1.57

16.89

2.7

2.2

2.96

2.85

g/l

1.65

402

2576

Alcohol use disorder, ICD-based

993

7481

1.34

16.88

1.7

2.4

2.99

2.86

g/l

3.59

898

6905

Viral hepatitis, including avohilmo

165

812

2.09

16.85

2.2

2.1

2.98

2.88

g/l

0.63

151

761

Dermatitis due to substances taken internally

145

682

2.20

16.79

3.8

2.7

2.87

2.99

g/l

0.73

135

623

Hypermobility syndrome

104

423

2.53

16.76

2.2

1.9

2.84

2.90

g/l

0.32

406

Hypothyreosis and Thyroxine purchase for inclusion criteria

2214

11941

1.22

16.74

2.2

2.4

2.81

2.90

g/l

4.05

2013

10825

Acute nephritic syndrome

261

3.07

16.74

2.3

2.6

2.98

2.95

g/l

0.10

239

Problems related to lifestyle

222

1210

1.87

16.72

1.5

2.4

2.93

2.88

g/l

0.34

206

1107

Vitamin deficiency

139

645

2.24

16.71

2.4

2.5

2.88

2.95

g/l

0.34

124

587

Vitamin deficiency, wide

139

645

2.24

16.71

2.4

2.5

2.88

2.95

g/l

0.34

124

587

Other and unspecified visual disturbances

285

1677

1.74

16.70

2.4

2.93

2.92

g/l

0.02

265

1535

Emotionally unstable personality disorder

201

1064

1.92

16.51

1.7

1.9

2.81

2.85

g/l

0.21

187

1006

Other viral hepatitis, including avohilmo

139

646

2.21

16.49

2.3

2.1

3.00

2.89

g/l

0.71

129

613

Poisoning by medicine

417

2696

1.57

16.47

2.1

2.3

2.99

2.86

g/l

1.97

382

2515

Olecranon bursitis

177

905

2.02

16.42

2.7

2.2

2.92

2.91

g/l

0.07

161

835

Diseases of the ear and mastoid process

2666

11169

1.20

16.41

2.3

2.78

2.92

g/l

9.97

2424

10232

Benign neoplasm: Ascending colon

433

2841

1.56

16.37

2.3

2.4

2.93

2.92

g/l

0.08

389

2561

Cystic kidney disease

401

2.59

16.37

2.0

2.5

3.20

2.95

g/l

1.46

369

Alcohol-induced chronic pancreatitis

178

914

2.02

16.34

1.8

2.5

3.06

2.89

g/l

1.18

157

852

Neuralgia and neuritis, unspecified

141

664

2.20

16.31

2.4

2.74

2.93

g/l

1.52

126

612

Acute posthaemorrhagic anaemia

109

462

2.47

16.30

3.2

2.6

3.13

3.05

g/l

0.32

411

Fentanyl

276

1616

1.74

16.29

5.7

1.8

2.96

2.92

g/l

0.29

240

1423

Ptosis of eyelid

336

2081

1.66

16.28

2.5

2.4

2.86

2.93

g/l

0.81

314

1883

Infections with a predominantly sexual mode of transmission

523

3546

1.49

16.21

2.1

2.80

2.83

g/l

0.28

483

3303

Other and unspecified mood [affective] disorders

131

598

2.24

16.18

1.8

2.1

2.92

2.89

g/l

0.13

123

558

Other disorders of bladder

338

2100

1.65

16.11

2.2

2.4

2.94

2.87

g/l

0.68

303

1894

Viral hepatitis

158

780

2.08

16.04

2.2

3.00

2.87

g/l

0.94

144

730

Malignant neoplasm of kidney, except renal pelvis

258

1496

1.78

16.03

1.9

1.4

3.12

2.90

g/l

2.63

238

1325

Transport accidents

951

5941

1.34

16.03

1.9

2.3

2.85

g/l

0.01

871

5535

Speech disturbances, not elsewhere classified

266

1556

1.76

16.02

1.9

2.4

2.79

2.95

g/l

1.81

231

1407

Other viral hepatitis

133

615

2.22

16.01

2.3

2.0

3.03

2.87

g/l

1.14

123

582

Other viral diseases, not elsewhere classified

384

2449

1.59

15.92

3.6

2.2

2.94

2.89

g/l

0.38

368

2252

Sequelae of injuries, of poisoning and of other consequences of external causes

551

3808

1.47

15.86

2.6

2.4

2.92

2.88

g/l

0.52

497

3513

Intestinal adhesions without obstruction

238

1352

1.81

15.85

3.8

2.2

3.04

2.94

g/l

0.84

212

1220

Specific personality disorders

425

2783

1.55

15.83

1.8

2.2

2.87

2.84

g/l

0.36

394

2598

Sequelae of injuries of lower limb

229

1286

1.83

15.80

2.4

2.98

2.87

g/l

0.95

214

1189

Unspecified nephritic syndrome

298

2.86

15.77

2.2

2.5

3.12

2.98

g/l

0.57

275

Inflammatory diseases of the central nervous system

212

1165

1.87

15.74

2.8

2.6

2.84

2.93

g/l

0.65

188

1068

Ankylosing spondylitis, ICD10

208

1138

1.88

15.64

1.6

2.4

3.04

2.89

g/l

1.32

199

1059

Angina pectoris

1514

8015

1.27

15.64

2.4

2.6

2.92

2.88

g/l

0.79

1397

7178

Impingement syndrome of shoulder

564

3930

1.46

15.56

2.4

2.5

2.70

2.90

g/l

4.67

501

3588

Hyperhidrosis

270

2.87

15.49

2.2

2.4

2.58

2.94

g/l

3.31

245

Injuries to the neck

503

3430

1.49

15.48

2.6

2.3

2.78

2.88

g/l

1.56

458

3159

Other specified/unspecified bacterial intestinal infections

190

1016

1.93

15.48

3.3

2.4

2.94

2.93

g/l

0.02

170

929

Cystic kidney disease, including avohilmo

102

430

2.48

15.47

2.0

2.5

3.18

2.96

g/l

1.32

395

Nummular dermatitis

231

1311

1.81

15.46

2.3

2.6

2.84

2.95

g/l

0.92

211

1191

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

385

2486

1.58

15.45

2.7

2.3

3.07

2.89

g/l

3.49

362

2279

Pemphigoid

108

470

2.44

15.45

1.5

2.4

2.95

3.03

g/l

0.38

101

420

Other demyelinating diseases of the central nervous system

363

2.60

15.42

1.7

2.1

2.67

2.86

g/l

1.06

344

Keratitis

833

6203

1.36

15.38

2.3

2.86

2.88

g/l

0.26

763

5651

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

375

2388

1.59

15.38

2.5

1.4

2.94

2.93

g/l

0.12

332

2079

COPD-related respiratory insufficiency

363

2323

1.60

15.37

2.0

2.5

3.16

2.88

g/l

5.50

319

2068

Familial hypercholesterolemia

403

2638

1.56

15.30

2.6

2.3

2.81

2.91

g/l

1.08

358

2334

Hallux rigidus

341

2149

1.62

15.26

2.1

2.6

2.82

2.89

g/l

0.68

294

1943

Other spirochaetal diseases, including avohilmo

830

6190

1.36

15.24

2.6

2.4

2.82

2.88

g/l

1.06

744

5656

Striking against or struck by other objects

709

5147

1.39

15.19

2.0

2.3

2.89

2.87

g/l

0.24

632

4763

Malignant neoplasm of urinary organs

277

1663

1.71

15.16

1.8

1.4

3.12

2.90

g/l

2.83

256

1466

Other specified/unspecified hearing loss

270

1611

1.72

15.16

2.5

2.3

2.81

2.98

g/l

2.19

257

1460

Erosion of teeth , including avohilmo

537

3722

1.46

15.15

2.4

2.2

2.85

g/l

0.06

501

3448

Unspecified urinary incontinence

255

1499

1.75

15.12

1.5

2.4

2.73

2.97

g/l

2.55

199

1337

Other bursopathies

334

2102

1.62

15.05

2.2

2.3

2.93

g/l

0.04

309

1899

Cervicocranial syndrome

254

1490

1.74

15.02

2.0

2.2

2.85

2.96

g/l

1.02

235

1339

Benign neoplasm: Rectum, anus and anal canal

574

4049

1.45

14.98

2.4

2.95

2.90

g/l

0.48

519

3658

Speech and linguistic disorders, excluding more controls

125

539

2.21

14.97

2.1

2.3

2.88

3.03

g/l

0.83

116

490

Anosmia

137

3.61

14.94

3.5

1.3

2.81

2.79

g/l

0.05

121

Other spirochaetal diseases

819

6116

1.36

14.92

2.6

2.4

2.82

2.88

g/l

1.13

734

5587

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

699

5015

1.39

14.91

2.1

2.2

2.84

2.85

g/l

0.07

643

4665

Macular pucker

485

3323

1.49

14.91

2.0

2.6

2.96

2.91

g/l

0.50

423

2994

Open wound of forearm

240

1390

1.77

14.90

2.3

2.99

2.96

g/l

0.21

217

1273

Left bundle-branch block

207

1151

1.85

14.86

1.7

2.3

2.84

2.88

g/l

0.22

177

1023

Spirochaetal infections, other/unspecified, including avohilmo

818

6112

1.36

14.85

2.6

2.4

2.82

2.88

g/l

1.02

733

5582

Ventral hernia

622

4454

1.42

14.80

2.7

2.3

2.90

2.91

g/l

0.07

573

4018

Benign thyroid growths and nodules

834

5809

1.35

14.68

2.2

2.4

2.92

g/l

0.05

752

5189

Tubulo-interstitial nephritis, not specified as acute or chronic

172

905

1.95

14.64

2.8

2.1

2.94

2.91

g/l

0.15

158

820

Viral and other specified intestinal infections, including avohilmo

480

3148

1.48

14.63

2.3

2.1

2.93

2.86

g/l

0.90

458

2889

Other localized connective tissue disorders

259

2.92

14.59

2.7

2.0

3.09

3.01

g/l

0.29

237

Behavioural syndromes associated with physiological disturbances and physical factors

2190

12362

1.21

14.58

2.1

2.4

2.85

2.89

g/l

1.21

1985

11269

Superficial injury of abdomen, lower back and pelvis

359

2313

1.58

14.55

2.2

2.89

2.92

g/l

0.19

322

2114

Other and unspecified injuries of head

203

1129

1.85

14.55

1.8

2.4

2.89

2.95

g/l

0.39

176

1020

Benign neoplasm: Caecum

331

2103

1.62

14.54

2.6

2.4

2.87

2.92

g/l

0.38

304

1906

Lyme disease, including avohilmo

810

6063

1.35

14.54

2.6

2.4

2.82

2.88

g/l

1.13

725

5542

Lyme disease

810

6063

1.35

14.54

2.6

2.4

2.82

2.88

g/l

1.13

725

5542

Postviral fatigue syndrome

5.89

14.54

1.2

2.3

2.73

2.72

g/l

0.01

Abnormality of white blood cells, not elsewhere classified

107

4.22

14.52

2.4

2.1

2.82

2.91

g/l

0.19

100

Otitis externa

534

3735

1.45

14.46

2.3

2.80

2.90

g/l

1.42

468

3437

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

123

575

2.18

14.39

1.6

2.0

2.94

2.87

g/l

0.41

108

549

Colonic or urogenital fistula

641

4634

1.40

14.38

2.5

2.4

2.84

2.89

g/l

0.63

577

4232

Benign paroxysmal vertigo

776

5786

1.36

14.37

2.1

2.4

2.76

2.93

g/l

5.36

692

5208

Acute pancreatitis (for exclusion)

521

3638

1.46

14.33

2.0

2.4

3.01

2.89

g/l

1.67

478

3309

Temporomandibular joint disorders, including avohilmo

852

6229

1.34

14.19

2.2

2.73

2.87

g/l

4.36

784

5724

Malignant melanoma, including Hilmo

448

3047

1.50

14.16

2.6

1.4

2.94

2.88

g/l

0.53

396

2720

Ulcerative colitis, NAS

304

1897

1.63

14.16

2.0

2.4

2.95

2.89

g/l

0.52

285

1747

Malignant melanoma

406

2708

1.53

14.15

2.7

1.4

2.94

2.88

g/l

0.50

359

2421

Other diseases of oesophagus

261

1573

1.70

14.08

2.4

2.5

2.77

2.95

g/l

1.93

242

1427

Insulin, fast-acting (human)

282

1732

1.65

13.97

1.7

2.1

2.90

g/l

0.03

264

1605

Disorders of orbit

125

599

2.17

13.96

3.4

2.6

3.01

2.95

g/l

0.21

119

550

Gingival hyperplasia

104

463

2.34

13.96

3.4

2.6

3.17

2.98

g/l

1.04

427

Myocarditis

430

2.36

13.87

2.6

2.1

2.73

2.71

g/l

0.06

387

Synovial cyst of popliteal space [Baker]

197

1103

1.84

13.85

2.5

2.2

2.93

2.95

g/l

0.12

182

996

Acute peritonitis

180

982

1.89

13.83

2.4

2.5

3.09

2.95

g/l

1.00

175

893

Diseases of peritoneum

271

1658

1.68

13.82

2.1

2.4

2.99

2.94

g/l

0.34

252

1498

Personal history of other diseases and conditions

188

1028

1.85

13.82

4.1

2.0

2.90

2.91

g/l

0.06

166

951

Drug-induced polyneuropathy

116

4.01

13.80

14.7

1.5

2.73

3.14

g/l

2.00

109

Trigger finger

334

2145

1.58

13.78

1.6

2.4

2.84

2.92

g/l

0.70

309

1964

Mouth breathing

915

7022

1.32

13.61

2.5

2.4

2.75

2.86

g/l

2.76

857

6480

Squamous cell neoplasms and carcinomas of the skin

301

1898

1.62

13.57

2.6

1.4

2.91

2.92

g/l

0.10

266

1642

Artificial joint re-operation

220

1285

1.77

13.54

2.0

2.5

3.01

2.93

g/l

0.49

201

1153

Gonarthrosis, primary, with knee surgery

1611

10271

1.23

13.49

2.3

2.5

2.96

2.90

g/l

1.27

1446

9268

Bacterial, viral and other infectious agents, including avohilmo

195

1096

1.82

13.45

3.3

2.3

2.93

g/l

0.00

184

1024

Mental and behavioural disorders due to sedatives or hypnotics

147

755

2.00

13.44

1.4

2.2

2.90

2.88

g/l

0.11

130

704

Chronic viral hepatitis

105

475

2.27

13.42

2.0

3.00

2.83

g/l

0.97

455

Other congenital malformations, including avohilmo

246

1477

1.69

13.31

2.0

2.4

3.00

2.90

g/l

0.88

232

1367

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

424

2891

1.49

13.22

2.8

2.3

3.08

2.90

g/l

3.93

401

2641

Drug-induced cataract

320

2.61

13.22

2.5

2.90

2.98

g/l

0.26

295

Cluster headache, strict

354

2.48

13.19

1.8

2.9

2.77

2.98

g/l

1.35

328

Dementia in Alzheimer disease

274

3618

0.62

13.18

1.6

2.3

2.76

2.99

g/l

2.95

204

3189

Carbimazole or st.post thyroidectomy, condition for graves disease

468

3253

1.46

13.18

2.4

2.3

2.93

2.89

g/l

0.41

429

2965

Other hearing loss

843

6247

1.32

13.06

2.4

2.3

2.87

2.98

g/l

2.87

743

5596

Eating disorder

116

549

2.14

13.05

1.4

1.7

2.79

2.89

g/l

0.63

110

524

Impacted cerumen

327

2123

1.58

13.05

2.3

2.4

2.84

2.92

g/l

0.72

243

1927

Malignant neoplasm of other connective and soft tissue

328

2.57

13.01

4.0

1.4

3.15

2.97

g/l

0.60

293

Background retinopathy and retinal vascular changes

293

2.67

12.98

1.8

3.0

2.88

3.03

g/l

0.55

270

Cervicobrachial syndrome

464

3227

1.46

12.98

2.2

2.3

2.76

2.91

g/l

3.08

436

2924

Benign neoplasm of mouth and pharynx

283

1779

1.63

12.96

3.2

2.4

2.87

2.92

g/l

0.34

255

1625

Benign neoplasm: Rectum

509

3612

1.44

12.96

2.4

2.96

2.90

g/l

0.64

459

3264

Infections with a predominantly sexual mode of transmission, including avohilmo

633

4235

1.38

12.91

2.1

2.0

2.81

2.84

g/l

0.34

587

3947

Benign neoplasm: Adrenal gland

225

1339

1.73

12.89

2.2

2.6

3.02

2.89

g/l

0.95

202

1224

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

115

553

2.17

12.83

2.5

3.00

2.99

g/l

0.03

106

508

Adrenocortical insufficiency

102

467

2.27

12.83

2.8

2.6

2.70

2.98

g/l

1.96

433

Other disorders of adrenal gland

117

565

2.14

12.80

2.6

2.5

2.73

2.94

g/l

1.56

110

528

Coeliac disease

274

1712

1.63

12.79

2.5

2.2

2.66

2.91

g/l

4.74

253

1562

Umbilical hernia

650

4804

1.37

12.78

2.1

2.4

2.93

2.88

g/l

0.62

606

4429

Acute pharyngitis

260

1583

1.65

12.77

2.8

2.1

2.84

2.87

g/l

0.24

247

1482

Alcohol-induced acute pancreatitis

101

462

2.28

12.75

2.1

2.6

3.00

2.91

g/l

0.29

432

Polycythaemia vera

104

484

2.25

12.63

2.5

1.4

3.06

2.96

g/l

0.44

422

Other abnormal uterine and vaginal bleeding

509

2579

1.44

12.59

2.2

2.3

2.76

3.02

g/l

5.29

418

2304

Cluster headache, wide

393

2.36

12.57

1.8

2.7

2.77

3.00

g/l

1.63

362

Pain and other conditions associated with female genital organs and menstrual cycle

353

1943

1.53

12.57

2.0

2.2

2.75

2.92

g/l

2.98

316

1779

Benign neoplasm: Rectosigmoid junction

134

688

2.04

12.56

2.2

2.7

2.83

2.97

g/l

0.82

119

627

Microscopic polyangiitis

4.35

12.48

1.5

2.0

3.57

3.11

g/l

1.22

Hepatic failure, not elsewhere classified

111

533

2.17

12.43

1.9

2.7

2.78

2.96

g/l

1.20

101

485

Anterior Iridocyclitis

472

3328

1.44

12.36

2.5

2.3

2.93

2.90

g/l

0.23

435

3040

Cholecystectomy

1767

12520

1.21

12.32

2.4

2.87

2.90

g/l

0.55

1604

11306

Other and unspecified injuries of lower leg

171

950

1.84

12.31

2.3

2.5

2.86

2.94

g/l

0.48

160

869

Fracture of neck

181

1028

1.82

12.28

3.2

2.3

2.77

2.96

g/l

2.03

164

934

Fall involving bed

115

564

2.13

12.25

2.4

2.5

3.05

3.08

g/l

0.10

501

Acute and subacute iridocyclitis

442

3086

1.45

12.22

2.6

2.3

2.94

2.90

g/l

0.33

407

2819

Superficial injury of thorax

366

2465

1.51

12.20

1.6

2.3

2.93

2.92

g/l

0.09

322

2251

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

513

3671

1.41

12.20

1.9

2.2

2.88

2.85

g/l

0.30

466

3421

Other specified and unspecified personality disorders

172

960

1.83

12.17

1.9

2.2

3.00

2.85

g/l

1.30

160

896

Other disorders of patella

301

1942

1.57

12.15

2.2

2.5

2.77

2.83

g/l

0.48

276

1811

Acute generalized exanthematous pustulosis

123

618

2.06

12.15

3.9

2.6

2.88

2.97

g/l

0.44

115

565

Parkinson's disease, strict definition, excluding more controls

333

2050

1.54

12.14

1.8

2.5

2.93

3.08

g/l

1.73

291

1845

Crohn disease

265

1665

1.62

12.07

1.7

2.3

2.98

2.88

g/l

1.03

248

1536

Lung cancer and mesothelioma

481

2888

1.43

12.05

2.2

2.0

3.31

2.80

g/l

19.29

438

2569

Retinal vascular occlusion

351

2356

1.52

12.05

2.5

2.4

2.98

2.93

g/l

0.36

317

2096

Eating disorders

154

830

1.88

12.04

2.0

1.9

2.84

2.89

g/l

0.26

145

777

Cardiac arrest

151

685

1.91

11.97

2.1

2.3

3.14

2.79

g/l

3.38

135

605

Follow-up examination after treatment for malignant neoplasms

239

1469

1.66

11.96

2.5

2.2

2.98

3.02

g/l

0.26

217

1318

Cardiomyopathy, Hypertrophic obstructive

218

2.86

11.87

1.8

2.7

3.14

3.00

g/l

0.47

196

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

353

2.40

11.86

1.5

1.9

2.79

2.78

g/l

0.04

341

Sleep disorders

2072

12080

1.19

11.85

2.0

2.4

2.85

2.89

g/l

1.28

1879

11013

Misadventures to patients during surgical and medical care

359

2427

1.51

11.80

2.2

2.3

2.96

2.90

g/l

0.56

323

2193

Other orthopaedic follow-up care

148

799

1.91

11.79

1.7

2.0

2.91

g/l

0.01

136

722

Sacroiliitis, not elsewhere classified

391

2.30

11.77

2.1

2.0

2.96

2.93

g/l

0.08

364

Autoimmune hepatitis

4.07

11.76

1.6

2.6

2.96

3.21

g/l

0.59

Total colectomy

108

524

2.13

11.73

2.6

2.94

2.92

g/l

0.05

102

485

Total colectomy operation

108

524

2.13

11.73

2.6

2.94

2.92

g/l

0.05

102

485

Deviated nasal septum

760

5814

1.32

11.69

2.7

2.4

2.75

2.90

g/l

4.82

699

5361

Other symptoms and signs involving the digestive system and abdomen

387

2658

1.48

11.67

2.3

2.4

2.75

2.96

g/l

3.28

333

2395

Fall on same level involving ice and snow

1388

11397

1.23

11.66

2.1

2.4

2.86

2.89

g/l

0.64

1234

10356

Artificial opening status

159

883

1.86

11.65

3.2

2.3

3.17

2.99

g/l

1.40

148

804

Parkinson's disease, excluding more controls

351

2173

1.51

11.65

1.9

2.6

2.95

3.07

g/l

1.31

306

1958

Polycystic ovarian syndrome, consortium definition

1431

6708

1.23

11.63

2.1

2.2

2.80

2.92

g/l

3.88

1255

6090

Carcinoma in situ of skin of upper limb, including shoulder

103

497

2.20

11.63

2.7

3.13

3.09

g/l

0.18

438

Retinal vascular disorders

353

2391

1.51

11.60

2.5

2.4

2.98

2.94

g/l

0.30

319

2128

Bacterial, viral and other infectious agents

177

1013

1.78

11.56

3.2

2.3

2.95

2.91

g/l

0.16

166

948

Enteropathic arthropathies

226

2.77

11.55

1.4

2.4

2.97

2.79

g/l

0.66

212

Superficial injury of wrist and hand

415

2893

1.45

11.52

2.0

2.2

2.79

2.88

g/l

1.34

380

2668

Exposure to other and unspecified inanimate mechanical forces

169

958

1.80

11.43

2.7

2.4

3.05

2.91

g/l

1.17

164

885

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

292

1899

1.56

11.43

1.9

2.3

2.98

2.85

g/l

1.49

266

1786

Disorders of myoneural junction and muscle in diseases classified elsewhere

107

3.81

11.41

1.6

2.4

2.85

3.02

g/l

0.37

Speech and linguistic disorders

126

620

1.98

11.41

2.1

2.0

2.88

3.00

g/l

0.66

117

570

Biological medicines for asthma

228

2.75

11.38

1.9

2.63

2.95

g/l

1.94

219

Glucagon-like peptide-1 (GLP-1) analogues

706

5378

1.33

11.34

1.8

2.6

2.89

2.83

g/l

0.87

656

4966

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

706

5378

1.33

11.34

1.8

2.6

2.89

2.83

g/l

0.87

656

4966

Other infective otitis externa

155

860

1.85

11.34

2.6

2.4

2.74

2.91

g/l

1.78

140

794

Anti-inflammatory and antirheumatic products, non-steroids

602

2212

1.38

11.33

2.6

2.4

2.99

2.95

g/l

0.32

550

2007

Disorders of psychological development

157

803

1.83

11.32

1.9

2.86

2.95

g/l

0.52

147

745

Alcohol abuse, main dg, excluding more controls

311

2058

1.53

11.28

1.3

2.5

2.93

2.87

g/l

0.51

280

1925

Menorrhagia

669

2783

1.35

11.28

2.0

2.2

2.78

3.00

g/l

5.93

570

2500

Emphysema

214

1304

1.69

11.24

2.7

2.5

3.09

2.87

g/l

2.85

197

1171

Excessive, frequent and irregular menstruation

713

2865

1.34

11.19

2.0

2.2

2.79

2.99

g/l

5.55

632

2580

Suggestive for eosinophilic asthma

237

1482

1.64

11.18

2.3

2.4

2.94

2.90

g/l

0.38

226

1357

Mental and behavioural disorders due to opioids

282

2.51

11.16

1.7

1.9

3.02

2.94

g/l

0.31

270

Symptoms and signs involving emotional state

303

2.46

11.01

1.7

2.1

3.00

g/l

0.01

277

Clear cell adenocarcinoma of kidney

133

712

1.93

10.99

1.6

1.4

3.10

2.93

g/l

0.99

122

632

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

238

1497

1.63

10.99

2.4

2.88

2.90

g/l

0.09

210

1359

Inflammatory diseases of female pelvic organs

1249

6953

1.24

10.96

1.8

2.3

2.84

2.90

g/l

1.30

1110

6294

Ovarian cyst

659

2820

1.35

10.94

2.1

2.2

2.82

2.99

g/l

4.08

603

2546

Inguinal hernia

1392

7613

1.22

10.91

2.7

2.3

2.86

2.90

g/l

0.99

1283

6925

IBD patients in KELA-register

446

3183

1.42

10.89

2.3

2.98

2.86

g/l

1.66

419

2956

Visual impairment including blindness (binocular or monocular)

191

1140

1.72

10.86

2.1

2.3

2.79

2.99

g/l

1.71

154

1018

Arthropathic psoriasis

261

1682

1.58

10.79

1.8

2.5

3.09

2.89

g/l

2.13

242

1557

Causalgia

162

3.05

10.73

1.2

2.2

2.49

2.91

g/l

1.99

156

D07AA Corticosteroids, weak (group I)

284

1860

1.54

10.72

1.8

2.3

2.98

2.90

g/l

0.66

256

1715

Pneumonia due to Streptococcus pneumoniae

103

508

2.09

10.71

5.6

1.9

2.87

2.89

g/l

0.06

456

Other and unspecified nerve root and plexus disorders, also in other diseases

465

3355

1.40

10.71

2.5

2.4

2.60

2.91

g/l

10.43

417

3088

Carcinoma in situ of skin

259

1675

1.59

10.71

2.1

2.5

3.04

2.96

g/l

0.59

238

1502

Traumatic subarachnoid haemorrhage

482

2.12

10.68

2.5

2.6

3.10

3.06

g/l

0.14

443

Other follicular disorders

156

882

1.81

10.66

2.5

2.3

2.80

2.88

g/l

0.55

145

821

Suicide or other Intentional self-harm

458

3296

1.40

10.65

1.9

2.3

2.92

2.87

g/l

0.48

417

3064

Hypothyroidism, strict autoimmune, 3 medication purchases required

1933

11034

1.18

10.65

2.1

2.4

2.83

2.90

g/l

2.52

1748

9989

MS-disease / Multiple Sclerosis

139

759

1.87

10.64

1.6

2.1

2.62

2.92

g/l

3.35

134

706

Bullous pemphigoid

368

2.33

10.62

1.4

2.6

2.98

3.07

g/l

0.36

329

Other/unspecified synovitis and tenosynovitis

247

1577

1.59

10.60

1.9

2.3

2.87

2.92

g/l

0.30

227

1435

Propionic acid derivatives

596

2212

1.37

10.58

2.5

2.4

2.97

2.95

g/l

0.11

540

2007

Mental disorders, not otherwise specified

153

864

1.80

10.48

1.9

2.3

2.86

2.88

g/l

0.10

147

806

Viral and other specified intestinal infections

328

2173

1.49

10.40

2.3

2.0

2.96

2.90

g/l

0.54

310

1996

Otalgia

192

1159

1.69

10.40

2.0

2.4

2.75

2.95

g/l

2.05

167

1059

Generalized skin eruption due to drugs and medicaments

106

536

2.05

10.36

4.1

2.7

2.83

2.99

g/l

0.83

493

Calculus of kidney and ureter

750

5837

1.30

10.36

2.1

2.4

2.94

2.89

g/l

0.63

685

5320

Blepharochalasis

759

5922

1.30

10.31

2.1

2.5

2.85

2.93

g/l

1.35

682

5321

Superficial injury of ankle and foot

228

1438

1.61

10.27

1.8

2.4

2.85

2.90

g/l

0.36

210

1343

Diabetic retinopathy, strict definition

433

2761

1.42

10.23

1.7

2.1

2.84

2.93

g/l

1.07

393

2515

Follicular lymphoma, hilmo

133

731

1.89

10.23

1.6

2.7

3.09

2.98

g/l

0.67

123

664

Colectomy operation

445

3221

1.41

10.19

2.7

2.4

3.01

2.92

g/l

1.24

407

2889

Other superficial mycoses, including avohilmo

204

1256

1.65

10.17

1.9

2.3

2.89

2.91

g/l

0.11

188

1158

Insomnia

1996

11883

1.17

10.11

2.0

2.4

2.85

2.89

g/l

1.12

1811

10837

Other/unspecified enthesopathies, not elsewhere classified

198

1215

1.66

10.09

1.8

2.2

2.86

2.94

g/l

0.48

181

1104

Paraplegia, diplegia of upper limbs

286

2.46

10.08

2.1

2.5

3.00

g/l

0.01

263

Diseases of tongue

149

847

1.80

10.06

2.8

2.1

2.67

2.98

g/l

3.20

135

754

Monoamine oxidase A inhibitors

267

1758

1.55

10.04

2.1

2.5

2.86

2.89

g/l

0.25

244

1607

Vascular diseases of the intestine

120

641

1.94

10.03

2.9

2.4

3.24

2.97

g/l

2.10

112

572

Carcinoma in situ of other and unspecified digestive organs

134

743

1.87

10.00

1.9

2.6

3.01

2.94

g/l

0.37

127

676

Cerebral cysts

126

682

1.89

9.99

1.5

2.4

2.70

2.98

g/l

2.15

114

629

Other disorders of nervous system

181

1092

1.70

9.95

2.8

2.5

2.67

2.95

g/l

3.89

162

1000

Other/unspecified disorders of vestibular function

124

672

1.91

9.93

1.7

2.6

2.97

2.96

g/l

0.05

111

616

Ganglion

402

2868

1.42

9.88

2.2

2.3

2.67

2.89

g/l

5.22

361

2618

Supplementary factors related to causes of morbidity and mortality classified elsewhere

698

5416

1.30

9.84

2.0

2.3

2.77

2.89

g/l

2.57

598

4935

Psoriatic arthropathies, ICD10

241

1560

1.58

9.83

1.9

2.4

3.06

2.89

g/l

1.63

223

1443

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

184

1106

1.68

9.83

1.7

2.2

2.93

2.91

g/l

0.12

174

1028

Cryoglobulinemia

13.44

9.82

4.4

1.3

3.01

3.04

g/l

0.03

Monoplegia

194

2.78

9.79

2.2

2.6

2.93

3.01

g/l

0.31

178

Hyperkinetic disorders, excluding more controls

113

550

1.93

9.73

1.4

1.8

2.64

2.80

g/l

1.09

107

529

Superficial injury of shoulder and upper arm

272

1811

1.53

9.71

2.3

2.2

2.85

2.92

g/l

0.50

245

1667

Secondary thrombocytopenia

167

2.94

9.70

4.2

1.7

3.20

2.99

g/l

0.50

156

Xerosis cutis

261

2.51

9.69

1.6

2.6

2.73

2.99

g/l

1.23

237

Disorders of optic nerve and visual pathways

202

1260

1.63

9.64

2.2

2.5

2.99

2.90

g/l

0.58

187

1161

Idiopathic pulmonary fibrosis

227

1461

1.60

9.63

2.1

2.4

3.09

2.92

g/l

1.90

210

1303

Crohn's disease NAS

133

741

1.83

9.61

1.9

2.4

2.99

2.90

g/l

0.51

123

686

Malignant neoplasm of digestive organs, including Hilmo

1027

6120

1.24

9.59

2.2

1.4

3.05

2.89

g/l

5.33

920

5457

Respiratory disorders in diseases classified elsewhere

191

2.79

9.57

1.7

2.2

2.99

3.03

g/l

0.10

177

Dermatographic urticaria

139

786

1.81

9.56

1.9

2.6

2.81

2.93

g/l

0.98

132

733

Entropion and trichiasis of eyelid

254

1678

1.55

9.55

2.4

2.5

2.89

2.95

g/l

0.41

225

1501

Dermatophytosis

339

2369

1.46

9.51

2.8

2.3

2.82

2.91

g/l

0.86

313

2158

Acute gastritis

188

1159

1.66

9.48

2.0

2.6

2.90

2.98

g/l

0.52

165

1050

Inflammatory bowel disease, strict (require KELA)

446

3263

1.38

9.46

2.3

2.98

2.87

g/l

1.42

419

3035

Asthma and opportunity respiratory infection

143

823

1.80

9.45

2.6

2.7

3.11

2.95

g/l

1.17

136

732

Attention to artificial openings

116

626

1.91

9.41

2.7

2.1

3.21

2.92

g/l

2.33

100

568

Other specified and unspecified retinal disorders

103

535

2.00

9.40

2.7

2.6

2.80

2.98

g/l

0.95

487

Malignant neoplasm of other connective and soft tissue, including Hilmo

111

592

1.94

9.33

4.4

1.4

3.13

2.94

g/l

0.90

102

527

Childhood asthma (age<16), excluding more controls

115

474

1.91

9.28

1.4

2.81

2.78

g/l

0.11

108

454

Disorders of oesophagus in diseases classified elsewhere

310

2.34

9.28

4.3

3.0

3.11

3.07

g/l

0.10

278

Type of accident

652

5060

1.30

9.22

2.0

2.3

2.77

2.90

g/l

2.46

554

4621

Carcinoma in situ of skin of trunk

114

619

1.92

9.21

3.1

2.4

3.01

3.04

g/l

0.14

107

550

Urolithiasis

805

6419

1.27

9.17

2.1

2.4

2.95

2.89

g/l

0.89

732

5841

Right bundle-branch block

511

2.00

9.16

2.9

2.3

3.03

2.93

g/l

0.46

454

Plantar fascial fibromatosis

210

1339

1.60

9.15

2.5

2.2

2.76

2.91

g/l

1.57

194

1232

Exfoliative dermatitis

128

3.17

9.15

1.7

2.5

3.09

3.12

g/l

0.04

113

Mental and behavioural disorders due to tobacco

200

1263

1.62

9.13

1.8

2.5

3.02

2.88

g/l

1.11

169

1176

Acidosis

293

2.36

9.12

1.7

2.4

3.22

2.97

g/l

1.10

268

Other and unspecified tonsillitis

505

3132

1.35

9.11

1.8

2.0

2.86

2.85

g/l

0.08

483

2946

Scabies, including avohilmo

248

1640

1.53

9.09

1.8

2.3

2.76

2.89

g/l

1.43

237

1537

Lactose intolerance

337

2.23

9.08

1.6

1.7

2.76

2.95

g/l

0.99

308

Fibrosis of liver

3.70

9.06

1.5

1.9

2.92

2.89

g/l

0.06

Abscess of anal and rectal regions

171

1041

1.67

9.00

1.4

2.2

3.00

2.88

g/l

0.90

158

966

Autoimmune hyperthyroidism

126

705

1.82

9.00

1.8

2.5

2.89

2.87

g/l

0.11

121

643

Psychotic depression

126

705

1.82

8.99

2.0

2.7

2.79

2.88

g/l

0.43

109

646

Other keratitis

238

1567

1.54

8.99

2.2

2.3

2.85

2.90

g/l

0.37

220

1441

Other psoriatic arthropathies

231

1513

1.56

8.98

1.9

2.4

3.06

2.89

g/l

1.47

214

1398

900

6251

1.25

8.96

2.3

2.4

2.94

2.96

g/l

0.17

763

5530

Other nonthrombocytopenic purpura

130

3.15

8.96

2.3

2.2

2.80

2.99

g/l

0.71

117

Exposure to other and unspecified animate mechanical forces

300

2.30

8.95

2.8

2.2

2.99

2.94

g/l

0.14

288

Benign neoplasm: Parathyroid gland

158

2.92

8.93

2.9

2.1

2.54

3.04

g/l

2.11

148

Melanocytic naevi of lower limb, including hip

107

572

1.92

8.92

3.0

2.4

2.87

2.95

g/l

0.37

102

530

Cluster headache, strict, including avohilmo

101

529

1.95

8.90

1.7

2.3

2.78

2.88

g/l

0.59

495

Deficiency of other B group vitamins

290

2.34

8.88

3.3

2.0

3.03

2.96

g/l

0.21

262

Other and unspecified disorders of vitreous body

1084

8753

1.22

8.86

2.4

2.5

2.79

2.90

g/l

3.28

978

7944

Childhood asthma (age<16)

115

482

1.88

8.85

1.4

2.81

2.78

g/l

0.12

108

461

Disorders of breast

989

7104

1.23

8.85

2.1

2.3

2.84

2.90

g/l

0.91

886

6404

Other or ill-defined heart diseases

114

622

1.87

8.84

2.3

3.18

2.89

g/l

1.78

559

Other renal tubulo-interstitial diseases

246

2.44

8.82

1.8

2.0

3.31

2.85

g/l

1.95

230

Disorders of magnesium metabolism

105

3.41

8.80

1.3

2.6

3.11

3.10

g/l

0.02

Tinnitus

561

4302

1.32

8.77

2.3

2.4

2.77

2.92

g/l

3.57

518

3942

Arterial embolism and thrombosis

155

929

1.71

8.76

1.4

2.4

3.17

2.94

g/l

1.74

138

835

COPD, hospital admissions 1, only main diagnosis

935

6537

1.24

8.75

2.0

2.4

3.16

2.90

g/l

11.86

836

5879

Congenital malformations of the circulatory system

272

1797

1.49

8.71

1.8

2.4

2.84

2.91

g/l

0.52

251

1660

Anogenital herpesviral [herpes simplex] infection, including avohilmo

166

1010

1.66

8.71

2.3

2.1

2.77

2.87

g/l

0.72

154

952

Procreative management

571

3598

1.32

8.70

1.9

2.2

2.90

2.86

g/l

0.37

544

3342

Smoking dependency

200

1279

1.59

8.68

1.8

2.5

3.02

2.89

g/l

1.05

169

1191

Endometriosis

627

2809

1.31

8.61

1.8

2.2

2.77

2.99

g/l

6.75

571

2530

Cluster headache, wide,, including avohilmo

106

571

1.90

8.59

1.7

2.3

2.78

2.90

g/l

0.78

531

Dissociative [conversion] disorders

331

2.19

8.58

1.3

2.0

2.82

2.96

g/l

0.74

308

Anogenital herpesviral [herpes simplex] infection

103

549

1.91

8.57

2.3

2.0

2.79

2.92

g/l

0.67

515

Other and unspecified glaucoma

207

1342

1.58

8.56

2.2

2.5

3.05

2.99

g/l

0.45

181

1190

Palmar fascial fibromatosis [Dupuytren]

381

2771

1.40

8.54

2.3

2.4

2.85

2.92

g/l

0.76

342

2490

Carrier of infectious disease

288

2.30

8.53

1.3

2.4

2.62

2.99

g/l

2.74

266

Cachexia

4.42

8.48

2.5

1.8

3.17

2.99

g/l

0.26

Malignant melanoma of skin

290

2017

1.46

8.42

2.7

1.4

2.93

2.88

g/l

0.38

258

1810

Adenomyosis (Endometriosis of uterus)

292

2028

1.46

8.41

2.3

2.85

3.02

g/l

2.52

270

1820

Other specified/unspecified spondylopathies

356

2.16

8.41

3.0

2.1

2.87

3.02

g/l

0.59

315

Bronchitis, not specified as acute or chronic

195

1250

1.59

8.37

2.2

2.4

2.86

2.89

g/l

0.16

175

1120

Congenital malformations and deformations of the musculoskeletal system

135

782

1.74

8.36

1.6

2.1

2.91

g/l

0.01

129

731

Malignant neoplasm of bladder, including Hilmo

299

2068

1.45

8.32

2.4

1.4

3.02

2.90

g/l

1.16

264

1836

Additional codes for the location of defect, injury or illness

140

829

1.73

8.31

1.5

2.6

2.66

2.95

g/l

2.92

134

763

Dislocation, sprain and strain of joint and ligaments of hip

107

588

1.88

8.27

1.6

2.5

3.04

3.02

g/l

0.08

539

Unstable angina pectoris

986

6367

1.23

8.27

2.5

2.94

2.89

g/l

0.78

904

5639

malignant neoplasm of male genital organs, including Hilmo

684

3230

1.28

8.19

2.2

1.4

2.91

2.87

g/l

0.49

623

2938

Allergic bronchopulmonary aspergillosis (ABPA)

7.30

8.19

2.4

3.48

2.81

g/l

1.55

Nasal polyp

446

3346

1.35

8.18

3.0

2.4

2.83

2.91

g/l

1.06

416

3056

Unspecified/other endometriosis

143

834

1.70

8.16

1.9

2.0

2.75

2.94

g/l

1.65

128

762

Necrosis of pulp, including avohilmo

1192

9885

1.20

8.13

2.3

2.83

2.86

g/l

0.42

1113

9105

Cardiac murmurs and other cardiac sounds

172

1064

1.62

8.11

2.7

2.2

2.96

2.95

g/l

0.01

160

956

Superficial injury of forearm

200

1299

1.56

8.08

2.2

2.3

2.88

2.92

g/l

0.28

179

1205

Event of undetermined intent

127

737

1.76

8.06

2.3

2.93

2.91

g/l

0.06

119

685

Golimumab

354

2.12

8.04

1.3

1.9

3.22

2.88

g/l

1.93

339

Crushed, pushed or stepped on by crowd or human stampede

124

715

1.76

8.01

2.6

2.2

2.94

2.93

g/l

0.01

116

667

Other sleep disorders

244

1657

1.49

8.00

1.8

2.5

2.86

2.95

g/l

0.78

211

1526

Hypopituitarism

136

806

1.72

7.98

2.7

2.4

2.78

2.93

g/l

0.89

127

759

Alzheimer disease, excluding more controls

458

2221

1.35

7.95

2.0

2.6

2.93

3.08

g/l

2.05

388

1992

Iridocyclitis in diseases classified elsewhere

240

2.39

7.94

2.0

2.3

2.91

3.02

g/l

0.30

223

Melanocytic naevi of trunk

261

1799

1.47

7.94

2.4

2.76

2.91

g/l

2.03

246

1662

Cholecystitis

357

2602

1.39

7.94

2.3

2.93

g/l

0.02

318

2330

Complications of cardiac and vascular prosthetic devices, implants and grafts

325

2.19

7.92

2.4

2.9

3.40

2.96

g/l

2.29

293

Other and unspecified rosacea

206

1356

1.55

7.89

2.2

2.4

2.83

2.90

g/l

0.46

193

1247

Wet age-related macular degeneration

517

3840

1.32

7.89

2.5

2.3

3.02

2.97

g/l

0.42

438

3340

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

302

2139

1.43

7.88

2.4

2.3

2.98

2.88

g/l

0.89

284

1986

Ulcerative colitis (strict definition, require KELA)

311

2215

1.42

7.86

2.4

2.3

2.97

2.88

g/l

0.80

292

2058

Specific development disorders of speech and language

455

1.94

7.84

1.8

2.2

2.94

3.08

g/l

0.66

413

Obsessive-compulsive disorder

466

1.93

7.81

1.9

2.1

2.80

2.93

g/l

0.64

443

Crohn's disease of small intestine

133

789

1.72

7.81

1.8

2.4

2.88

2.92

g/l

0.21

123

730

Postzoster neuralgia

230

2.42

7.80

3.9

2.1

2.84

3.09

g/l

0.93

204

Malignant melanoma of skin, including Hilmo

341

2475

1.40

7.79

2.6

1.4

2.92

2.88

g/l

0.35

305

2217

Chondropathies

300

2130

1.43

7.75

2.1

2.2

2.91

2.89

g/l

0.12

266

1968

Other disorders of iris and ciliary body

395

2.05

7.73

2.1

2.7

2.98

g/l

0.01

359

Astigmatism

123

717

1.75

7.66

2.2

2.4

2.74

2.95

g/l

1.73

115

654

Redundant prepuce, phimosis and paraphimosis

414

3052

1.35

7.63

1.9

2.5

2.89

2.91

g/l

0.17

388

2832

Alzheimer’s disease (Late onset), excluding more controls

402

1933

1.37

7.63

2.0

2.6

2.94

3.07

g/l

1.46

341

1723

Viral warts, including avohilmo

408

3051

1.35

7.62

2.1

2.3

2.84

2.88

g/l

0.31

379

2810

Coronary artery bypass grafting

697

4130

1.27

7.62

1.7

2.5

3.16

2.89

g/l

9.43

633

3649

Rosacea

276

1939

1.44

7.60

2.1

2.4

2.84

2.88

g/l

0.27

259

1780

Primary coxarthrosis, bilateral

776

6307

1.24

7.59

2.2

2.5

2.83

2.93

g/l

2.11

696

5614

Melanoma in situ

133

800

1.72

7.58

2.4

2.7

2.96

g/l

0.01

111

721

Scleritis and episcleritis

132

789

1.71

7.58

2.2

2.87

2.90

g/l

0.11

123

735

Thyrotoxicosis with toxic multinodular goitre

165

1047

1.62

7.55

1.8

2.4

3.13

2.94

g/l

1.70

146

933

Spontaneous rupture of synovium and tendon

191

1252

1.55

7.49

1.9

2.3

2.80

2.92

g/l

0.93

170

1138

Thyrotoxicosis with diffuse goitre

277

1952

1.44

7.48

2.0

2.3

2.90

2.89

g/l

0.12

258

1789

Hemiplegia

120

702

1.75

7.48

2.1

2.4

2.87

2.97

g/l

0.72

106

639

Drug-induced hypoglycaemia without coma

203

2.47

7.46

2.2

2.5

3.12

3.03

g/l

0.22

185

Type 1 diabetes, definitions combined

128

757

1.70

7.46

2.0

2.1

2.77

2.88

g/l

0.60

118

716

Chronic hepatitis, not elsewhere classified

456

1.94

7.45

1.7

2.6

2.86

2.91

g/l

0.19

426

Other Crohn's disease

125

739

1.72

7.44

1.5

2.2

3.18

2.88

g/l

2.63

116

685

Lactose intolerance, other/unspecified

305

2.16

7.43

1.6

1.8

2.78

2.94

g/l

0.68

280

Type 1 diabetes, strict (exclude DM2)

127

751

1.71

7.41

2.0

2.1

2.77

2.88

g/l

0.65

117

710

Other and/or unspecified nontoxic goitre

201

1337

1.53

7.40

2.4

2.93

2.94

g/l

0.05

187

1209

Acute bronchiolitis

296

2.10

7.39

5.4

1.8

2.96

2.99

g/l

0.08

271

Hepatocellular carcinoma, including Hilmo

423

1.98

7.37

2.5

1.4

2.92

2.99

g/l

0.34

371

Extreme obesity with alveolar hypoventilation

104

588

1.82

7.36

2.1

2.8

3.14

2.88

g/l

2.05

536

Pediculosis, acariasis and other infestations, including avohilmo

298

2132

1.41

7.35

1.7

2.3

2.81

2.89

g/l

0.82

282

1982

Bursitis of shoulder

307

2.16

7.34

3.3

2.3

2.81

3.02

g/l

0.88

284

Complications of genitourinary prosthetic devices, implants and grafts

348

2.08

7.32

1.8

2.1

3.10

2.94

g/l

0.61

313

Alcohol dependence

597

4728

1.27

7.31

1.6

2.6

3.03

2.85

g/l

4.02

535

4383

Malignant neoplasm of breast, HER-positive

662

3931

1.26

7.31

2.1

1.4

2.96

2.88

g/l

1.07

576

3493

Malignant neoplasm of breast, ER-positive, including Hilmo

663

3937

1.26

7.25

2.1

1.4

2.96

2.88

g/l

1.08

577

3498

Portal vein thrombosis

206

2.44

7.24

2.1

2.6

3.14

2.97

g/l

0.42

193

Achilles tendinitis

215

1459

1.50

7.13

2.7

2.3

2.80

2.91

g/l

0.90

196

1351

Oesophagitis

133

812

1.68

7.11

2.3

2.6

3.08

2.96

g/l

0.68

126

748

Coxarthrosis, primary, with hip surgery

1260

9982

1.18

7.10

2.2

2.5

2.88

2.92

g/l

0.83

1124

8941

Disorders of speech understanding and production

370

2.00

7.09

1.9

2.3

2.96

3.11

g/l

0.55

331

Other symptoms and signs involving general sensations and perceptions

103

587

1.80

7.08

2.2

2.6

2.74

2.99

g/l

2.08

533

Testicular dysfunction

435

1.93

7.06

1.6

2.5

2.82

2.90

g/l

0.25

407

Autonomic disorders

312

2.12

7.06

1.9

2.5

2.75

3.02

g/l

1.67

285

Unspecified lump in breast

336

2474

1.38

7.05

2.0

2.4

2.93

2.92

g/l

0.04

305

2225

Arthropathy in ulcerative colitis

148

2.70

7.04

1.5

1.9

3.01

2.96

g/l

0.10

141

Other and unspecified psoriasis

163

1048

1.59

7.04

2.1

2.5

2.95

2.93

g/l

0.10

153

963

Presence of other devices

637

5027

1.26

7.03

2.7

2.3

2.51

2.95

g/l

23.80

565

4488

Periapical abscess

1003

8416

1.20

7.01

2.2

2.4

2.88

2.87

g/l

0.19

921

7743

Bell's palsy

256

1804

1.44

6.99

2.3

2.70

2.94

g/l

4.13

230

1639

Duodenal ulcer

273

1949

1.42

6.95

1.9

2.5

3.03

2.94

g/l

0.75

253

1758

Panniculitis affecting regions of neck and back

438

1.92

6.94

2.0

2.2

2.82

2.96

g/l

0.64

404

Later onset COPD

818

5411

1.23

6.88

1.7

2.5

3.17

2.91

g/l

11.01

726

4805

Somnolence, stupor and coma

100

570

1.80

6.87

1.6

2.8

2.95

3.02

g/l

0.26

514

Other aneurysm

142

890

1.63

6.87

2.2

2.5

3.10

2.92

g/l

1.08

134

811

Organic, including symptomatic, mental disorders

1449

8803

1.17

6.85

2.2

2.4

2.92

2.93

g/l

0.24

1237

7918

Malignant neoplasm of prostate, including Hilmo

669

3167

1.26

6.84

2.2

1.5

2.91

2.88

g/l

0.33

608

2877

Orthopaedic devices associated with adverse incidents

318

2.12

6.84

1.4

2.3

2.31

3.03

g/l

4.85

287

Varicose veins

1470

9601

1.16

6.83

2.5

2.3

2.86

2.90

g/l

0.84

1318

8650

Alcohol abuse, main dg

311

2274

1.38

6.81

1.3

2.3

2.93

2.89

g/l

0.32

280

2120

Nontoxic goitre/thyroid nodule

683

5542

1.24

6.81

2.3

2.4

2.91

2.93

g/l

0.16

619

4963

Psoriasis (vulgaris), strict definition

420

1.93

6.80

1.4

2.6

2.78

2.92

g/l

0.68

393

Excessive attrition of teeth

1241

10514

1.17

6.77

2.4

2.3

2.72

2.87

g/l

7.49

1141

9683

Malignant neoplasm of mesothelium and soft tissue

101

581

1.79

6.76

3.6

1.4

3.28

2.96

g/l

1.61

514

Paralytic ileus

559

1.80

6.76

3.8

2.3

3.16

2.95

g/l

0.99

503

Thrombotic microangiopathy

3.59

6.75

4.0

1.5

3.03

3.02

g/l

0.02

Thiazolidinediones

294

2139

1.40

6.75

1.7

2.5

2.99

2.90

g/l

0.68

268

1931

Other and specified injuries of hip and thigh

318

2.09

6.74

1.7

2.4

2.90

3.08

g/l

0.67

289

Follicular cysts of skin and subcutaneous tissue

402

3061

1.33

6.74

2.5

2.3

2.91

2.88

g/l

0.19

375

2807

Ulcerative colitis (strict definition, all Crohn cases excluded)

265

1890

1.42

6.73

2.6

2.3

2.98

2.88

g/l

0.88

248

1757

Other and unspecified parapsoriasis

3.57

6.73

1.4

1.8

2.86

3.19

g/l

0.90

Atypical facial pain

119

717

1.70

6.71

2.1

2.5

2.94

g/l

0.02

108

653

Abnormal blood-pressure reading, without diagnosis

102

589

1.77

6.69

2.2

2.4

3.06

2.91

g/l

0.76

529

Sudden idiopathic hearing loss

249

1763

1.44

6.69

2.1

2.4

2.76

2.95

g/l

2.20

216

1614

Visual field defects

205

1400

1.49

6.68

2.1

2.3

2.94

g/l

0.01

183

1272

Malignant neoplasm of breast, including Hilmo

812

4274

1.22

6.67

2.1

1.4

2.95

2.87

g/l

1.27

717

3820

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

331

2452

1.36

6.67

2.4

2.3

2.97

2.88

g/l

0.92

312

2274

Disorders of tooth development and eruption

277

1613

1.41

6.66

1.8

2.2

2.90

g/l

0.02

254

1474

Orchitis and epididymitis

210

1440

1.48

6.66

2.1

2.4

2.82

2.93

g/l

0.85

194

1313

Malignant neoplasm of breast, HER2-negative, including Hilmo

812

4275

1.22

6.66

2.1

1.4

2.95

2.87

g/l

1.24

717

3821

Viral warts

189

1268

1.51

6.66

2.0

2.4

2.82

2.91

g/l

0.65

179

1165

Postmenopausal bleeding

609

2533

1.27

6.64

2.2

2.3

2.93

3.03

g/l

1.30

540

2263

Other condition

295

2149

1.39

6.64

2.3

2.2

2.83

2.92

g/l

0.86

274

1974

Retinal detachment with retinal break

323

2392

1.37

6.62

2.9

2.4

2.94

2.90

g/l

0.30

289

2172

Allergic contact dermatitis

245

1731

1.43

6.58

1.7

2.4

2.90

2.88

g/l

0.12

222

1583

Other and unspecified vascular occlusions

250

1779

1.43

6.56

2.5

3.04

2.94

g/l

0.72

226

1587

Urethral stricture

146

932

1.60

6.55

2.2

2.5

2.99

2.88

g/l

0.61

131

846

Ulcerative enterocolitis

335

2.02

6.51

1.9

2.4

3.06

2.89

g/l

0.53

310

Excessive earwax

1564

12380

1.15

6.48

2.5

2.4

2.79

2.91

g/l

5.11

1375

11239

Disorders of ocular muscles, binocular movement, accommodation and refraction

938

7810

1.20

6.47

2.2

2.3

2.80

2.87

g/l

1.32

867

7139

Open wound of abdomen, lower back and pelvis

329

2.03

6.46

1.9

2.5

2.95

2.93

g/l

0.04

310

Other benign neoplasms of skin

879

7351

1.20

6.46

3.0

2.4

2.76

2.92

g/l

4.96

777

6634

Other and unspecified nonorganic psychotic disorders

312

2303

1.37

6.42

1.7

2.3

2.97

2.87

g/l

0.97

283

2153

Malignant neoplasm of breast, HER2-negative

798

4240

1.22

6.42

2.1

1.4

2.95

2.87

g/l

1.21

703

3786

Melanocytic naevi

624

5045

1.25

6.42

2.7

2.3

2.82

2.88

g/l

0.85

593

4611

Other salmonella infections

480

1.84

6.39

2.9

2.2

2.95

2.90

g/l

0.17

438

Seborrhoeic dermatitis

222

1554

1.45

6.35

2.4

2.5

2.74

2.94

g/l

2.63

200

1416

Malignant neoplasm of breast

798

4245

1.22

6.34

2.1

1.4

2.95

2.87

g/l

1.18

703

3791

Other deformities of toe(s)

467

1.85

6.32

1.8

2.3

2.81

2.89

g/l

0.26

419

Chondrocostal junction syndrome [Tietze]

511

1.81

6.32

2.3

2.2

2.92

2.99

g/l

0.28

463

Other congenital malformations of skin, including avohilmo

151

978

1.57

6.30

2.0

2.4

2.98

2.91

g/l

0.43

140

901

Use of donepezil

380

4709

0.76

6.30

1.8

2.3

2.82

2.99

g/l

2.02

304

4110

Injury of muscle and tendon at hip and thigh level

213

1482

1.46

6.28

2.0

2.4

2.79

2.89

g/l

0.79

197

1386

Nonsuppurative otitis media, including avohilmo

517

3535

1.27

6.28

2.2

2.92

2.88

g/l

0.43

488

3263

Postprocedural disorders of digestive system, not elsewhere classified

476

1.84

6.27

1.8

2.7

3.13

2.97

g/l

0.74

436

Amenorrhoea

539

1.77

6.27

1.9

2.1

2.83

2.88

g/l

0.19

504

Use of antiglaucoma preparations and miotics

215

1503

1.46

6.26

2.3

2.5

2.97

2.98

g/l

0.06

186

1322

severe traumatic brain injury, does not include concussion

558

4474

1.26

6.26

2.3

2.97

2.94

g/l

0.30

484

4009

Malignant neoplasm of liver and intrahepatic bile ducts, including Hilmo

123

763

1.65

6.24

2.1

1.4

2.95

2.97

g/l

0.09

107

667

Benign neoplasm: Descending colon

186

1268

1.50

6.20

2.0

2.6

2.98

2.93

g/l

0.22

159

1162

Pneumothorax

163

1080

1.54

6.19

2.5

2.3

2.95

2.92

g/l

0.14

151

990

Paget disease

3.35

6.18

2.6

1.3

2.74

3.02

g/l

1.01

Moderate visual impairment, binocular

464

1.84

6.18

1.7

2.1

2.68

3.10

g/l

2.26

412

Other noninflammatory disorders of vulva and perineum

184

1248

1.49

6.17

2.0

2.3

2.83

2.98

g/l

1.38

165

1132

Benign neoplasm: Duodenum

422

1.90

6.17

2.8

2.7

3.02

3.01

g/l

0.02

384

Benign neoplasm: Other and unspecified parts of mouth

509

1.80

6.16

2.8

2.6

3.02

2.95

g/l

0.25

466

Irregular menses

786

4886

1.21

6.14

2.1

2.2

2.79

2.87

g/l

1.47

723

4511

Arthropathy in hypersensitivity reactions classified elsewhere

13.49

6.10

1.6

1.2

2.82

2.67

g/l

—

Other epidermal thickening

109

660

1.69

6.09

1.9

2.6

2.73

2.94

g/l

1.36

603

Fracture at wrist and hand level

691

5660

1.22

6.08

2.4

2.90

2.88

g/l

0.15

620

5195

Pustulosis palmaris et plantaris

101

600

1.73

6.07

2.2

2.5

3.05

2.92

g/l

0.70

558

Use of anticholinesterases

740

6872

0.82

6.06

2.1

2.4

2.90

2.96

g/l

0.71

606

6078

N06DA Anticholinesterases

740

6872

0.82

6.06

2.1

2.4

2.90

2.96

g/l

0.71

606

6078

Postprocedural musculoskeletal disorders, not elsewhere classified

183

1249

1.50

6.06

2.7

2.4

2.86

2.93

g/l

0.38

172

1131

Other obstructive and reflux uropathy

436

1.85

6.05

1.9

2.2

2.99

2.91

g/l

0.32

402

malignant neoplasm of male genital organs

653

3195

1.24

6.02

2.2

1.5

2.93

2.87

g/l

0.67

595

2905

Injury of muscle and tendon at lower leg level

324

2436

1.35

6.00

2.5

2.82

2.87

g/l

0.47

306

2265

Disorders of parathyroid gland, other and/or unspecified

108

2.90

5.99

1.4

1.8

3.05

3.03

g/l

0.03

100

Other disorders of optic [2nd] nerve and visual pathways

139

897

1.58

5.96

2.4

2.6

3.06

2.93

g/l

0.74

127

823

Diffuse brain injury

367

1.92

5.94

2.5

2.1

3.04

3.06

g/l

0.07

341

Recurrent dislocation and subluxation of joint

101

602

1.70

5.90

1.9

2.3

2.86

2.81

g/l

0.16

570

Injury of eye and orbit

268

1962

1.38

5.89

1.9

2.3

2.84

2.88

g/l

0.28

242

1829

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

246

3368

0.72

5.88

1.9

1.5

3.01

2.88

g/l

1.06

223

3009

Gluteal tendinitis

583

1.72

5.85

2.1

2.4

2.82

2.91

g/l

0.38

537

Open wound of hip and thigh

370

1.91

5.83

1.3

2.5

3.12

2.93

g/l

0.86

351

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

118

735

1.62

5.81

1.8

2.4

2.84

2.82

g/l

0.06

103

689

Malignant neoplasm of eye and adnexa, including Hilmo

201

2.28

5.81

2.3

1.4

2.91

2.90

g/l

0.02

176

Assault

199

1387

1.45

5.79

1.9

2.1

3.02

2.88

g/l

1.07

182

1318

Otitis externa, unspecified

221

1572

1.42

5.79

2.1

2.4

2.78

2.91

g/l

1.17

202

1446

Aortic valve malfunction, age under 60 years

184

1268

1.47

5.76

1.9

2.3

3.08

2.86

g/l

1.98

171

1187

Benign neoplasm: Small intestine

112

696

1.66

5.74

2.5

2.6

3.03

2.96

g/l

0.30

102

633

Sulfonylureas

920

6194

1.19

5.74

1.9

2.5

3.03

2.93

g/l

2.22

820

5490

Thyroiditis

146

961

1.55

5.73

2.3

2.4

2.88

2.91

g/l

0.12

130

882

Left ventricular outflow tract obstruction (LVOTO), broad definition

192

1335

1.46

5.72

1.9

2.4

3.09

2.86

g/l

2.15

179

1248

Other salmonella infections, including avohilmo

549

1.73

5.72

2.8

2.3

3.00

2.90

g/l

0.40

504

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

220

2.17

5.70

1.7

1.8

3.09

2.94

g/l

0.52

209

Injuries to the wrist and hand

2279

13578

1.12

5.70

2.2

2.4

2.87

2.89

g/l

0.39

2082

12378

Drug-induced neutropenia

169

1151

1.50

5.68

3.6

2.6

3.19

2.90

g/l

2.53

164

1056

Bicipital tendinitis

108

665

1.66

5.67

2.0

2.5

2.84

2.90

g/l

0.24

102

622

Pulmonary oedema

277

2.06

5.66

2.9

2.6

3.15

3.08

g/l

0.16

245

Inflammatory disease of uterus

222

1587

1.41

5.63

1.8

2.2

2.92

2.87

g/l

0.35

199

1464

Hydrocele

269

1988

1.37

5.63

2.4

2.6

2.79

2.95

g/l

1.89

246

1815

Other predominantly sexually transmitted diseases, not elsewhere classified

238

1722

1.39

5.61

2.2

2.71

2.86

g/l

1.62

218

1618

Hordeolum and other deep inflammation of eyelid

125

800

1.59

5.58

2.5

2.6

2.89

2.91

g/l

0.09

109

744

Other otitis externa (chronic)

147

976

1.53

5.57

2.6

3.00

2.91

g/l

0.46

121

897

Malignant neoplasm of mesothelium and soft tissue, including Hilmo

151

1009

1.52

5.56

3.7

1.4

3.25

2.92

g/l

2.66

138

889

Alzheimer’s disease (Early onset)

782

0.45

5.56

1.3

2.2

3.07

3.06

g/l

0.02

687

Triptan medication for migraine, min. 3 purchases

910

5759

1.19

5.56

2.2

2.74

2.85

g/l

3.22

853

5343

Other disorders of penis

208

1475

1.43

5.55

1.7

2.5

2.79

2.93

g/l

1.24

187

1353

Diabetic maculopathy

293

2076

1.35

5.55

1.5

2.1

2.88

2.94

g/l

0.44

270

1883

Pustular psoriasis

108

670

1.65

5.53

2.2

2.4

3.06

2.93

g/l

0.67

101

617

Other other unspecified disorders of the circulatory system

533

1.73

5.53

2.1

2.5

2.97

2.95

g/l

0.06

483

Spontaneous abortion

548

4517

0.81

5.48

2.1

2.4

2.75

2.87

g/l

2.25

511

4126

Malignant neoplasm of prostate

645

3132

1.23

5.46

2.2

1.5

2.92

2.87

g/l

0.49

587

2844

Ectropion of eyelid

114

720

1.62

5.46

1.6

2.5

3.08

3.03

g/l

0.17

631

Senility

112

2.67

5.45

1.7

2.1

2.75

3.32

g/l

1.67

100

Other and unspecified trigeminal disorders

174

2.32

5.45

1.4

2.1

2.62

2.87

g/l

0.77

160

Lichen simplex chronicus

453

1.79

5.43

2.6

2.8

2.92

2.98

g/l

0.18

416

Lagophthalmos

188

2.29

5.43

2.0

2.3

2.82

2.98

g/l

0.58

172

Complications of other internal prosthetic devices, implants and grafts

106

659

1.65

5.40

2.8

2.3

2.95

2.96

g/l

0.02

100

593

Abnormal spermatozoa

176

2497

0.69

5.34

2.1

2.6

2.55

2.88

g/l

5.09

158

2282

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

132

2.50

5.29

5.0

1.9

2.76

2.95

g/l

0.78

123

Crohn's disease of large intestine

584

1.67

5.29

1.6

2.3

2.96

2.90

g/l

0.27

540

Other obstetric conditions, not elsewhere classified

317

1510

1.33

5.28

1.7

1.8

2.75

2.74

g/l

0.08

300

1443

Other secondary coxarthrosis

495

1.74

5.27

1.7

2.4

2.94

2.95

g/l

0.02

455

Postprocedural disorders of nervous system

109

684

1.61

5.27

2.3

2.0

2.56

2.94

g/l

3.88

101

644

Burns and corrosions

251

1857

1.37

5.22

2.0

2.2

3.03

2.91

g/l

1.04

231

1725

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

200

1236

1.42

5.20

1.4

1.6

2.69

2.83

g/l

1.48

188

1177

Convalescence

110

696

1.61

5.19

2.1

2.57

2.91

g/l

3.44

633

Postpartum haemorrhage

178

2079

0.70

5.14

1.9

2.1

2.67

2.80

g/l

1.31

164

1955

Seborrhoeic keratosis

603

4987

1.22

5.13

2.4

2.80

2.89

g/l

1.67

550

4470

Glucosamine medication

1227

8565

1.15

5.11

2.4

2.93

g/l

0.05

1097

7621

Impotence

133

883

1.54

5.10

1.9

2.4

2.75

2.93

g/l

1.45

121

803

Epiphora

331

1.91

5.08

2.3

2.4

3.01

2.99

g/l

0.05

300

Premature rupture of membranes

132

1405

0.66

5.08

1.9

2.0

2.58

2.79

g/l

2.29

124

1331

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

266

1993

1.34

5.05

2.1

2.2

2.72

2.86

g/l

1.43

244

1876

Atrophic disorders of skin

322

2483

1.31

5.05

2.1

2.2

2.91

g/l

0.03

296

2240

Brachial plexus disorders

150

1020

1.49

5.05

2.5

2.4

2.61

2.87

g/l

3.82

143

965

Other and unspecified bullous disorders

155

2.37

5.05

3.3

2.3

2.97

2.98

g/l

0.02

141

Corns and callosities

149

1015

1.49

5.04

2.1

2.4

2.78

2.92

g/l

1.10

137

929

Salpingitis and oophoritis

335

2598

1.30

5.03

1.8

2.5

2.93

2.89

g/l

0.35

305

2371

Degenerative macular diseases

303

2323

1.32

5.02

2.1

2.4

2.89

2.95

g/l

0.43

271

2065

Episcleritis

104

655

1.62

5.01

2.1

2.2

2.81

2.88

g/l

0.34

614

Tobacco use

108

687

1.60

5.00

1.6

2.4

2.97

2.93

g/l

0.21

103

643

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

607

5034

1.21

4.99

2.6

2.3

2.92

2.88

g/l

0.53

554

4630

Other retinal artery occlusion

370

1.84

4.97

2.2

2.8

2.90

3.05

g/l

0.48

336

Other and unspecified follicular disorders

503

1.70

4.95

3.0

2.5

2.72

2.94

g/l

1.37

473

Acute laryngitis and tracheitis

150

1007

1.48

4.93

1.6

2.0

2.91

2.93

g/l

0.13

138

937

Dislocation, sprain and strain of joints and ligaments at neck level

255

1909

1.35

4.92

2.2

2.3

2.82

2.87

g/l

0.39

237

1780

Other specified/unspecified disorders of bone/cartilage

334

1.87

4.92

2.2

2.68

2.89

g/l

1.06

314

Benign neoplasm of middle ear and respiratory system

179

1269

1.43

4.91

2.5

2.88

2.94

g/l

0.37

167

1158

Malignant neoplasm, without specification of site, including Hilmo

111

715

1.58

4.88

3.0

1.4

3.36

2.96

g/l

2.69

101

620

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

116

755

1.56

4.84

1.7

2.3

2.87

2.96

g/l

0.42

110

696

Post-traumatic wound infection, not elsewhere classified

343

1.85

4.84

2.5

2.6

2.90

2.92

g/l

0.07

317

Corneal scars and opacities

380

1.81

4.83

2.9

2.7

3.06

3.01

g/l

0.15

347

Monocytic leukaemia

3.56

4.82

3.7

1.4

3.28

3.08

g/l

0.27

Retinal haemorrhage

411

1.78

4.81

4.1

2.8

2.90

3.05

g/l

0.56

372

Other disorders of pigmentation

105

671

1.60

4.81

3.0

2.3

2.81

2.96

g/l

0.91

608

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

301

1442

1.32

4.80

1.5

1.8

2.75

2.73

g/l

0.13

285

1380

Central retinal artery occlusion

360

1.84

4.79

3.7

2.5

3.03

3.04

g/l

0.01

323

Hyperaldosteronism

404

1.78

4.78

3.2

2.7

3.08

3.01

g/l

0.21

371

Malignant neoplasm of colon, including Hilmo

426

3413

1.25

4.75

2.6

1.4

3.09

2.90

g/l

2.81

379

3024

UC patients in KELA-register (code 208), prior to 1994

611

1.62

4.74

2.5

2.6

2.87

2.92

g/l

0.17

565

Acute suppurative otitis media

339

2467

1.29

4.73

3.0

2.1

2.82

2.86

g/l

0.33

316

2308

Other arterial embolism and thrombosis

430

1.74

4.64

1.4

2.5

3.16

3.00

g/l

0.59

388

Single delivery by forceps and vacuum extractor

818

0.62

4.63

1.6

2.83

2.85

g/l

0.07

772

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

387

3048

1.26

4.62

2.1

2.82

2.85

g/l

0.30

358

2827

Other misadventures during surgical and medical care

349

1.83

4.62

1.9

2.9

3.15

2.99

g/l

0.57

321

Benign neoplasm: Pituitary gland, craniopharyngeal duct

107

693

1.57

4.62

2.8

2.5

2.69

2.92

g/l

1.73

639

All dysplastic lesions of the cervix uteri, vagina or vulva

405

3167

1.25

4.59

2.2

2.0

2.85

2.80

g/l

0.49

373

2937

Other and unspecified iridocyclitis

100

640

1.59

4.56

2.9

2.4

3.08

2.92

g/l

0.87

584

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

557

3799

1.22

4.54

2.3

1.5

3.27

2.89

g/l

12.75

508

3378

Congenital malformations of cardiac septa

107

672

1.56

4.54

1.6

2.3

2.95

2.93

g/l

0.09

624

Unspecified misadventure during surgical and medical care

133

907

1.49

4.53

2.2

2.6

2.91

2.95

g/l

0.15

117

834

Malignant neoplasm, without specification of site

463

1.70

4.53

2.9

1.4

3.31

3.02

g/l

1.17

398

Ulcerative proctitis

111

728

1.55

4.51

1.4

2.3

2.88

2.89

g/l

0.01

102

671

Benign neoplasm: Pancreas

473

1.70

4.50

2.5

2.8

2.74

2.99

g/l

1.50

429

!Aliquae complicationes praecoces traumatis

595

1.61

4.50

2.8

2.5

3.04

2.94

g/l

0.37

552

Early complications of trauma

595

1.61

4.50

2.8

2.5

3.04

2.94

g/l

0.37

552

Retinal breaks without detachment

367

2926

1.27

4.49

2.5

2.82

2.89

g/l

0.70

327

2675

Benign neoplasm: Liver/bile ducts

330

1.83

4.48

2.2

2.0

2.75

2.94

g/l

0.95

311

Nonsuppurative otitis media

334

2274

1.28

4.48

2.0

2.1

2.91

2.90

g/l

0.09

313

2090

Other and unspecified mononeuropathies, also in other diseases

397

1.76

4.47

2.0

2.4

2.74

3.02

g/l

1.28

360

Tongue abnormality

143

993

1.47

4.45

2.8

2.5

2.66

2.94

g/l

2.66

129

899

Disorders of refraction and accommodation

490

4012

1.22

4.44

2.0

2.2

2.80

2.88

g/l

0.92

453

3704

Benign neoplasm of meninges

242

1833

1.34

4.43

1.9

2.4

2.88

2.94

g/l

0.42

213

1650

Benign neoplasm: Liver

288

1.89

4.42

2.2

2.1

2.76

2.91

g/l

0.66

272

Other, unspecified and serous retinal detachments

467

1.69

4.41

2.2

2.7

2.81

2.99

g/l

0.79

428

Type 1 diabetes, strict definition

478

1.66

4.40

1.4

1.7

2.75

2.82

g/l

0.28

460

Complications of labour and delivery

858

5530

0.86

4.40

2.6

2.3

2.79

2.88

g/l

1.98

800

5022

Benign neoplasm of urinary organs

116

775

1.53

4.39

2.0

2.7

2.86

2.97

g/l

0.51

108

706

Disorders of synovium and tendon in diseases classified elsewhere

253

1.95

4.39

1.9

2.1

2.89

2.97

g/l

0.22

234

Other noninflammatory disorders of vagina

151

1060

1.44

4.39

2.4

2.84

2.98

g/l

1.07

134

954

Disorders of optic nerve, not elsewhere classified

304

1.87

4.38

2.6

2.9

2.99

3.00

g/l

0.02

278

Asthma mixed form (mode), excluding more controls

512

1.64

4.37

2.1

1.6

2.63

2.83

g/l

1.21

452

Contusion of other and unspecified parts of foot

528

1.63

4.36

2.1

2.4

2.79

2.92

g/l

0.73

494

Benign neoplasm of major salivary glands

218

1631

1.36

4.35

1.9

2.5

2.99

2.93

g/l

0.41

200

1481

Other female pelvic inflammatory diseases

302

2360

1.29

4.35

1.6

2.5

2.84

2.90

g/l

0.41

249

2140

Colorectal cancer, including Hilmo

610

4782

1.20

4.34

2.6

1.4

3.03

2.90

g/l

2.43

543

4233

Meralgia paraesthetica

454

1.69

4.32

1.5

2.4

2.93

g/l

0.01

418

Crohn disease (strict definition, require KELA, min 2 HDR)

104

680

1.55

4.30

1.9

2.2

2.94

2.92

g/l

0.11

631

Infective dermatitis

230

1736

1.34

4.30

1.8

2.5

2.86

2.92

g/l

0.41

206

1589

Burns and corrosions of multiple and unspecified body regions

248

1.94

4.28

1.9

2.8

3.30

2.94

g/l

1.21

234

Procedures for purposes other than remedying health state

291

1.87

4.28

1.9

1.7

2.84

2.88

g/l

0.13

272

Crohn disease (strict definition, require KELA)

106

697

1.54

4.28

1.9

2.3

2.92

2.91

g/l

0.04

648

Subacute thyroiditis

479

1.66

4.25

2.7

2.3

2.87

2.95

g/l

0.33

439

Other lesions of median nerve

389

1.74

4.22

1.3

2.4

2.90

3.09

g/l

0.72

344

Flat foot [pes planus] (acquired)

173

1254

1.39

4.19

1.8

2.7

2.77

2.89

g/l

0.90

154

1144

Benign neoplasm: Skin of eyelid, including canthus

356

2854

1.26

4.19

3.2

2.3

2.78

2.93

g/l

2.25

315

2580

Uterine polyps

548

2660

1.21

4.18

1.9

2.3

2.86

3.01

g/l

2.73

490

2389

Nontoxic multinodular goitre

434

3554

1.23

4.18

2.1

2.4

2.97

2.95

g/l

0.13

383

3178

Leisure time condition

375

3023

1.25

4.17

1.7

2.3

2.73

2.92

g/l

3.03

299

2752

Benign neoplasm: Skin of ear and external auricular canal

616

1.58

4.16

2.2

2.5

2.75

3.00

g/l

1.90

558

Benign neoplasm of eye and adnexa

239

1825

1.33

4.16

1.8

2.4

2.82

2.91

g/l

0.73

212

1663

Oesophageal obstruction

545

1.61

4.15

3.3

2.8

2.90

3.03

g/l

0.56

492

Nail disorders

163

1173

1.41

4.14

2.0

2.3

2.90

2.88

g/l

0.09

150

1080

Hyperfunction of pituitary gland

489

1.64

4.14

2.8

2.1

2.82

2.94

g/l

0.53

459

Sequelae of injuries of neck and trunk

376

1.74

4.13

3.2

2.7

2.93

g/l

0.00

349

Other neurotic disorders

100

656

1.55

4.13

1.6

2.6

3.03

2.96

g/l

0.28

594

Acne, including avohilmo

219

1327

1.34

4.13

1.7

1.8

2.97

2.84

g/l

1.26

207

1249

Conductive and sensorineural hearing loss

1918

11560

1.11

4.12

2.4

2.78

2.93

g/l

9.65

1692

10533

Benign neoplasm: salivary glands, exclude unknown (D119)

195

1448

1.37

4.12

2.0

2.5

2.99

2.91

g/l

0.46

179

1319

Benign neoplasm: Spinal meninges

163

2.19

4.12

1.4

2.1

2.88

3.06

g/l

0.31

146

Lichen ruber planus, wide definition including periferal and oral lichen planus

499

4151

1.21

4.10

2.4

2.81

2.91

g/l

1.62

455

3766

Contusion of toe(s) without damage to nail

259

1.89

4.08

1.2

2.6

2.61

2.90

g/l

1.54

248

Chronic iridocyclitis

101

666

1.54

4.08

2.0

2.4

2.84

2.93

g/l

0.45

609

Dystonia

113

763

1.51

4.07

1.4

2.5

2.64

2.93

g/l

2.66

104

705

Schizophrenia or delusion, excluding more controls

503

4131

1.21

4.07

2.0

2.4

2.95

2.87

g/l

1.11

450

3818

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

149

1064

1.42

4.00

1.9

1.4

2.97

2.92

g/l

0.24

131

936

Other congenital malformations of the digestive system, including avohilmo

552

1.59

4.00

1.5

2.5

2.96

2.93

g/l

0.08

507

Congenital iodine-deficiency syndrome/hypothyroidism

426

1.68

4.00

3.3

2.0

2.79

3.01

g/l

1.04

383

Lichen planus, including avohilmo

421

3456

1.23

3.98

2.4

2.79

2.92

g/l

2.04

385

3132

Other congenital malformations of upper alimentary tract

0.00

3.94

0.0

2.5

—

2.98

—

Focal epilepsy

432

3556

1.22

3.94

2.1

2.3

2.91

g/l

0.01

381

3238

Focal epilepsy, strict definition

407

3332

1.23

3.93

2.1

2.3

2.93

2.92

g/l

0.05

358

3034

HSIL lesion of the cervix uteri, vagina or vulva

264

2055

1.29

3.92

2.1

2.0

2.88

2.81

g/l

0.59

240

1910

Malnutrition

293

1.82

3.91

1.7

2.2

3.12

3.03

g/l

0.19

262

Burns and corrosions of external body surface, specified by site

192

1433

1.35

3.90

2.0

2.4

3.04

2.91

g/l

0.96

174

1334

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

111

753

1.49

3.90

1.9

2.4

2.95

2.89

g/l

0.25

103

698

Carcinoma in situ of skin of ear and external auricular canal

288

1.84

3.87

1.8

2.3

2.91

2.98

g/l

0.24

251

Dissection of aorta

500

1.62

3.87

2.3

2.7

3.12

2.97

g/l

0.67

455

Malignant neoplasm of bladder

155

1121

1.40

3.85

1.9

1.4

3.12

2.90

g/l

1.81

139

979

Medical abortion

1198

5753

1.13

3.84

1.8

2.4

2.90

g/l

0.01

1071

5168

Triptan medication for migraine, single purchase ok

1392

8451

1.12

3.84

2.2

2.3

2.77

2.87

g/l

4.31

1296

7778

Migraine, single triptan purchase ok & required. ICD-code if available is included

1392

8451

1.12

3.84

2.2

2.3

2.77

2.87

g/l

4.31

1296

7778

Secondary parkinsonism, excluding more controls

309

1.79

3.84

3.0

2.1

2.83

3.07

g/l

0.85

282

Viral infections of the central nervous system

131

921

1.44

3.83

2.3

2.4

3.02

2.94

g/l

0.31

118

844

Disorder of external ear, unspecified

463

1.63

3.79

2.8

2.7

2.92

2.94

g/l

0.06

429

Cholangitis (primary sclerosing, PSC)

136

966

1.43

3.79

1.9

2.5

3.05

2.96

g/l

0.48

123

878

Amyloidosis of skin

7.85

3.78

3.0

1.1

1.96

3.07

g/l

—

Vulvovaginal ulceration/inflammation in other diseases

105

709

1.50

3.77

1.8

2.3

2.70

2.90

g/l

1.46

663

Congenital malformations of heart and great arteries

209

1539

1.33

3.77

2.0

2.4

2.85

2.91

g/l

0.40

190

1425

Malignant neoplasm of head and neck, including Hilmo

207

1572

1.33

3.76

2.5

1.4

2.82

2.89

g/l

0.56

190

1392

Contact with heat and hot substances

630

1.53

3.75

1.8

2.4

3.15

2.94

g/l

1.12

584

Use of memantine

601

5660

0.85

3.75

1.9

2.3

2.93

2.97

g/l

0.47

472

4976

Use of other anti-dementia drugs

601

5660

0.85

3.75

1.9

2.3

2.93

2.97

g/l

0.47

472

4976

Benign neoplasm: Parotid gland

175

1300

1.37

3.73

2.1

2.4

2.99

2.92

g/l

0.38

162

1188

Assault by bodily force

106

719

1.49

3.72

1.9

2.2

2.89

g/l

0.00

687

Colitis, primary sclerosing, strict definition

2.45

3.72

2.7

2.5

3.24

2.98

g/l

0.86

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

512

4307

1.19

3.71

1.8

2.3

2.88

2.87

g/l

0.12

468

3992

Focal brain injury

123

861

1.45

3.69

2.1

2.5

2.96

3.04

g/l

0.41

105

790

Appendectomy

1261

10755

1.12

3.68

2.4

2.3

2.87

2.86

g/l

0.08

1155

9887

Maternal care for other conditions predominantly related to pregnancy

245

1857

1.29

3.67

2.0

2.75

2.77

g/l

0.13

234

1761

Degeneration of nervous system due to alcohol

322

1.76

3.67

1.3

2.8

2.76

2.99

g/l

1.17

296

603

4810

1.18

3.66

2.2

2.3

2.91

2.98

g/l

0.86

509

4216

Other and unspecified acute skin changes due to ultraviolet radiation

368

1.70

3.64

2.1

2.4

2.93

3.05

g/l

0.50

330

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

164

1211

1.37

3.64

2.2

2.5

2.93

g/l

0.01

147

1103

Status epilepticus

460

1.62

3.63

1.7

2.7

2.81

3.08

g/l

1.59

416

Single spontaneous delivery

632

3898

0.85

3.62

2.7

2.1

2.89

2.96

g/l

0.99

579

3457

Viral infections of the central nervous system, including avohilmo

140

1007

1.41

3.62

2.2

2.5

3.01

2.93

g/l

0.36

126

924

Spasmodic torticollis

415

1.65

3.59

1.4

2.1

2.71

2.91

g/l

1.06

387

Degeneration of the brain due to alcohol

324

1.75

3.59

1.3

2.8

2.76

3.01

g/l

1.32

298

Other disorders of skin and subcutaneous tissue in diseases classified elsewhere

5.99

3.59

2.8

1.1

2.07

3.13

g/l

—

Graves disease, strict definition

178

1332

1.35

3.59

2.2

2.3

2.82

2.88

g/l

0.47

164

1232

Campylobacter enteritis

339

1.72

3.57

2.2

2.4

2.77

3.00

g/l

1.09

312

Acute alcohol intoxication, ICD10

382

3142

1.22

3.57

1.4

2.4

2.93

2.87

g/l

0.59

346

2930

Other disorders of Eustachian tube

401

1.66

3.55

1.6

2.3

2.85

3.01

g/l

0.65

371

Familial hypercholesterolemia, with ischemic heart disease

234

1827

1.30

3.54

2.1

2.5

2.87

2.92

g/l

0.26

207

1616

Contact with and exposure to communicable diseases

383

3135

1.22

3.53

2.2

2.1

2.63

2.83

g/l

4.86

372

2944

Lateral epicondylitis

226

1754

1.30

3.51

1.8

2.3

2.67

2.89

g/l

2.46

207

1617

Macular cyst

530

1.57

3.49

2.4

2.8

2.85

3.01

g/l

0.75

483

Graves ophthalmopathy, strict

289

1.78

3.49

1.1

2.0

3.03

2.98

g/l

0.14

269

Pre-eclampsia or eclampsia

322

2608

1.24

3.48

2.5

2.2

2.79

2.83

g/l

0.34

300

2406

Crohn disease (strict definition, all UC cases excluded)

552

1.54

3.48

1.7

2.5

2.96

2.93

g/l

0.07

513

Colitis, primary sclerosing

126

2.20

3.47

2.5

2.2

3.11

2.98

g/l

0.35

120

Other disorders of cornea

205

1576

1.32

3.46

2.1

2.3

2.84

2.92

g/l

0.57

187

1437

Benign neoplasm: Kidney

547

1.55

3.45

2.1

2.7

2.97

2.95

g/l

0.07

499

Lichen planus

287

2303

1.26

3.44

2.7

2.3

2.76

2.93

g/l

2.48

261

2084

Pre-eclampsia or poor fetal growth

403

3328

1.21

3.43

2.4

2.1

2.78

2.81

g/l

0.23

376

3088

Other disorders of the genitourinary system

288

2314

1.26

3.42

2.2

2.4

3.04

2.93

g/l

0.99

261

2074

Other facial nerve disorders

352

1.68

3.38

2.0

2.2

2.87

2.96

g/l

0.23

320

Malignant neoplasm of digestive organs

870

5861

1.14

3.37

2.3

1.4

3.05

2.89

g/l

4.38

774

5218

Melanoma in situ of trunk

256

1.82

3.36

2.3

2.8

2.73

3.05

g/l

1.22

233

Strabismus

479

4037

1.19

3.35

2.2

2.3

2.79

2.89

g/l

1.57

441

3692

Other disorders of bone density and structure

285

1.75

3.34

1.9

2.2

2.66

2.91

g/l

1.23

267

Pneumonitis due to solids and liquids

187

1429

1.32

3.32

2.0

2.3

3.09

2.96

g/l

1.04

154

1284

Delivery

639

3899

0.86

3.31

2.6

2.1

2.89

2.96

g/l

1.06

588

3458

Disturbance of activity and attention

108

734

1.44

3.31

1.4

1.6

2.61

2.86

g/l

2.31

102

705

Ulcer of oesophagus

152

1128

1.37

3.31

2.3

2.7

2.93

2.96

g/l

0.12

135

1025

Diseases of appendix

1515

12325

1.10

3.30

2.6

2.3

2.84

2.88

g/l

0.75

1385

11305

Prepatellar bursitis

584

1.51

3.30

2.6

2.3

2.81

2.92

g/l

0.44

536

Corneal ulcer

346

2843

1.23

3.30

2.3

2.2

2.88

2.89

g/l

0.07

319

2605

Noninflammatory disorders of female genital tract

663

2867

1.16

3.29

2.3

2.2

2.90

2.99

g/l

1.54

598

2582

Other and unspecified mononeuropathies of upper limb

355

1.67

3.28

1.5

2.4

2.87

2.91

g/l

0.14

333

Malignant neoplasm of small intestine, including Hilmo

442

1.60

3.27

2.1

1.4

3.04

2.93

g/l

0.35

390

Other puerperal infections

519

1.53

3.27

1.7

2.48

2.85

g/l

3.62

497

Melanocytic naevi of upper limb, including shoulder

295

1.73

3.26

2.0

2.4

2.80

2.98

g/l

0.76

276

Type 1 diabetes, strict definition, subgroup 1

439

1.58

3.25

1.3

1.6

2.76

2.83

g/l

0.23

422

Atopic conjunctivitis

473

1.56

3.25

1.5

2.1

2.93

2.92

g/l

0.01

439

Complications peculiar to reattachment and amputation

2.46

3.24

1.9

2.7

3.12

2.92

g/l

0.44

Other and unspecified disorders of skin and subcutaneous tissue

131

953

1.39

3.24

1.8

2.5

2.41

2.92

g/l

6.04

104

870

Arterial embolism and thrombosis of lower extremity artery

563

1.52

3.24

1.5

2.6

3.17

3.00

g/l

0.82

507

Malignant neoplasm of liver and intrahepatic bile ducts

459

1.58

3.23

1.9

1.4

3.05

2.99

g/l

0.20

406

conjunctival haemorrhage

174

1324

1.33

3.21

2.3

2.4

2.83

2.93

g/l

0.73

159

1201

Use of disulfiram, acamprosate or naltrexone

150

1115

1.36

3.21

1.5

2.3

2.91

2.87

g/l

0.24

134

1047

Inflammatory diseases of prostate (prostatitis)

272

2188

1.25

3.21

2.1

2.6

2.65

2.92

g/l

5.40

253

2011

Hyperkinetic disorders

113

779

1.42

3.20

1.4

1.6

2.64

2.85

g/l

1.76

107

746

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

272

2185

1.25

3.20

2.1

2.2

2.75

2.87

g/l

1.40

252

2002

Residual foreign body in soft tissue

588

1.50

3.19

2.0

2.4

2.79

2.94

g/l

0.69

549

Brain meningioma

104

729

1.45

3.19

2.4

1.4

2.98

2.89

g/l

0.37

635

Hereditary angioödema type 1

6.90

3.18

10.1

1.0

2.10

3.03

g/l

—

Acute appendicitis

1389

11708

1.10

3.18

2.6

2.3

2.84

2.87

g/l

0.66

1276

10754

Postpartum hemorraghe, parous women as controls

178

1942

0.76

3.17

1.9

2.1

2.67

2.73

g/l

0.42

164

1839

Granuloma annulare

187

1.93

3.17

1.9

2.69

2.97

g/l

1.32

174

Trigeminal neuralgia

119

856

1.41

3.15

2.5

2.4

2.87

2.94

g/l

0.29

110

780

Polyp of the female genital tract

558

2703

1.17

3.14

2.0

2.3

2.87

3.01

g/l

2.56

504

2425

Malignant neoplasm of colon

339

2798

1.22

3.13

2.8

1.4

3.08

2.91

g/l

2.03

303

2468

Physiological and behavioural disorders associated with sexual development and orientation

8.12

3.12

1.0

5.8

2.35

2.94

g/l

—

Other noninflammatory disorders of uterus, except cervix

447

2513

1.19

3.12

2.4

2.3

2.92

3.03

g/l

1.32

396

2242

Benign neoplasm: Cerebral meninges

215

1690

1.29

3.12

2.0

2.4

2.88

2.94

g/l

0.36

193

1528

Combinations of oral blood glucose lowering drugs

653

5695

1.15

3.11

1.8

2.6

2.90

2.87

g/l

0.23

605

5187

All dysplastic lesions of the cervix uteri

322

2600

1.22

3.10

2.2

2.1

2.83

2.79

g/l

0.39

300

2429

Septal defects

635

1.47

3.10

1.7

2.4

2.85

2.91

g/l

0.26

590

Other diseases of gallbladder

102

717

1.45

3.10

2.6

2.82

2.98

g/l

0.79

644

Blindness, monocular

133

2.11

3.10

4.3

2.1

2.91

3.00

g/l

0.14

123

Endocrine disorders, other/unspecified

229

0.34

3.10

1.5

2.3

2.86

3.02

g/l

—

216

Other drug-induced secondary parkinsonism

147

2.06

3.09

2.3

2.60

3.12

g/l

1.58

136

Abrasion of teeth

723

6351

1.14

3.08

2.6

2.4

2.72

2.88

g/l

4.72

663

5806

Postpartum hemorraghe, all women as controls

178

2249

0.77

3.06

1.9

2.0

2.67

2.78

g/l

0.94

164

2129

Acute alcohol intoxication

513

4400

1.17

3.05

1.5

2.5

2.98

2.86

g/l

2.09

463

4064

Pedestrian injured in transport accident

132

973

1.37

3.02

1.7

2.3

3.00

2.94

g/l

0.25

120

892

Benign neoplasm of breast

233

1857

1.27

3.01

2.3

2.85

2.93

g/l

0.57

207

1665

Hereditary sideroblastic anaemia

3.01

2.8

1.5

2.79

2.85

g/l

0.10

HSIL lesion of the cervix uteri

219

1731

1.27

2.98

1.9

2.1

2.87

2.79

g/l

0.65

202

1622

Non-small cell lung cancer, including Hilmo

337

2623

1.21

2.95

2.0

1.4

3.32

2.89

g/l

10.99

306

2326

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

158

1200

1.33

2.95

2.3

2.5

2.92

2.94

g/l

0.12

142

1094

Malignant neoplasm of head and neck

169

1298

1.32

2.93

2.1

1.4

2.81

2.90

g/l

0.65

155

1152

Brain meningioma, including Hilmo

105

750

1.42

2.93

2.3

1.4

2.98

2.89

g/l

0.39

653

Other acute skin changes due to ultraviolet radiation

503

1.52

2.92

2.0

2.3

2.94

3.00

g/l

0.25

458

Haemangioma and lymphangioma, any site

174

1343

1.31

2.91

2.9

2.5

2.82

2.91

g/l

0.54

162

1234

Abdominal aortic aneurysm (AAA)

230

1823

1.26

2.91

1.8

2.4

3.25

2.88

g/l

6.21

203

1611

Pyoderma

237

1.77

2.91

1.9

2.4

2.85

2.93

g/l

0.19

221

Appendicitis, broad definition

1490

12239

1.09

2.91

2.6

2.3

2.83

2.87

g/l

0.92

1364

11229

Other problems related to primary support group, including family circumstances

134

967

1.36

2.90

1.8

2.2

2.88

2.87

g/l

0.01

124

908

Benign neoplasm: Larynx

464

1.54

2.89

2.6

2.7

2.75

2.98

g/l

1.34

424

Haemorrhagic disorder due to circulating anticoagulants

231

1.79

2.88

1.9

2.4

3.57

3.03

g/l

1.82

206

Vascular dementia (subcortical)

670

1.45

2.88

3.4

2.3

3.05

3.11

g/l

0.23

587

Acquired absence of limb

137

2.04

2.88

2.5

1.8

2.97

3.20

g/l

0.44

127

Other ulcerative colitis

668

1.44

2.88

1.4

2.5

2.97

2.90

g/l

0.26

618

Acute appendicitis, no complications

1024

9163

1.11

2.87

2.7

2.3

2.82

2.86

g/l

0.82

946

8465

Melanoma in situ of other and unspecified parts of face

232

1.79

2.87

2.3

2.6

3.06

3.05

g/l

0.02

209

Leiomyoma of uterus

1211

6147

1.11

2.87

2.3

2.87

2.91

g/l

0.66

1071

5537

Chorioretinal inflammation

385

1.59

2.86

1.5

2.3

2.61

2.96

g/l

1.88

357

Disorders of lacrimal system and orbit in diseases classified elsewhere

323

1.64

2.84

1.1

2.0

3.02

2.95

g/l

0.18

301

Sequelae of injuries of head

671

1.43

2.82

2.7

2.4

3.14

2.88

g/l

1.83

621

Dronedarone medication

435

1.55

2.81

2.3

2.6

3.16

2.99

g/l

0.54

384

Other and unspecified mononeuropathies of lower limb

379

1.59

2.81

1.7

2.2

2.93

2.96

g/l

0.06

345

Injury of other and unspecified intrathoracic organs

130

970

1.36

2.79

1.9

2.3

2.99

2.96

g/l

0.11

121

887

Other changes in lacrimal passages

4.69

2.79

2.9

1.7

2.65

3.28

g/l

—

Vascular dementia

244

1904

1.25

2.78

2.6

2.3

2.98

3.04

g/l

0.39

203

1664

Foreign body entering into or through eye or natural orifice

140

1056

1.34

2.78

2.7

2.4

2.97

2.91

g/l

0.30

126

985

Dislocation of lens

226

1.77

2.77

2.8

2.6

2.85

3.08

g/l

0.78

212

Other and unspecified abdominal hernia

633

1.45

2.77

1.6

2.1

2.90

2.99

g/l

0.40

576

Ventricular septal defect, a heart condition

152

1.93

2.75

1.5

1.8

3.23

3.00

g/l

0.64

144

Recurrent and persistent haematuria

105

2.17

2.75

1.4

2.6

2.86

2.99

g/l

0.23

Asthma mixed form (mode)

574

1.46

2.75

2.1

1.7

2.63

2.86

g/l

1.57

510

Graves ophthalmopathy

326

1.63

2.75

1.1

2.0

3.02

2.93

g/l

0.25

302

Other maternal disorders predominantly related to pregnancy

724

5120

0.88

2.74

2.3

2.83

2.85

g/l

0.24

675

4716

Haemangioma, any site

163

1259

1.31

2.74

2.6

2.5

2.85

2.92

g/l

0.34

151

1155

Focal epilepsy, mode (most common among epilepsy diagnosis)

371

3130

1.19

2.74

2.1

2.3

2.86

2.92

g/l

0.51

322

2852

Systemic sclerosis,strict definition

119

2.09

2.73

1.4

1.8

2.80

2.98

g/l

0.39

112

Benign neoplasm: Choroid

150

1148

1.32

2.73

1.6

2.7

2.65

2.93

g/l

2.96

131

1046

Lung diseases due to external agents

315

2624

1.21

2.71

2.8

2.4

3.10

2.92

g/l

2.44

271

2357

Malignant neoplasm of oral cavity, including Hilmo

619

1.44

2.70

2.3

1.4

2.88

2.95

g/l

0.39

549

Other diseases of spinal cord

399

1.56

2.69

2.6

2.8

2.83

2.95

g/l

0.50

369

Corneal degeneration

259

1.71

2.68

1.4

2.4

2.98

3.00

g/l

0.04

236

Other acquired deformities of musculoskeletal system and connective tissue

612

1.44

2.67

2.2

2.3

3.15

2.93

g/l

1.06

562

Reduction defects of unspecified limb

8.48

2.67

1.0

2.44

2.56

g/l

—

Other strabismus

357

2998

1.19

2.66

2.3

2.78

2.90

g/l

1.77

331

2754

Bitten or struck by other mammals

181

1422

1.28

2.66

2.8

2.4

2.96

2.88

g/l

0.54

171

1316

Nonspecific lymphadenitis

696

1.41

2.65

1.9

2.2

2.76

2.86

g/l

0.41

650

Convergent concomitant strabismus

554

1.46

2.65

2.3

2.2

2.88

2.94

g/l

0.20

513

Other peripheral vertigo

199

1585

1.27

2.65

1.8

2.6

2.85

2.93

g/l

0.54

176

1442

Injury of nerves and spinal cord at neck level

306

1.64

2.65

2.7

2.8

2.56

3.02

g/l

2.54

279

Benign neoplasm of other and unspecified intrathoracic organs

149

1.94

2.63

2.9

2.3

3.00

2.97

g/l

0.05

136

Other blood glucose lowering drugs, excl. Insulins

364

3083

1.19

2.62

1.9

2.5

2.97

2.92

g/l

0.34

333

2748

Sensorineural hearing loss

1821

11251

1.08

2.61

2.4

2.78

2.94

g/l

9.36

1602

10235

Moyamoya

7.81

2.61

1.2

1.0

2.76

2.80

g/l

—

Maternal care related to the fetus and amniotic cavity and possible delivery problems

474

3221

0.86

2.60

2.6

2.1

2.76

2.83

g/l

0.79

449

2991

Osteochondrodysplasia with defects of growth of tubular bones and spine

5.84

2.60

1.0

1.2

3.48

2.46

g/l

—

Viral encephalitis, not elsewhere classified/unspecified

261

1.68

2.60

3.5

2.5

3.16

2.97

g/l

0.42

239

Colorectal cancer

523

4369

1.15

2.59

2.7

1.5

3.03

2.90

g/l

2.16

467

3860

Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinaemia

4.98

2.59

11.9

1.1

3.01

3.20

g/l

—

Hepatocellular carcinoma

324

1.61

2.57

2.2

1.4

3.03

2.98

g/l

0.15

283

Myocardial infarction, with ST-elevation

407

3485

1.18

2.57

1.9

2.4

3.14

2.91

g/l

4.72

370

3114

Status post-ami

638

4268

1.14

2.56

1.7

2.5

3.01

2.89

g/l

2.01

566

3769

Car occupant injured in other and unspecified transport accidents

303

2530

1.20

2.54

2.0

2.3

2.81

2.90

g/l

0.98

276

2336

Paralytic strabismus

148

1144

1.31

2.52

2.2

2.5

2.81

2.95

g/l

0.82

134

1045

Atrial septal defect

370

1.55

2.52

1.9

2.1

3.11

3.01

g/l

0.36

344

Alzheimer’s disease (Early onset), excluding more controls

564

0.59

2.51

1.3

2.3

3.07

3.11

g/l

0.08

497

Allergic contact dermatitis due to drugs in contact with skin

303

1.62

2.50

2.3

2.1

2.99

2.97

g/l

0.04

282

Tracheo-bronchomalasia

3.92

2.49

1.8

3.9

2.59

2.67

g/l

—

Polypectomy (DHB20)

132

1008

1.33

2.46

2.8

2.4

2.89

2.95

g/l

0.37

124

930

Other and unspecified disorders of orbit

2.46

1.5

2.7

3.26

2.93

g/l

0.46

hereditary angioödema type 3

7.03

2.45

1.0

2.48

2.56

g/l

—

Other disorders of breast

236

1932

1.23

2.45

2.4

2.78

2.90

g/l

1.12

206

1756

Respiratory tuberculosis, confirmed

258

1.67

2.44

1.9

2.5

3.04

g/l

0.00

231

Sixth [abducent] nerve palsy

499

1.47

2.44

2.8

2.7

2.88

3.00

g/l

0.35

448

Respiratory tuberculosis, confirmed, including avohilmo

266

1.65

2.44

1.9

2.5

3.06

3.03

g/l

0.06

238

Myopia

181

1439

1.27

2.43

2.0

2.3

2.74

2.90

g/l

1.56

171

1340

Dentofacial anomalies [including malocclusion]

1288

9245

1.09

2.43

2.3

2.74

2.87

g/l

5.53

1179

8515

Contact with other and unspecified heat and hot substances

2.29

2.43

4.9

1.9

3.19

2.96

g/l

0.36

Sequelae of injuries of upper limb

174

1379

1.27

2.43

2.6

2.5

2.78

2.90

g/l

0.73

156

1275

Other specified disorders of external ear

583

1.43

2.43

2.0

2.7

2.96

g/l

0.00

540

Malignant neoplasm of pancreas

1151

0.71

2.42

1.7

1.4

3.04

2.92

g/l

0.56

1013

Malignant neoplasm of small intestine

322

1.59

2.41

2.5

1.4

3.00

2.96

g/l

0.07

284

Other and unspecified primary disorders of muscles

2.22

2.40

1.4

2.7

3.16

2.95

g/l

0.61

Medial epicondylitis

426

1.50

2.40

1.4

2.2

2.70

2.91

g/l

0.99

400

Inguinal or femoral hernia, bilateral

237

1948

1.23

2.40

2.8

2.4

2.83

2.88

g/l

0.42

212

1772

Congenital varicose veins

2.93

2.39

2.4

2.1

2.75

3.09

g/l

0.66

118

1548

0.75

2.38

1.3

2.4

3.12

2.92

g/l

1.32

1409

Alzheimer’s disease (Atypical or mixed)

196

2386

0.80

2.38

1.9

2.3

2.88

3.02

g/l

1.02

161

2064

Seminoma of testis, including Hilmo

2.31

2.38

1.6

1.4

2.92

2.76

g/l

0.21

Inguinal hernia, bilateral

233

1914

1.23

2.37

2.8

2.4

2.82

2.88

g/l

0.47

208

1740

Follow-up care involving plastic surgery

485

1.46

2.37

1.7

2.0

2.57

2.88

g/l

1.75

445

Proteinuria and renal glomerular damage; focal glomerulonephritis

4.43

2.36

1.1

3.2

3.30

3.16

g/l

—

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

169

1.81

2.35

2.8

2.2

3.01

2.99

g/l

0.04

160

Endometriosis of pelvic peritoneum

237

1770

1.22

2.35

1.5

2.3

2.68

2.95

g/l

4.45

215

1616

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

105

782

1.36

2.34

1.7

1.4

3.05

2.95

g/l

0.51

683

Pre-eclampsia

279

2332

1.20

2.34

2.7

2.2

2.76

2.83

g/l

0.64

257

2155

Malignant neoplasm of endocrine gland, including Hilmo

143

1112

1.30

2.34

2.7

1.4

2.79

2.88

g/l

0.63

131

987

Viral encephalitis, not elsewhere classified/unspecified, including avohilmo

269

1.63

2.34

3.5

2.5

3.16

2.98

g/l

0.39

247

Benign neoplasm: Prostate

113

2.04

2.34

1.9

3.1

2.61

3.08

g/l

1.41

Delivery, wide proxy

533

3223

0.87

2.33

2.5

2.1

2.91

3.00

g/l

1.33

486

2815

Ulcerative rectosigmoiditis

134

1034

1.31

2.32

1.9

2.4

2.97

2.89

g/l

0.46

121

965

Glaucoma-related operations

137

1063

1.31

2.32

2.6

2.94

3.01

g/l

0.32

123

942

Laparoscopic right hemicolectomy

138

1072

1.31

2.32

2.4

2.5

2.95

2.97

g/l

0.08

118

966

Acute lymphadenitis

629

1.40

2.32

2.6

2.4

3.11

2.92

g/l

0.80

582

Conductive hearing loss, unspecified

157

1238

1.28

2.31

2.3

2.4

2.88

2.94

g/l

0.30

143

1135

Alzheimer disease

754

5994

0.89

2.30

2.0

2.4

2.99

2.96

g/l

0.35

625

5273

Schizophrenia

175

2179

0.80

2.29

2.4

2.3

3.03

2.88

g/l

1.34

156

2028

Thyroiditis, unspecified

186

1.76

2.29

1.3

1.8

3.01

2.93

g/l

0.13

173

Glaucoma suspect

709

7892

0.89

2.28

2.3

2.4

2.81

2.93

g/l

2.44

635

7070

Vertigo of central origin

240

1.67

2.28

2.1

2.8

2.44

3.05

g/l

3.51

215

Malignant neoplasm of bronchus and lung, including Hilmo

476

3467

1.15

2.28

2.1

1.5

3.30

2.88

g/l

13.73

433

3077

Effects of foreign body entering through natural orifice

443

3855

1.15

2.28

2.3

2.4

2.79

2.88

g/l

1.20

403

3566

Other disorders of conjunctiva

308

2608

1.19

2.28

2.5

2.3

2.81

2.93

g/l

1.24

282

2360

Chromophobe cell carcinoma of kidney

2.30

2.28

2.4

1.2

2.87

2.84

g/l

0.04

Other acquired deformities of ankle and foot

2.11

2.26

1.6

2.3

2.79

2.82

g/l

0.03

Ankle and foot

107

2.03

2.26

1.5

2.3

2.53

3.02

g/l

1.52

Nontoxic single thyroid nodule

142

1110

1.29

2.26

2.5

2.3

2.76

2.92

g/l

1.28

133

1011

Ingrowing nail

650

1.38

2.25

2.2

2.4

2.95

2.93

g/l

0.11

600

Hypertrophic disorders of skin

633

1.39

2.24

2.5

2.3

2.86

2.95

g/l

0.39

588

Chondromalacia

360

1.53

2.24

1.6

2.2

2.84

2.89

g/l

0.10

343

Other and unspecified degenerative diseases of nervous system

485

1.45

2.22

2.1

2.5

2.84

3.02

g/l

0.85

437

Alport

4.66

2.21

1.5

3.8

3.42

3.07

g/l

—

Fall on and from ladder

155

1229

1.27

2.21

3.2

2.5

2.68

2.93

g/l

2.78

142

1130

Varicose veins of other sites

117

897

1.32

2.16

2.7

2.4

2.66

2.90

g/l

1.82

101

826

Malignant neoplasm of other and unspecified parts of tongue, including Hilmo

275

1.59

2.16

2.6

1.3

2.92

2.95

g/l

0.07

243

Arthropathy in Crohn disease

109

1.98

2.14

1.0

2.3

2.95

2.90

g/l

0.08

104

Non-small cell lung cancer, adenocarcinoma

135

1057

1.29

2.14

1.9

1.4

3.39

2.91

g/l

5.89

122

930

Acute nasopharyngitis (common cold)

184

1479

1.24

2.14

1.8

2.2

2.80

2.90

g/l

0.92

172

1385

Malignant neoplasm of thyroid gland, including Hilmo

127

986

1.30

2.14

2.7

1.4

2.78

2.88

g/l

0.66

115

875

Diseases of middle ear and mastoid

1011

7549

1.10

2.13

2.5

2.2

2.82

2.87

g/l

0.84

940

6915

All dysplastic lesions of the vagina

324

1.54

2.12

2.5

2.0

2.77

2.92

g/l

0.60

304

Schizoaffective disorder

113

865

1.32

2.11

1.8

2.3

2.92

2.89

g/l

0.16

103

810

Presbycusis

375

3209

1.16

2.10

2.5

2.3

2.97

3.03

g/l

0.55

319

2824

Respiratory tuberculosis, bacteriologically and histologically confirmed

269

1.59

2.10

1.9

2.5

3.04

g/l

0.01

240

Pedal cyclist injured in noncollision transport accidents

193

1578

1.23

2.09

1.8

2.3

2.79

2.92

g/l

1.16

174

1463

Occupational exposure to risk-factors

493

0.60

2.08

3.8

2.7

2.10

2.91

g/l

4.47

459

Suppurative and unspecified otitis media

517

4047

1.13

2.08

2.8

2.1

2.82

2.87

g/l

0.54

485

3740

Embedded teeth, including avohilmo

727

1.34

2.08

2.6

1.9

2.68

2.91

g/l

1.45

684

Colorectal neuroendocrine tumor and carcinoma

154

1.79

2.08

4.4

1.4

2.61

2.89

g/l

1.39

139

Otitis media, unspecified

136

982

1.28

2.08

2.9

2.1

2.84

2.94

g/l

0.55

131

908

Ménière disease

195

1599

1.23

2.07

1.8

2.6

2.80

2.94

g/l

1.26

176

1451

Alkalosis

3.26

2.06

2.0

2.7

2.89

3.07

g/l

—

Use of levodopa decarboxylase inhibitor

337

2905

1.17

2.05

2.1

2.4

2.88

2.92

g/l

0.28

294

2589

Paroxysmal nocturnal haemoglobinuria [Marchiafava-Micheli]

5.27

2.03

1.0

2.26

4.03

g/l

—

Congenital malformations of genital organs

110

838

1.31

2.03

1.7

2.0

2.75

2.89

g/l

1.05

103

790

Macular hole

138

1094

1.28

2.02

1.9

2.6

2.97

2.93

g/l

0.17

122

989

Other diseases of peritoneum

673

1.36

2.01

1.6

2.6

2.78

2.96

g/l

1.01

613

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

511

4395

1.13

2.01

3.0

1.5

3.30

2.89

g/l

11.66

464

3940

Chalazion

202

1668

1.22

2.00

3.0

2.4

2.67

2.92

g/l

3.44

183

1534

Cerebral aneurysm, nonruptured

170

1380

1.24

2.00

1.9

2.5

2.91

2.90

g/l

0.05

154

1269

Pilonidal cyst

110

846

1.31

1.99

2.1

2.2

3.03

2.88

g/l

0.88

102

803

Meningitis

631

1.36

1.98

3.0

2.4

2.83

2.90

g/l

0.28

584

Open wound of wrist and hand

851

7500

1.10

1.97

2.5

2.3

2.88

2.87

g/l

0.08

788

6921

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

105

804

1.31

1.97

2.1

2.4

2.71

2.79

g/l

0.37

100

760

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

429

1.44

1.96

1.6

2.4

2.60

2.99

g/l

3.99

398

Use of peginterferon beta-1a

3.07

1.96

1.9

1.3

2.30

2.80

g/l

—

Malignant neoplasm of thymus, including Hilmo

2.35

1.96

4.7

1.2

3.24

2.78

g/l

0.57

Carcinoma in situ of other and unspecified sites

738

1.34

1.96

3.1

2.5

2.93

2.98

g/l

0.15

673

Use of rivastigmine

310

3585

0.86

1.96

2.5

2.3

3.02

2.99

g/l

0.23

261

3119

Other disorders of skin and subcutaneous tissue related to radiation

3.45

1.94

1.1

3.26

g/l

—

Congenital obstruction of the pelviureteric junction

2.02

1.94

3.7

2.5

3.21

2.97

g/l

0.57

Examination and encounter for administrative purposes

141

1126

1.26

1.92

2.5

2.4

2.98

3.02

g/l

0.17

131

1031

Erectile dysfunction

181

1488

1.23

1.92

2.3

2.5

2.94

2.90

g/l

0.21

166

1349

Burn and corrosion of wrist and hand

406

1.44

1.91

1.6

2.3

2.98

2.89

g/l

0.25

381

Neovascular glaucoma

636

1.35

1.91

2.5

2.4

3.13

2.98

g/l

0.69

573

Palindromic rheumatism

114

1.89

1.91

1.4

1.9

2.92

2.83

g/l

0.12

104

Hypertrophic scar

575

1.37

1.91

2.7

2.2

2.88

2.97

g/l

0.36

532

Oral lichen planus, including avohilmo , including avohilmo

142

1138

1.26

1.90

2.3

2.5

2.80

2.90

g/l

0.60

128

1042

Undefined dementia

197

2184

0.83

1.89

2.2

2.3

2.83

3.04

g/l

2.12

165

1873

Unspecific neurodegenerative disorder

999

7423

0.92

1.89

2.1

2.5

2.91

2.95

g/l

0.56

816

6616

Carcinoma in situ, bladder

674

1.34

1.87

3.2

2.6

2.87

2.98

g/l

0.40

616

Malignant neoplasm of oral cavity

476

1.41

1.86

2.0

1.4

2.93

2.97

g/l

0.14

421

Perforation of tympanic membrane

183

1511

1.22

1.85

2.1

2.3

2.72

2.93

g/l

2.51

165

1373

Glaucoma secondary to other eye disorders

640

1.35

1.84

2.5

2.6

3.13

2.98

g/l

0.70

576

Vascular dementia (other)

116

1.88

1.84

1.7

2.5

3.23

3.07

g/l

0.29

102

Unspecified mental disorder

690

6257

1.11

1.84

2.0

2.3

2.92

2.87

g/l

0.79

633

5742

Myositis ossificans

2.89

1.83

2.1

2.5

2.45

2.96

g/l

—

Oral lichen planus

428

1.43

1.83

2.1

2.4

2.93

2.94

g/l

0.03

394

Malignant neoplasm of eye, brain and central nervous system, including Hilmo

119

938

1.28

1.83

2.3

1.4

2.89

2.91

g/l

0.08

105

829

Malignant neoplasm of stomach, including Hilmo

116

912

1.28

1.82

1.3

1.4

3.11

2.94

g/l

0.85

105

795

Other intracranial haemorrhages

513

1.39

1.82

2.2

2.5

2.96

3.01

g/l

0.15

457

Foreign body in alimentary tract

100

772

1.31

1.82

1.6

2.5

2.98

2.96

g/l

0.07

705

Cysts of oral region, not elsewhere classified

105

816

1.30

1.81

3.0

2.5

2.90

2.92

g/l

0.07

753

Other and unspecified intracranial injuries

403

1.43

1.81

1.8

2.5

2.78

2.96

g/l

0.75

366

Transient acantholytic dermatosis [Grover]

2.71

1.81

1.2

2.4

2.91

3.02

g/l

—

Varus deformity, not elsewhere classified

124

1.82

1.79

1.4

2.5

2.43

2.77

g/l

0.97

114

Other contact dermatitis

130

1040

1.26

1.77

1.8

2.5

2.74

2.94

g/l

1.71

112

952

Renal cell carcinoma of kidney

456

1.40

1.76

2.2

1.5

3.15

2.97

g/l

0.56

395

Neuroendocrine tumor and carcinoma of rectum

2.40

1.75

4.6

1.1

2.55

2.82

g/l

0.65

Endometriosis ASRM stages 1,2

245

2088

1.18

1.74

1.5

2.1

2.68

2.85

g/l

2.14

221

1929

Parkinson's disease, including avohilmo

376

3312

1.14

1.74

1.9

2.4

2.94

2.93

g/l

0.03

326

2959

Lichen sclerosus et atrophicus

219

1852

1.19

1.73

2.2

2.3

2.89

2.94

g/l

0.34

197

1652

Malignant neoplasm of respiratory system and intrathoracic organs

465

3436

1.13

1.73

2.1

1.5

3.29

2.89

g/l

11.68

419

3058

Aneurysms, operations, SAH

337

2947

1.15

1.73

2.0

2.3

2.93

2.89

g/l

0.25

296

2680

Injuries involving multiple body regions

458

1.39

1.72

2.4

3.11

2.96

g/l

0.62

425

Dislocation, sprain and strain of joints and ligaments of knee

1090

9142

1.08

1.71

1.9

2.4

2.80

2.85

g/l

0.91

993

8454

Tonsillectomy and adenotomy

656

5023

0.91

1.70

2.0

2.1

2.76

2.83

g/l

1.13

610

4710

Malignant neoplasm of tongue, including Hilmo

342

1.45

1.69

2.8

1.3

2.92

2.96

g/l

0.10

303

Benign neoplasm: Orbit, unspecified

2.00

1.69

3.3

2.3

2.96

2.85

g/l

0.15

Benign neoplasm: Skin of trunk

599

1.33

1.66

3.0

2.4

2.70

2.91

g/l

1.23

553

HSIL lesion of the vulva

237

1.55

1.66

3.8

2.1

2.87

2.99

g/l

0.28

220

Vascular dementia (mixed)

353

1.44

1.65

2.4

2.2

2.81

3.08

g/l

0.90

311

Disorders of endocrine glands in diseases classified elsewhere

3.77

1.64

1.0

1.1

2.86

3.06

g/l

—

Outcome of delivery

168

849

1.22

1.64

1.8

2.0

2.80

2.81

g/l

0.05

162

811

Alcohol withdrawal state with delirium

128

1034

1.25

1.64

1.3

2.4

3.12

2.92

g/l

1.32

107

961

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

664

0.70

1.64

1.9

2.3

2.68

2.92

g/l

1.09

614

Dysplasia of cervi uteri

334

2053

1.15

1.64

2.2

2.1

2.78

2.93

g/l

2.32

302

1867

Maternal care for known or suspected abnormality of pelvic organs

215

1711

0.85

1.63

2.7

2.1

2.75

2.80

g/l

0.32

201

1608

Colon adenocarcinoma

258

2226

1.17

1.62

2.8

1.4

3.01

2.90

g/l

0.90

227

1956

Carcinoma in situ of skin of lip

2.24

1.62

1.2

1.4

3.48

3.07

g/l

0.43

Separation of retinal layers (serosa)

567

1.34

1.62

2.3

2.5

2.89

2.94

g/l

0.21

526

Recurrent dislocation of patella

320

1.45

1.60

1.5

2.0

2.81

2.79

g/l

0.04

306

Other and unspecified injuries of shoulder and upper arm

405

1.40

1.60

1.9

2.6

2.93

3.02

g/l

0.19

372

Vasomotor rhinitis (mode)

133

1083

1.24

1.59

2.1

2.6

2.63

2.92

g/l

2.79

116

990

Arthropod-borne viral fevers and viral haemorrhagic fevers

117

1448

0.80

1.58

3.5

2.5

2.82

2.92

g/l

0.61

108

1335

Benign neoplasm: Other parts of oropharynx

130

1.74

1.57

2.9

1.9

2.48

3.04

g/l

2.48

121

Benign mammary dysplasia

270

2344

1.16

1.57

2.7

2.3

2.88

2.95

g/l

0.49

240

2094

Tuberculosis, IBD comorbidity

144

1185

1.23

1.56

2.0

2.3

2.96

2.98

g/l

0.06

123

1055

Pleural plaque

224

1920

1.18

1.56

2.2

2.3

2.80

2.91

g/l

0.92

197

1717

Endometriosis diagnosis and infertility diagnosis occurring together

129

1049

1.24

1.55

1.6

2.3

2.70

2.81

g/l

0.65

116

987

Unspecified dementia

196

2070

0.84

1.55

2.2

2.3

2.82

3.03

g/l

1.99

164

1805

Viral haemorrhagic fevers, not elsewhere classified/unspecified

1155

0.78

1.54

3.4

2.4

2.72

2.92

g/l

1.55

1071

Felty syndrome

1.97

1.54

1.5

2.2

2.63

3.07

g/l

0.98

Malignant neoplasm of stomach

783

1.28

1.53

1.3

1.4

3.08

2.97

g/l

0.39

686

Contraceptive management

507

3925

0.90

1.53

2.2

2.77

2.84

g/l

1.10

473

3688

Pleural plaque without asbestos

697

1.30

1.52

2.0

2.6

2.98

3.02

g/l

0.17

622

Maternal care for (suspected) damage to fetus from alcohol

2.95

1.52

1.2

1.4

3.07

2.59

g/l

—

Parkinson's disease, strict definition

333

2942

1.14

1.52

1.8

2.4

2.93

2.92

g/l

0.09

291

2632

Other diseases of biliary tract

182

1537

1.19

1.51

2.4

2.99

2.96

g/l

0.16

164

1387

Other acantholytic disorders

2.25

1.50

1.4

2.7

2.97

3.07

g/l

0.13

Generalized epilepsy, strict definition

194

1.56

1.50

1.7

2.2

2.59

2.93

g/l

1.09

185

Benign neoplasm: Endocrine pancreas

102

1.83

1.50

1.8

2.4

2.68

3.11

g/l

1.53

Hereditary lymphedema, including avohilmo

2.65

1.49

1.0

1.6

3.14

3.24

g/l

—

Disturbances of smell and taste

619

1.31

1.49

3.5

2.9

2.85

2.93

g/l

0.30

569

Other sideroblastic anaemias

2.21

1.49

1.2

1.4

3.20

3.24

g/l

0.05

Gonococcal infection, including avohilmo

411

1.38

1.48

2.1

1.9

2.94

2.92

g/l

0.07

383

Tuberculosis, wide, including avohilmo

152

1266

1.21

1.48

2.0

2.4

2.98

2.99

g/l

0.05

129

1128

Contact with other hot fluids

318

1.43

1.48

1.2

2.3

2.92

2.95

g/l

0.07

300

Gestational diabetes (for exclusion)

302

2365

0.88

1.47

1.8

2.0

2.85

2.74

g/l

1.34

282

2249

Vertical strabismus

447

1.36

1.45

1.9

2.6

2.80

2.98

g/l

0.65

412

Other specified and unspecified disorders of lens

157

1.64

1.45

1.5

2.7

2.52

3.18

g/l

2.97

142

Malignant neoplasm of endocrine gland

118

960

1.24

1.45

2.2

1.4

2.74

2.89

g/l

1.13

110

852

Other articular cartilage disorders

278

1.46

1.44

2.2

2.3

2.72

2.83

g/l

0.37

255

Benign neoplasm of male genital organs

312

1.43

1.44

1.7

2.7

2.67

2.92

g/l

1.35

286

Small plaque parapsoriasis

2.37

1.44

1.9

2.1

3.04

3.23

g/l

—

Calcaneal spur

149

1.64

1.43

1.9

1.8

2.91

2.95

g/l

0.10

137

Tooth eruption problems

127

1004

1.22

1.43

2.3

1.9

2.76

2.90

g/l

0.72

120

944

Radial styloid tenosynovitis [de Quervain]

631

1.29

1.43

2.4

2.3

2.86

2.92

g/l

0.21

589

Lesion of radial nerve

483

1.34

1.43

2.3

2.4

2.84

2.99

g/l

0.49

445

Lack of expected normal physiological development

2.33

1.43

1.0

1.1

2.82

2.98

g/l

—

Endometriosis of ovary

267

2196

1.15

1.42

1.7

2.3

2.75

2.98

g/l

4.17

236

1991

LSIL lesion of the vagina

173

1.59

1.42

1.2

1.8

2.77

2.92

g/l

0.37

165

Maternal care for other known or suspected fetal problems

160

1197

0.84

1.42

1.5

1.9

2.62

2.76

g/l

1.55

154

1140

All dysplastic lesions of the vulva

571

1.31

1.42

2.5

2.3

2.93

g/l

0.01

529

Calculus of lower urinary tract

111

902

1.24

1.40

2.3

2.6

2.98

2.96

g/l

0.08

821

Mixed conductive and sensorineural hearing loss

268

2350

1.15

1.39

2.5

2.3

2.84

2.98

g/l

1.50

232

2126

Any dementia, excluding more controls

939

6003

1.08

1.39

2.2

2.5

2.92

2.95

g/l

0.39

793

5349

Ill-defined and unknown causes of mortality

162

1910

0.84

1.36

2.4

3.03

2.97

g/l

0.27

140

1702

Single delivery by caesarean section

157

1064

0.84

1.34

2.1

1.6

2.75

2.88

g/l

0.95

149

1009

LSIL lesion of the cervix uteri, vagina or vulva

178

1518

1.18

1.33

2.8

2.2

2.85

2.81

g/l

0.18

165

1412

Papillary adenocarcinoma of thyroid gland

665

1.27

1.33

1.9

1.4

2.69

2.83

g/l

0.76

596

Labour and delivery complicated by fetal stress [distress]

161

1239

0.84

1.33

1.7

1.8

2.73

2.76

g/l

0.18

155

1179

Benign neoplasm of brain and other parts of central nervous system

116

953

1.23

1.33

2.2

2.5

2.88

2.94

g/l

0.31

872

Amblyopia ex anopsia

428

1.34

1.33

1.4

2.1

2.82

3.00

g/l

0.68

399

Benign neoplasm: Lip

310

1.41

1.31

3.3

2.3

2.78

2.97

g/l

0.67

279

Tuberculosis, wide

148

1247

1.20

1.31

2.0

2.4

2.97

2.99

g/l

0.09

125

1111

Benign neoplasm of soft tissue of retroperitoneum and peritoneum

1.88

1.29

1.8

2.3

2.77

3.04

g/l

0.55

Other benign neoplasm of uterus: Corpus uteri

107

1.72

1.29

4.1

2.1

2.33

3.00

g/l

1.89

100

Melanoma in situ of lower limb, including hip

115

1.70

1.29

2.1

2.3

3.15

2.98

g/l

0.37

108

Use of galantamine

137

1627

0.84

1.28

1.6

2.4

2.90

3.01

g/l

0.65

105

1419

Malignant neoplasm of thyroid gland

109

894

1.23

1.27

2.3

1.4

2.71

2.89

g/l

1.29

101

795

Long labour

217

2111

0.87

1.27

2.4

2.1

2.75

2.80

g/l

0.39

206

1981

Other disorders of male genital organs

458

1.32

1.26

1.5

2.5

2.69

2.94

g/l

1.23

421

Disorders of globe

390

1.35

1.25

2.8

2.6

2.97

2.96

g/l

0.03

354

Injury of muscle and tendon at shoulder and upper arm level

777

7236

1.08

1.25

2.4

2.81

2.88

g/l

1.32

708

6646

Seminoma of testis

1.94

1.24

1.8

1.3

2.83

2.77

g/l

0.06

Non-small cell lung cancer

216

1863

1.15

1.23

1.8

1.4

3.38

2.88

g/l

9.03

195

1634

Deep bite

142

1051

1.19

1.22

2.5

2.3

2.74

2.91

g/l

1.06

128

983

Gonococcal infection

400

1.34

1.22

2.2

1.9

2.95

2.92

g/l

0.10

373

Interstitial cystitis (chronic), drug-induced

2.18

1.21

1.1

1.7

2.41

3.12

g/l

—

Heterophoria

115

954

1.21

2.8

2.4

2.63

2.93

g/l

4.05

110

882

Benign neoplasm of bone and articular cartilage

131

1101

1.20

1.8

2.4

2.70

2.91

g/l

2.08

112

1018

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

105

864

1.22

1.20

2.1

2.3

2.71

2.86

g/l

0.95

100

814

Accidental poisoning by and exposure to alcohol

168

0.53

1.20

1.3

2.7

2.80

2.95

g/l

—

158

Oligomenorrhoea

332

1.37

1.19

1.9

2.4

2.73

2.97

g/l

1.52

305

Other mental disorders due to brain damage and dysfunction and to physical disease

270

2400

1.13

1.19

2.8

2.4

2.83

2.93

g/l

1.01

229

2152

Non-small cell lung cancer, squamous, helper endpoint

893

0.79

1.19

1.8

2.5

3.23

2.98

g/l

1.23

797

Acute appendicitis, with complications

365

3299

1.11

1.18

2.5

2.4

2.90

2.88

g/l

0.11

330

3034

Pregnancy with abortive outcome

1183

5813

1.06

1.17

2.0

2.4

2.88

2.91

g/l

0.35

1063

5210

Parkinson's disease

351

3169

1.11

1.17

1.9

2.4

2.95

2.92

g/l

0.19

306

2838

Pregnancy, childbirth and the puerperium

485

2768

0.91

1.17

1.9

2.1

2.97

3.01

g/l

0.39

436

2391

Discharge from other and unspecified firearms

0.00

1.16

0.0

2.3

—

2.97

—

Whooping cough, including avohilmo

134

1.58

1.15

1.4

2.4

2.91

2.85

g/l

0.11

129

Alzheimer disease, including avohilmo

894

6591

0.94

1.15

2.0

2.4

2.96

g/l

0.03

744

5823

Transient global amnesia

148

1727

0.85

1.15

2.6

2.4

2.65

2.97

g/l

4.73

127

1578

Cytomegaloviral hepatitis

2.43

1.15

1.9

2.4

3.44

2.98

g/l

—

Tuberculosis of other organs, strict, including avohilmo

379

1.34

1.14

2.3

2.6

3.04

3.13

g/l

0.21

336

Contact with machinery

150

1749

0.85

1.14

2.3

2.63

2.89

g/l

2.74

136

1621

Contact with other hot metals

175

1.51

1.14

1.6

2.4

3.38

2.97

g/l

1.16

161

Disorders of eyelid in diseases classified elsewhere

431

1.31

1.14

1.2

2.7

2.89

3.00

g/l

0.39

395

Dislocation, sprain and strain of joints and ligaments of head

413

1.32

1.14

1.8

1.9

2.66

2.93

g/l

1.29

382

Malignant neoplasm of other and unspecified urinary organs

2.07

1.14

1.0

1.3

2.59

2.88

g/l

—

Peritonsillar abscess

303

2716

1.12

1.14

3.2

2.2

2.87

g/l

0.03

284

2515

Other factor of the environment

151

1.55

1.13

2.8

2.0

2.94

3.02

g/l

0.17

141

Female infertility

392

2128

1.11

1.13

2.0

2.2

2.83

2.92

g/l

1.08

364

1949

Tuberculosis of other organs, strict

371

1.34

1.13

2.3

2.6

3.05

3.12

g/l

0.15

328

Benign lipomatous neoplasm

585

5416

1.08

1.13

2.6

2.4

2.84

2.89

g/l

0.60

535

4925

Vestibular neuronitis

167

1443

1.16

1.12

2.4

2.5

2.94

2.91

g/l

0.12

151

1319

Secondary parkinsonism

415

1.32

1.12

3.0

2.6

2.83

3.04

g/l

0.75

375

Unequal limb length (acquired)

2.02

1.12

2.6

2.7

2.80

2.73

g/l

—

Antepartum haemorrhage, not elsewhere classified

681

1.24

1.12

2.5

2.0

2.78

2.79

g/l

0.03

648

Malignant neoplasm of hypopharynx, including Hilmo

1.77

1.11

1.4

1.2

3.17

2.98

g/l

0.25

Secondary parkinsonism+Parkinsonism in other disease

425

1.31

1.11

3.0

2.7

2.83

3.02

g/l

0.66

385

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

246

2187

1.13

1.09

2.7

2.4

2.89

2.90

g/l

0.09

223

2016

Perforation of oesophagus

1.76

1.08

1.1

2.3

2.72

3.05

g/l

0.89

Benign neoplasm: Connective and other soft tissue of trunk, unspecified

1.75

1.08

1.8

2.3

3.16

3.01

g/l

0.15

Other or unspecified paralytic strabismus

1.75

1.07

1.0

2.7

2.81

2.90

g/l

0.15

Other nonscarring hair loss

113

1.62

1.07

1.5

2.4

2.47

2.98

g/l

1.39

106

Tuberculosis of other organs

314

1.36

1.07

2.1

2.6

3.06

3.14

g/l

0.14

278

Other complications of labour and delivery, not elsewhere classified

663

0.79

1.05

1.4

1.6

2.71

2.76

g/l

0.20

631

Foreign body or object entering through skin

751

1.22

1.05

3.1

2.4

2.76

2.91

g/l

0.88

701

Benign neoplasm: Long bones of lower limb

367

1.32

1.04

1.6

2.1

2.53

2.90

g/l

2.08

345

Benign neoplasm: Heart

1.96

1.04

1.6

2.0

3.00

2.89

g/l

—

Reduction defects of lower limb, including avohilmo

2.12

1.04

3.3

3.6

2.47

2.92

g/l

—

Benign neoplasm: other/unspecified salivary gland

403

1.31

1.04

1.5

2.5

2.92

3.00

g/l

0.24

363

Benign lipomatous neoplasm of other sites/unspecified

169

1473

1.15

1.04

3.1

2.4

2.86

2.94

g/l

0.39

160

1334

Other ill-defined and unspecified causes of mortality

151

1742

0.86

1.03

2.3

2.4

3.07

2.97

g/l

0.58

130

1551

Malignant neoplasm of other and ill-defined sites, including Hilmo

213

1.43

1.03

1.2

1.3

3.15

2.99

g/l

0.26

184

Other benign neoplasms of connective and other soft tissue

169

1475

1.15

1.02

2.8

2.4

2.80

2.93

g/l

1.03

152

1349

Postmenopausal atrophic vaginitis

501

2517

1.09

1.01

2.5

2.3

2.71

3.01

g/l

11.92

453

2259

Eustachian salpingitis and obstruction

781

1.21

1.01

2.1

2.88

2.86

g/l

0.09

732

Obstructed labour due to malposition and malpresentation of fetus

192

2016

0.88

1.00

1.6

2.0

2.83

2.81

g/l

0.15

185

1906

Abnormal findings in secretions and smears from cervix uteri vagina vulva

733

5052

1.07

1.00

2.2

2.89

2.84

g/l

0.69

678

4621

LSIL lesion of the cervix uteri

127

1086

1.17

0.99

2.9

2.3

2.83

2.82

g/l

0.03

118

1028

Hypertrophy of breast in women and men

301

2724

1.11

0.99

2.0

2.4

2.80

2.86

g/l

0.53

276

2505

Lifestyle-related condition

140

1.52

0.99

3.0

2.0

2.91

3.02

g/l

0.22

129

Gastrointestinal stromal tumor and sarcoma

165

1.48

0.99

1.2

1.4

3.27

2.93

g/l

0.48

147

Malignant neoplasm of peripheral nerves and autonomic nervous system, including Hilmo

1.86

0.99

1.2

3.43

2.94

g/l

—

Ovarian dysfunction, other/unspecified

1.83

0.98

2.9

2.2

3.00

3.01

g/l

—

Intermittent heterotropia

530

1.25

0.97

2.0

2.2

2.59

2.98

g/l

3.17

489

Colorectal adenocarcinoma

418

3798

1.09

0.97

2.6

1.5

2.99

2.90

g/l

1.16

366

3364

Thromboangiitis obliterans

1.82

0.96

1.1

2.8

2.70

3.02

g/l

—

Benign neoplasm: Scrotum

1.81

0.96

1.3

1.4

2.90

3.05

g/l

—

Malignant neoplasm of nasal cavity and sinuses

1.68

0.96

5.9

1.3

2.87

2.98

g/l

0.13

Erythema intertrigo

355

1.31

0.96

2.5

2.8

2.95

3.02

g/l

0.21

325

Carcinoma in situ of breast, lobular

101

1.62

0.96

4.1

2.3

2.91

3.08

g/l

0.31

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

134

1157

1.16

0.95

1.9

2.3

2.91

2.85

g/l

0.28

128

1064

Unattended death

146

0.54

0.94

4.5

1.8

2.61

3.03

g/l

—

131

Dementia, including avohilmo

1227

7975

1.05

0.94

2.1

2.5

2.87

2.95

g/l

1.76

1024

7139

Frontotemporal dementia

1.64

0.93

2.2

2.0

3.60

3.08

g/l

—

Abscess of Bartholin gland

269

1.35

0.93

3.2

2.1

2.89

2.98

g/l

0.25

253

Hereditary corneal dystrophies

581

1.23

0.93

1.8

2.6

2.90

2.96

g/l

0.18

526

Other fall from one level to another

380

3490

1.09

0.93

2.2

2.4

2.91

2.90

g/l

0.06

349

3216

Foreign body in respiratory tract

672

1.21

0.92

2.7

2.4

3.02

2.95

g/l

0.26

617

Dengue, including avohilmo

2.16

0.91

4.8

1.5

3.18

2.96

g/l

—

2.12

0.90

6.2

3.0

2.33

2.79

g/l

—

Acute drug-induced interstitial lung disorder

119

1.55

0.90

9.0

2.0

3.36

3.02

g/l

0.83

109

Severe visual impairment, monocular

144

1.48

0.89

1.3

2.6

2.83

2.99

g/l

0.32

133

Dementia in other diseases classified elsewhere

835

1.18

0.85

1.7

2.5

3.05

2.98

g/l

0.25

750

Alzheimer’s disease, strict definition

590

5071

0.94

0.85

1.9

2.3

3.01

2.97

g/l

0.40

492

4445

Other appendicitis

133

1161

1.15

0.84

3.3

2.5

2.79

2.92

g/l

1.14

117

1080

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

145

1274

1.14

0.84

2.0

2.5

2.71

2.89

g/l

1.45

132

1166

Right hemicolectomy

117

1013

1.16

0.84

3.6

2.5

3.05

2.98

g/l

0.32

112

913

False labour

250

1713

0.90

0.83

1.8

2.0

2.67

2.80

g/l

1.70

244

1631

Specific developmental disorder of motor function

1.89

0.82

1.0

2.3

2.65

3.03

g/l

—

Pathological resorption of teeth

491

1.23

0.81

1.2

2.6

2.95

2.94

g/l

0.01

459

Bacterial meningitis

446

1.24

0.80

3.7

2.6

2.63

2.89

g/l

1.44

413

810

1.17

0.80

2.1

2.4

2.81

3.06

g/l

1.74

694

Burn and corrosion confined to eye and adnexa

242

1.33

0.79

1.8

2.4

3.00

2.89

g/l

0.23

232

Excessive vomiting in pregnancy

785

1.18

0.79

2.1

2.3

2.70

2.87

g/l

1.05

738

Complications predominantly related to the puerperium

326

3003

1.09

0.79

2.0

2.2

2.72

2.82

g/l

1.19

308

2784

Presbyopia

121

1056

1.15

0.78

1.5

2.4

2.82

2.88

g/l

0.24

112

994

Malignant neoplasm of bronchus and lung

392

3041

1.08

0.78

2.0

1.5

3.33

2.90

g/l

12.08

352

2699

Schizophrenia or delusion

503

4712

1.07

0.78

2.0

2.2

2.95

2.88

g/l

1.01

450

4341

Frontotemporal dementia, wide, incl. Pick's disease

107

1.53

0.78

2.1

1.9

3.55

3.09

g/l

0.60

Short Achilles tendon (acquired)

315

0.72

0.78

2.9

2.6

2.14

2.94

g/l

4.51

293

Female infertility, cervical, vaginal, other or unspecified origin

352

2077

1.09

0.77

2.1

2.2

2.86

2.92

g/l

0.50

328

1901

Convergence insufficiency and excess

115

1.49

0.77

1.3

2.0

2.35

2.98

g/l

2.18

108

Anomalies of dental arch relationship, including avohilmo

256

2110

1.10

0.77

2.3

2.4

2.68

2.87

g/l

2.30

227

1969

Other vitreous opacities

631

1.20

0.77

3.4

2.6

2.58

2.91

g/l

2.31

581

Benign neoplasm: Conjunctiva

467

1.23

0.77

1.4

2.7

3.03

3.00

g/l

0.08

433

Malignant neoplasm of hypopharynx

1.74

0.77

1.0

1.2

3.62

3.00

g/l

—

Malignant neoplasm of ovary, including Hilmo

920

0.84

0.77

3.1

1.4

3.12

2.90

g/l

1.10

811

Diabetes mellitus in pregnancy

263

1831

0.91

0.77

1.5

2.0

2.85

2.76

g/l

0.91

248

1744

Supervision of high-risk pregnancy

208

1125

1.11

0.77

1.8

1.9

2.70

2.82

g/l

1.23

197

1070

Pedal cyclist injured in transport accident

371

3442

1.08

0.76

2.1

2.3

2.79

2.90

g/l

1.55

336

3179

Infliximab

149

1.42

0.76

1.2

1.8

3.08

2.89

g/l

0.38

143

Other osteochondropathies

817

1.17

0.76

2.6

2.3

2.95

g/l

0.01

758

Anomalies of pupillary function

236

1.33

0.75

2.7

2.3

2.68

2.95

g/l

1.13

221

Exposure to other specified electric current

208

0.67

0.74

2.3

2.1

2.59

2.93

g/l

1.22

197

Mental retardation, excluding more controls

287

1.28

0.74

1.8

2.5

2.87

2.96

g/l

0.27

264

Malignant neoplasm of nasopharynx

1.85

0.74

1.0

1.3

2.93

2.94

g/l

—

Divergent concomitant strabismus

106

922

1.15

0.73

2.1

2.3

2.79

2.92

g/l

0.91

848

Other chromosome abnormalities, not elsewhere classified

2.03

0.73

1.2

2.9

2.64

2.89

g/l

—

Schizophrenia, schizotypal and delusional disorders

506

4756

1.07

0.73

2.0

2.2

2.96

2.88

g/l

1.06

453

4384

Hypertrophy of breast

249

2278

1.10

0.73

1.5

2.3

2.81

2.85

g/l

0.33

227

2095

Other corneal oedema

126

1.45

0.72

3.1

2.0

2.62

3.03

g/l

0.60

118

Other and unspecified disease of Bartholin gland

417

1.23

0.72

1.9

2.4

2.98

2.96

g/l

0.08

383

Gender identity disorders

1.59

0.71

1.0

2.0

2.86

2.95

g/l

—

Malignant neoplasm of breast, ER-negative, including Hilmo

375

3267

1.08

0.71

2.0

1.4

2.96

2.91

g/l

0.38

331

2870

Nontoxic diffuse goitre

473

1.21

0.70

3.1

2.4

3.02

2.96

g/l

0.18

426

Necrobiosis lipoidica, not elsewhere classified

1.63

0.69

3.5

2.3

2.75

3.02

g/l

0.43

Vascular dementia (undefined)

752

1.17

0.69

2.0

2.1

3.00

3.12

g/l

0.40

651

Complications following abortion and ectopic and molar pregnancy

520

1.20

0.69

1.5

2.7

2.69

2.92

g/l

1.18

477

Oral leukoplakia, including avohilmo

402

1.23

0.68

1.6

2.4

2.95

2.97

g/l

0.05

371

Other congenital malformations of respiratory system

1.85

0.67

1.0

1.5

3.86

2.85

g/l

—

Whooping cough

1.65

0.67

1.0

3.5

3.06

2.84

g/l

—

Wilms' tumor, including Hilmo

1.57

0.67

1.0

1.3

3.55

2.91

g/l

0.79

Retained placenta and membranes, without haemorrhage

137

1533

0.89

0.67

2.7

2.2

2.74

2.86

g/l

0.87

129

1416

Caught, crushed, jammed or pinched in or between objects

586

1.18

0.66

1.5

2.5

2.69

2.92

g/l

1.49

549

Typhoid and paratyphoid fevers, including avohilmo

1.60

0.66

1.3

1.4

3.31

3.06

g/l

0.19

Benign neoplasm of ovary

306

2841

1.08

0.66

2.3

2.4

2.97

2.92

g/l

0.39

281

2541

Glaucoma

1352

11083

1.04

0.65

2.3

2.4

2.85

2.93

g/l

2.21

1198

9953

Erosion and ectropion of cervix uteri

432

1.21

0.65

3.3

2.3

3.01

3.04

g/l

0.07

389

Acute poliomyelitis, including avohilmo

177

0.67

0.64

1.6

2.2

3.39

3.02

g/l

0.35

161

Pedestrian injured in collision with car, pick-up truck or van

305

1.26

0.64

1.3

2.3

3.05

3.01

g/l

0.07

280

Tetralogy of Fallot, a congenital heart defect.

1.75

0.64

1.6

2.4

3.08

3.04

g/l

—

Von Willebrand disease

129

1.41

0.64

2.5

2.2

2.79

3.00

g/l

0.81

122

Dementia due to Parkinson's disease

480

0.80

0.64

1.3

2.4

3.14

3.04

g/l

0.19

428

Congenital malformations of eye, ear, face and neck

626

1.17

0.63

3.4

2.2

2.67

2.94

g/l

2.36

579

Aggressive periodontitis

306

1.25

0.63

2.2

2.5

3.08

2.98

g/l

0.26

284

Acute poliomyelitis

176

0.67

0.63

1.6

2.2

3.39

3.02

g/l

0.35

160

Valgus deformity, not elsewhere classified

1.57

0.63

1.1

1.9

2.87

2.86

g/l

0.02

Burn and corrosion of trunk

370

1.22

0.62

1.3

2.7

3.06

2.97

g/l

0.25

345

Communicating hydrocephalus

307

1.25

0.62

1.5

2.8

3.14

3.03

g/l

0.21

279

Primary amenorrhea

1.68

0.61

2.0

1.5

3.12

2.81

g/l

—

Malignant neoplasm of nasopharynx, including Hilmo

1.60

0.61

1.0

1.3

2.80

2.91

g/l

—

L01XE Protein kinase inhibitors

102

901

1.14

0.61

3.1

2.7

3.27

2.95

g/l

1.84

828

Postpartum haemorrhage due to retained placenta

973

0.87

0.60

2.0

1.9

2.66

2.72

g/l

0.32

927

Embolic stroke

788

1.15

0.60

2.0

2.5

3.13

3.02

g/l

0.43

712

Benign neoplasm: Skin of other and unspecified parts of face

200

1834

1.09

0.60

3.7

2.4

2.68

2.94

g/l

3.09

174

1661

Burns and corrosions confined to eye and internal organs

290

1.25

0.60

2.1

2.3

2.90

g/l

0.00

275

Pregnancy hypertension

553

4695

1.05

0.58

2.5

2.2

2.82

2.83

g/l

0.12

521

4317

Poor fetal growth

856

1.14

0.58

1.7

1.9

2.73

2.77

g/l

0.18

815

Motor disorders

1.71

0.57

1.0

2.2

2.65

3.07

g/l

—

Circumscribed brain atrophy

347

1.22

0.57

1.8

2.7

2.95

3.04

g/l

0.22

314

Other menopausal disorders

465

2452

1.06

0.55

2.4

2.3

2.74

2.99

g/l

8.48

431

2225

Toxic effects of substances chiefly nonmedicinal as to source

139

1532

0.90

0.55

1.6

2.4

2.75

2.91

g/l

1.36

127

1420

Lesion of sciatic nerve

707

0.86

0.54

1.3

2.5

2.71

3.01

g/l

1.71

623

Lesion of plantar nerve

105

938

1.12

0.54

2.3

2.4

2.63

2.95

g/l

2.97

845

Malignant neoplasm of pancreas, including Hilmo

132

1457

0.90

0.54

2.1

1.4

3.11

2.89

g/l

1.87

119

1291

Acute and transient psychotic disorders

164

1500

1.10

0.54

2.2

2.4

2.98

2.90

g/l

0.60

146

1395

Ethmoidectomy

205

1895

1.08

0.53

2.8

2.4

2.69

2.90

g/l

2.41

189

1758

Use of dimethyl fumarate

1.44

0.52

1.0

2.5

2.50

2.71

g/l

—

Sequelae of infectious and parasitic diseases

113

1016

1.12

0.52

2.8

2.2

2.95

g/l

0.01

104

924

Other and unspecified injuries of abdomen, lower back and pelvis

170

1.30

0.52

2.0

2.2

3.42

2.95

g/l

0.60

157

Other congenital malformations of limb(s)

1.51

0.52

1.0

2.0

3.38

2.82

g/l

—

Malignant neoplasm of nasal cavity and middle ear

1.52

0.51

5.5

1.3

2.54

2.88

g/l

—

Other benign neoplasms of uterus

105

944

1.12

0.50

3.2

2.3

2.89

3.03

g/l

0.52

822

Other benign neoplasm of uterus: Other parts/unspecified

736

1.14

0.50

3.0

2.3

2.97

3.08

g/l

0.34

631

Fistulae involving female genital tract

234

1.25

0.50

2.2

2.3

3.37

3.01

g/l

0.63

211

Prolapse and hernia of ovary and fallopian tube

635

1.14

0.50

1.8

2.2

2.93

3.17

g/l

1.63

534

L02BB Anti-androgens

175

1896

0.92

0.50

2.0

2.4

3.06

2.89

g/l

1.34

155

1692

Hypermetropia

101

905

1.12

0.50

2.3

2.87

2.94

g/l

0.28

831

Anisometropia and aniseikonia

409

1.18

0.49

2.8

2.5

2.81

2.96

g/l

0.54

375

Malignant neoplasm of palate

1.52

0.49

2.4

1.1

2.90

2.87

g/l

—

Unspecified jaundice

757

1.13

0.48

1.6

2.5

3.15

3.00

g/l

0.65

684

Morphin

318

1.20

0.47

1.8

1.7

2.94

2.99

g/l

0.15

282

Infections of genitourinary tract in pregnancy

100

1109

0.90

0.47

2.5

2.3

2.89

2.90

g/l

0.05

1021

ILD medications: nintedanib

0.59

0.47

1.0

1.6

2.72

2.90

g/l

—

Benign neoplasm: Short bones of lower limb

117

0.68

0.46

1.5

2.6

2.61

2.99

g/l

—

111

Benign leiomyoma with endometriosis

282

2657

1.06

0.46

2.2

2.4

2.85

2.93

g/l

0.68

248

2384

Injury of muscle and tendon at wrist and hand level

224

2095

1.07

0.45

2.0

2.4

2.91

g/l

0.02

212

1933

Abnormalities of forces of labour

110

998

1.10

0.45

1.7

2.1

2.65

2.82

g/l

1.58

104

956

Hydatidiform mole

141

0.70

0.45

6.5

2.1

2.41

2.92

g/l

—

134

L02BA Anti-estrogens

287

2707

1.06

0.45

1.9

2.3

3.05

2.89

g/l

1.76

252

2447

Cervical polyps

155

1431

1.09

0.44

2.2

2.3

2.81

2.98

g/l

1.45

147

1289

Endometriosis of intestine

113

1.33

0.43

1.0

2.7

2.75

2.91

g/l

0.32

107

Otosclerosis

131

1204

1.09

0.43

2.0

2.6

2.85

2.90

g/l

0.20

116

1100

Other specified and unspecified strabismus

122

1.32

0.43

1.9

2.4

2.71

2.90

g/l

0.25

112

Use of rasagiline

425

1.16

0.42

1.5

2.9

2.83

2.98

g/l

0.55

385

Myiasis, including avohilmo

0.00

0.42

0.0

3.7

—

2.91

—

Degenerative diseases of the nervous system

889

6592

0.97

0.41

2.0

2.4

2.97

2.95

g/l

0.15

746

5834

Infections of breast associated with childbirth

286

1.19

0.41

1.3

1.7

2.49

2.93

g/l

3.55

275

Other congenital musculoskeletal deformities, including avohilmo

0.00

0.41

0.0

1.0

—

2.71

—

Obstetric embolism

0.00

0.41

0.0

1.1

—

3.57

—

Disorder of visual pathways, unspecified

0.00

0.41

0.0

1.6

—

2.95

—

Need for immunization against certain single viral diseases

0.00

0.41

0.0

1.4

—

2.72

—

Pneumoconiosis due to dust containing silica

1.35

0.41

2.4

2.7

3.35

2.91

g/l

—

Benign neoplasm: Pineal gland

0.00

0.41

0.0

1.6

—

2.75

—

Other and unspecified heterotropia

1.49

0.41

1.8

1.1

3.08

2.90

g/l

—

Congenital malformations of breast, including avohilmo

132

1.29

0.40

1.0

2.1

2.86

2.91

g/l

0.12

127

Struck by thrown, projected or falling objec

597

1.13

0.40

1.5

2.6

2.65

2.91

g/l

1.64

560

Malignant neoplasm of other and ill-defined digestive organs

106

1.33

0.39

1.3

3.64

3.07

g/l

0.93

Mental and behavioural disorders due to use of volatile solvents

0.00

0.39

0.0

3.2

—

2.80

—

Myocardial infarction, unclassifiable

456

4243

0.96

0.39

1.8

2.3

3.05

2.95

g/l

1.16

405

3739

Cyst of Bartholin Gland

419

1.15

0.39

2.5

2.2

2.94

2.93

g/l

0.02

393

Sequelae of infectious and parasitic diseases, including avohilmo

114

1048

1.09

0.38

2.8

2.2

2.96

2.95

g/l

0.04

105

951

Pre-eclampsia superimposed on chronic hypertension

1.40

0.38

1.0

1.4

2.78

2.60

g/l

—

Mental retardation

323

1.17

0.38

1.8

2.1

2.87

2.96

g/l

0.25

303

Universal erythroderma, KELA reimbursement

179

1.24

0.38

1.5

2.4

2.72

3.07

g/l

1.51

165

Kela-code for severe mental illness

584

5638

1.04

0.37

2.0

2.3

2.94

2.87

g/l

0.97

532

5171

Carcinoma in situ of cervix uteri

896

1.10

0.37

2.0

2.1

2.83

2.87

g/l

0.11

840

Congenital malformations of breast

125

1.29

0.37

1.0

1.6

2.88

2.91

g/l

0.08

120

malignant neoplasm of female genital organs, including Hilmo

302

2739

1.05

0.37

2.3

1.4

3.15

2.92

g/l

2.91

270

2389

Malignant neoplasm of vulva, including Hilmo

189

1.23

0.36

2.6

1.5

3.12

2.97

g/l

0.19

164

Chronic suppurative otitis media, including avohilmo

117

1080

1.09

0.36

1.6

2.5

2.98

2.95

g/l

0.09

110

986

Crossbite

544

1.12

0.36

1.4

2.1

2.81

2.87

g/l

0.17

520

Benign neoplasm: Short bones of upper limb

189

1.23

0.36

1.7

2.2

2.60

2.99

g/l

1.32

178

Malignant neoplasm of rectum, including Hilmo

220

2078

1.06

0.36

2.8

1.4

2.94

2.90

g/l

0.32

196

1841

Chronic myringitis

0.62

0.36

3.6

2.0

2.04

2.92

g/l

—

Non-small cell lung cancer, adenocarcinoma, helper endpoint

135

1256

1.08

0.35

1.9

2.5

3.39

2.97

g/l

4.80

122

1136

Antenatal screening

225

1188

1.06

0.35

2.1

1.9

2.82

2.84

g/l

0.11

220

1132

Endometriosis ASRM stages 3,4

344

3291

1.05

0.35

1.7

2.2

2.72

2.89

g/l

3.29

306

2974

Mandibular prognathia

123

0.73

0.35

1.2

2.1

2.59

2.95

g/l

—

117

Use of ropinirole

575

1.12

0.35

2.1

2.9

2.90

2.97

g/l

0.18

526

Motorcycle rider injured in noncollision transport accidents

264

1.18

0.35

1.7

2.1

2.56

2.89

g/l

1.54

251

Non-allergic asthma

132

1227

1.08

0.35

2.2

2.5

3.08

2.93

g/l

1.01

122

1121

Premature separation of placenta [abruptio placentae]

189

0.79

0.34

1.4

2.1

2.93

2.85

g/l

0.10

182

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

978

7787

0.97

0.34

2.3

2.84

2.86

g/l

0.27

903

7118

Postpartum care and examination

655

0.92

0.33

1.8

1.6

2.49

2.83

g/l

3.06

621

Benign neoplasm of other and unspecified female genital organs

644

0.90

0.32

1.9

2.5

2.57

2.95

g/l

2.00

583

Mental retardation, wide definition

357

1.14

0.32

1.7

2.2

2.80

2.97

g/l

0.63

334

Superficial injuries involving multiple body regions

314

1.15

0.31

3.3

2.3

2.97

2.93

g/l

0.09

294

Malignant neoplasm of eye, brain and central nervous system

551

1.11

0.31

1.6

1.4

2.91

2.88

g/l

0.07

493

Malignant neoplasm of breast, HER-negative

339

3126

1.04

0.31

2.0

1.4

2.98

2.91

g/l

0.56

297

2737

Malignant neoplasm of other endocrine glands and related structures, including Hilmo

1.31

0.31

3.6

1.2

2.59

2.93

g/l

—

Contact with other specified venomous animals

1.30

0.30

1.1

2.7

2.33

3.02

g/l

3.22

Stenosis and insufficiency of lacrimal passages

166

1568

1.06

0.30

2.3

2.5

2.71

2.95

g/l

2.76

144

1415

Maltreatment syndromes

429

1.12

0.30

2.3

2.0

2.85

2.84

g/l

0.04

408

Persistent delusional disorders

106

1138

0.93

0.29

2.2

2.4

3.05

2.93

g/l

0.60

1032

Respiratory tuberculosis

881

1.08

0.29

2.0

2.5

2.97

3.00

g/l

0.09

783

Respiratory tuberculosis, confirmed and not-confirmed

881

1.08

0.29

2.0

2.5

2.97

3.00

g/l

0.09

783

Dementia due to Parkinsons disease, excluding more controls

345

1.14

0.29

1.3

2.7

3.14

3.08

g/l

0.10

310

Malignant neoplasm of rectosigmoid junction, including Hilmo

421

1.12

0.29

2.7

1.4

3.25

3.00

g/l

0.76

373

Primary angle-closure glaucoma

763

0.91

0.28

2.5

2.6

2.87

2.98

g/l

0.40

679

Drug-induced tremor

1.29

0.28

1.3

2.4

3.06

3.01

g/l

0.08

malignant neoplasm of female genital organs

245

2503

0.96

0.28

2.1

1.4

3.10

2.92

g/l

1.55

219

2178

L02BX Other hormone antagonists and related agents

106

1133

0.93

0.27

1.8

2.6

3.36

2.89

g/l

3.38

1031

Suppurative otitis media, unspecified

279

0.86

0.27

1.6

2.2

3.02

3.01

g/l

0.01

253

Other bursal cyst

196

1.18

0.27

2.3

2.1

2.50

3.00

g/l

3.12

180

Open bite that required surgery (Lefort1 or BSSO)

1.24

0.27

1.0

1.8

2.15

2.94

g/l

—

Prophylactic surgery

1.22

0.27

5.4

1.3

2.56

2.94

g/l

—

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

639

5396

1.03

0.26

2.4

2.2

2.84

g/l

0.06

602

4936

Primary open-angle glaucoma

722

7111

0.98

0.26

2.3

2.4

2.82

2.95

g/l

3.03

630

6289

Normotensive glaucoma

184

1754

1.05

0.26

2.1

2.5

2.74

2.96

g/l

2.59

163

1571

Alzheimer’s disease (Late onset)

566

4782

0.97

0.25

2.0

2.3

3.00

2.98

g/l

0.24

470

4180

Neuroendocrine tumor and carcinoma of stomach

1.23

0.25

2.1

1.2

3.62

3.00

g/l

—

Cervical root disorders

1.21

0.25

1.0

1.9

2.47

3.09

g/l

—

Other noninflammatory disorders of cervix uteri

763

1.08

0.25

2.8

2.4

2.92

3.03

g/l

0.42

679

Alcoholic cardiomyopathy

1.30

0.24

1.3

2.7

3.00

3.01

g/l

—

Malignant neoplasm of adrenal gland, including Hilmo

1.17

0.24

1.6

1.2

3.07

2.88

g/l

—

Coarctation of the aorta

1.17

0.24

8.6

1.9

2.80

2.90

g/l

—

Dementia

1123

7538

1.02

0.24

2.1

2.5

2.88

2.95

g/l

1.26

934

6735

FESS (DNB20)

190

1818

1.05

0.23

2.5

2.4

2.65

2.90

g/l

3.25

174

1686

Acquired stenosis of external ear canal

143

1.20

0.23

1.6

1.8

3.08

3.03

g/l

0.06

132

Abnormal findings in bronchial washings nasal secretions pleural fluid sputum throat scrapings

1.33

0.23

1.0

1.6

2.52

3.10

g/l

—

Use of levodopa decarbox-comt-inhibitor

567

0.91

0.23

1.1

2.8

2.96

2.99

g/l

0.09

514

Any dementia

1019

6916

1.02

0.23

2.2

2.4

2.93

2.96

g/l

0.26

855

6138

Family history of malignant neoplasm

149

1419

1.05

0.22

3.1

2.2

2.87

g/l

0.01

140

1301

Viral infections of central nervous system, not elsewhere classified/unspecified

125

1.21

0.22

1.6

2.4

2.72

2.96

g/l

0.56

117

Neurological devices associated with adverse incidents

0.00

0.22

0.0

1.0

—

3.27

—

Fitting and adjustment of external prosthetic device

1.23

0.22

1.6

1.3

3.62

2.85

g/l

—

Plasmodium vivax malaria

0.00

0.22

0.0

1.1

—

2.99

—

Plasmodium vivax malaria, including avohilmo

0.00

0.22

0.0

1.1

—

2.99

—

Dental pulpitis, including avohilmo

1704

10758

1.01

0.22

2.1

2.4

2.77

2.87

g/l

4.25

1595

9926

Myiasis

0.00

0.22

0.0

5.0

—

3.04

—

Glanders and melioidosis

0.00

0.22

0.0

1.0

—

3.06

—

Glanders and melioidosis, including avohilmo

0.00

0.22

0.0

1.0

—

3.06

—

Melanoma in situ of eyelid, including canthus

0.00

0.21

0.0

4.7

—

2.98

—

Premenstrual syndrome

107

1.22

0.21

1.2

2.4

2.56

2.92

g/l

0.96

102

Underdevelopment of the second kidney

0.00

0.21

0.0

4.8

—

3.11

—

Carcinoma in situ of breast, intraductal

149

1422

1.05

0.21

2.4

2.3

2.94

2.88

g/l

0.24

127

1291

Congenital heart conduction disorder

0.00

0.21

0.0

1.0

—

3.24

—

Supernumerary ureter

0.00

0.21

0.0

1.0

—

3.12

—

Pinta [carate], including avohilmo

0.00

0.21

0.0

1.0

—

3.02

—

Serous carcinoma of ovary

101

0.79

0.21

2.0

1.5

3.21

3.03

g/l

—

Complications of anaesthesia during pregnancy

0.00

0.21

0.0

1.1

—

2.83

—

Ascariasis, including avohilmo

0.00

0.21

0.0

1.3

—

3.19

—

Other congenital musculoskeletal deformities

0.00

0.21

0.0

1.0

—

2.93

—

Kela-code for behavioural disturbances in mental retardation

103

0.77

0.21

1.6

2.0

2.39

3.03

g/l

—

Trisomy 21 (Down syndrome) due to meiotic nondisjunction

0.00

0.21

0.0

1.0

—

3.14

—

Glaucoma secondary to eye trauma

1.25

0.21

1.5

2.4

3.94

3.08

g/l

0.77

Inflammatory disease of cervix uteri

102

964

1.06

0.21

1.4

2.4

2.67

2.94

g/l

2.25

873

Exposure to electric transmission lines

0.00

0.21

0.0

4.6

—

3.05

—

Birth injury to peripheral nervous system

0.00

0.21

0.0

4.5

—

2.81

—

Pedal cyclist injured in other and unspecified transport accidents

167

1600

1.05

0.21

2.2

2.3

2.83

2.93

g/l

0.60

151

1476

Constitutional tall stature

0.00

0.21

0.0

1.0

—

3.08

—

Medical treatment for female infertility

166

1716

0.96

0.20

1.8

1.9

2.74

2.75

g/l

0.06

157

1634

Foreign body on external eye

220

2121

1.04

0.20

2.5

2.3

2.63

2.88

g/l

3.83

202

1985

Other congenital malformations of spinal cord

0.00

0.20

0.0

1.1

—

2.96

—

Unicornuate uterus

0.00

0.20

0.0

1.1

—

2.89

—

Other obstructed labour

870

0.94

0.19

1.9

2.3

2.81

2.87

g/l

0.21

819

Malignant neoplasm of penis

1.16

0.19

4.0

1.3

3.42

2.86

g/l

—

Alzheimer’s disease (Atypical or mixed), excluding more controls

178

1278

1.04

0.19

2.0

2.4

2.86

3.12

g/l

2.36

148

1123

Hydrocephalus

126

1319

0.95

0.19

2.3

2.6

2.94

3.00

g/l

0.25

106

1179

Female genital prolapse

488

2651

1.02

0.18

2.2

2.3

2.83

3.02

g/l

3.76

439

2374

Disorders of acoustic nerve

415

1.09

0.18

3.2

2.5

2.94

3.05

g/l

0.32

379

Malignant neoplasm of accessory sinuses, including Hilmo

1.22

0.18

5.0

1.3

3.47

2.89

g/l

—

Endometriosis of rectovaginal septum and vagina

114

1088

1.05

0.18

1.6

2.3

2.60

3.02

g/l

5.47

101

981

Puerperal sepsis

185

1785

1.04

0.18

2.4

2.3

2.83

2.86

g/l

0.17

175

1651

Malignant neoplasm of corpus uteri, including Hilmo

157

1510

1.04

0.18

1.6

1.4

3.18

2.92

g/l

1.90

136

1314

Subarachnoid haemorrhage

187

1805

1.04

0.18

2.0

2.4

2.93

2.94

g/l

0.04

160

1633

Carcinoma in situ of middle ear and respiratory system

0.72

0.17

2.8

2.0

2.76

3.03

g/l

—

Benign neoplasm: Bronchus and lung

194

0.87

0.17

1.6

2.2

3.13

3.02

g/l

0.17

180

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS